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SUMMARY
The ‘'Streptococcus miller! group" (SMG) are part of the 
commensal flora, inhabiting the mouth, respiratory and 
gastrointestinal tracts. They are now recognised as 
significant pathogens with a proclivity for pyogenic 
infections such as dental, liver and brain abscesses, as 
well as being involved in endocarditis and other
diseases. Much confusion had surrounded the nomenclature 
and taxonomy of the group until recently, when three
distinct species s. anglnosus, s. constellatus and 5. jntermedi us
were identified. This led to greater characterisation of 
the group, but its pathogenicity is less well understood. 
The aim of the work in this thesis was therefore to
examine some of the factors of the SMG which contribute 
to causation of infection.
A group of strains for analysis were collected by 
isolating organisms from dental abscesses, clinical 
infections of non-oral source and dental plague. These 
represented the three species and were tested for 
Lancefield grouping, haemolysin, hyaluronidase and DNase 
production and ability to agglutinate red blood cells. 
The majority of strains were Lancefield non-groupable, 
but where a grouping could be determined, group F 
predominated. Toxin and enzyme activity varied and could 
not be attributed to species or isolate type, and no 
strains agglutinated RBCs. Therefore, a heterogenous
XXV
group of isolates was collected for further
i nvest i gat i on.
Encapsulation had been suggested as a virulence factor 
for the SMG by previous investigators (Brook and Walker 
1985 : Lewis et al 1988), although the mechanism was 
unclear. Therefore, the capsule of the SMG was
investigated by negative staining and electron
microscopy. All but one strain were encapsulated with 
small and large capsule types revealed by both methods. 
Hyaluronic acid was shown to be a component of the 
capsule as treatment with hyaluronidase removed capsule 
to varying degrees. Bacterial cell surface
hydrophobicity was measured using two methods, with 
results of each showing good correlation. Strains 
exhibited both hydrophobic and hydrophilic 
characteristics, with possession of capsule or species 
and isolate type having no bearing on this property.
Willcox and Knox (1990) found that dental abscess
isolates adhered to BEC to a greater extent than other 
SMG organisms, and this was investigated. This was 
indeed found to be true, with dental abscess isolates 
adhering more readily than both clinical and plaque 
isolates. It was found that capsule hindered the 
adherence of the SMG to BEC, as treatment of strains with 
hyaluronidase caused increased adherence. Cell surface 
hydrophobicity had no effect on ability to adhere to BEC.
sxvx
It was suggested that the capsule masked specific 
adhesins on the SMG surface which adhered to receptors on 
the BEC.
The opsonic requirements of the SMG were investigated as 
was their ability to elicit a chemiluminescent response 
from PMNL. Opsonization was found to increase 
chemiluminescence, with serum concentrations of 15% or 
more proving optimum. A range of chemiluminescence 
values were obtained, but these could not be related to 
either species or isolate type. In addition, capsule and 
cell surface hydrophobicity played no part in either 
opsonization or chemiluminescence.
In addition, phagocytosis of the SMG was further studied 
to determine if they were able to resist ingestion. 
Capsule was found to be antiphagocytic,strains with large 
capsules being ingested less readily than those with 
small capsules. This property was confirmed, as 
treatment with hyaluronidase to remove capsule resulted 
in increased ingestion efficacy. Again no relevance 
could be attributed to either isolate type or species in 
the level of Ingestion produced, and cell surface 
hydrophobicity again appeared to play no role.
Therefore the aims of the work were achieved, with a 
greater understanding of some of the pathogenicity 
factors of the SMG having been obtained. However, these
x x v i i
are still only a small part of the whole picture as to 
why the SMG frequently cause purulent infection, either 
as the sole infecting organism or within a mixed 
infection, and much further work is required. It is 
hoped that an increased understanding of the group will 
in turn lead to better disease management of patients 
infected with this clinically significant group of 
bacteria.
x x v i i i
CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW
1.1 GENERAL INTRODUCTION
Organisms of the "streptococcus miiieri group" (SMG) are part 
of the commensal flora of the mouth, nasopharynx, 
gastrointestinal and urogenital tracts of man. They have 
been shown to cause serious pyogenic infections such as 
brain, liver, lung and dental abscesses as well as having 
a role in other infections such as endocarditis. 
Although the fact that the SMG cause a series of 
infections is well documented, the virulence factors of 
the group are less well studied. The purpose of this 
work was to examine a range of factors which may aid in 
the ability of the SMG to colonise and damage host 
tissues and to evade the host's defence mechanisms,
A review of the current information on the SMG relating 
to taxonomy, infections, therapy and pathogenesis will 
serve as an introduction to the practical work.
1.2 CHARACTERISATION OF THE SMG
1.2.1 TAXONOMY OF THE STREPTOCOCCUS MILLERI GROUP
The name streptococcus miiieri is not included in the 
Approved List of Bacterial Names (Skerman et al 1980) and 
there has been much confusion and debate over the 
nomenclature and taxonomy of organisms of the 
Streptococcus miiieri group (SMG). There have been a 
multitude of names used to describe such organisms, the 
first reference being by Andrews and Border (1906) who 
described s.anginosus as a variant of s.pyogenes associated 
with sore throats. The original isolates are no longer 
available for comparison with the type strain (Hardie 
1984). The terms intermedins and constellatus have been 
used since the 1920‘s by many authors to describe 
viridans streptococci isolated anaerobically (Facklam and 
Carey 1985) . The SMG have also frequently been described 
as minute haemolytic streptococci, as first described by 
Long and Bliss (1934). Streptococcus MG was used by 
Mirick et al (1944) to describe a non-haemolytic organism 
isolated from the respiratory tract of humans. The title 
Streptococcus miiieri was introduced by Guthoff (1956) to 
describe a group of non-haemolytic streptococci isolated 
from dental abscesses. Finally the names s. anginosus- 
constellatus and s.MG-intermedius have also been used (Facklam 
1977).
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Such disarray within the classification of the SMG was 
addressed in a series of studies by Coleman and Williams 
as summarized in 1972. Within the s.miiieri cluster were 
included the following; s.miiieri (Guthoff), Streptococcus 
MG (Mirick), all group F strains of streptococci, certain 
non-haemolytic streptococci of groups A,C and G, strains 
possessing an Ottens and Winkler typing antigen but no 
Lancefield group, minute haemolytic streptococci (Long 
and Bliss 1934). This clarified the situation, but the 
schene was not universally accepted, particularly in the 
USA.
Facklam (1977) found similarities between Streptococcus- 
MG and S.intermedius, and s.constellatus and S.anginosus, and 
also considerable physiological and serological 
similarity between these two clusters. He therefore 
divided them for epidemiological purposes into three 
types: s.MG-intermedius (non-# haemolytic, lactose
fermenter), s.anginosus-consteiiatus (non-# haemolytic, 
lactose nonfermenter) and s.anginosus ( # haemolytic). Thus 
a universally accepted taxonomy for s.miiieri was not 
apparent. Facklam (1984) illustrated the differences 
between American and British taxonomic schemes and 
changed S.anginosus-constellatus to S. constellatus with S.MG- 
intermedius becoming s.intermedius and s.anginosus remaining 
unchanged.
Several workers have further pursued this question, 
attempting to find additional or alternative means by 
which to clarify SMG taxonomy. Workers have disagreed on 
the homogeneity of the SMG, some finding it to be 
homogeneous in phenotypic tests (Lutticken et al 1978; 
French et al 1989) and DNA-DNA hybridisation (Ezaki et al 
1986 ; Coykendall et al 1987). Others have reported 
heterogeneity. Aluyi and Drucker (1983) found variation 
in whole cell trimethy1silyl-sugar profiles of 39 strains 
of s.miiieri from various body sites. Cookson et al 
(1989) performed qualitative and quantitative analysis of 
the cellular fatty acids of 21 strains finding no 
qualitative difference, but quantitative data analysis 
revealed three groups. s.anginosus and s. constellatus were 
indistinguishable but separate from the other two groups, 
these being s.intermedius with a wide fermentation pattern 
and S.intermedius with a narrow fermentation pattern. 
Yakushiji et al (1988) found serological variation in 71 
oral isolates of s.miiieri, obtaining 10 serotypes (a-j) 
on the basis of cell-surface carbohydrate antigens, with 
only 4 strains untypable. Drucker and Lee (1983) 
calculated DNA base pair ratios (mol % guanine+cytosine) 
for 18 strains of s.miiieri and found values ranging from 
36.6-42% G+C, indicating genetic heterogeneity.
Whiley and collaborators have undertaken a series of 
studies in an attempt to clarify the position of
heterogeneity within SMG. Whiley et al (1981) found 
heterogeneity after SDS-polyacrylamide gel 
electrophoresis of 23 strains of s.miJJeri. DNA-DNA 
hybridisation studies by Whiley and Hardie (1989) 
revealed 4 homology groups from 25 strains. Groups 1-3 
corresponded to s. constellatus, S.anginosus and s. intermedius, 
with group 4 being named s.parasanguis^ SDS-PAGE analysis 
of these strains confirmed the identification of 3 
distinct groupings within the SMG. This led in 1990 to 
development of a scheme for phenotypic differentiation of 
the 3 DNA homology groups by enzymic action on 
fluorogenic compounds, which allowed a collection of 157 
strains to be identified (Whiley et al 1990). The 
culmination of this work saw Whiley and Beighton (1991) 
publishing amended descriptions recognising s.anginosus, 
S. constellatus and S.intermedius as distinct species.
Winstanley et al (1992) used a combination of 
conventional biochemical tests and pyrolysis mass 
spectrometry, after a similar combination had proved 
successful in identifying coryneform bacteria (Hindmarch 
et al 1990). This work found 5 clearly distinct groups, 
three corresponding to the DNA homology groups suggested 
by Whiley and Hardie (1989) representing s.anginosus, 
s. constellatus and s.intermedius, with group 4 containing 3 
Lancefield group C # haemolytic strains, and group 5 
possibly representing a second biotype of s.anginosus^
This wealth of evidence supporting 3 groupings within the 
SMG has led to the general acceptance of three species, 
S.anginosus, S. constellatus and S.intermedius, ending the 
controversy over taxonomy of the group which has hindered 
the study of pathogenicity.
1.2.2 ASSOCIATION OF SMG WITH INFECTION AND BODY SITE
Acceptance of the existence of three species within the 
SMG gave rise to two areas of investigation, the first 
being assessment of the available test systems for 
identifying these species , and secondly, as a result of 
the three species identification, the relation of these 
to specific sites of isolation or infections. Ahmet, 
Warren and Houang (1995) compared the commercially 
available Rapid ID 32 Strep test with the fluorogenic 
identification system of Whiley et al (1990) and found 
them to yield similar identifications. Flynn and Rouff 
(1995) found an 88%-98% agreement in identification 
between traditional tests and the FTou-card Miiieri 
system. Further to the development of the fluorogenic 
system of Whiley et ai (1990), where discrimination 
between s.anginosus and s. constellatus was problematic, 
Whiley et al (1995) examined the 168-238 rRNA intergenic 
spacer region of the genome of SMG strains. This has 
been suggested as being useful in determining 
phylogenetic relationships between bacteria, aiding
strain identification (Greisen et al 1994), This readily 
distinguished between s.anginosus and s, constellatus, 
although s.intermedius and S.anginosus Were not reliably 
distinguished by this method. Jacobs et al (1996) found 
42 of 399 Streptococcus miiieri" Strains reacted with the 
16S rRNA gene sequence of both s. constellatus and 
S.intermedius probes and classified this as a distinct type 
within the group. This supports the suggestion by Jacobs 
(1997) that although the phylogenetic validity of the 
current taxonomy has been confirmed there is likely to be 
further investigation. The ability to accurately
identify three species of SMG has led to greater 
understanding of species distribution and production of 
clinical conditions, Whiley et al (1992) found
S.intermedius to foe associated with brain and liver 
abscesses, possibly due to possession of a range of 
tissue degrading enzymes. s.anginosus, which are of two 
biotypes, were isolates from the gastrointestinal and 
urogenital tracts (broad fermentation pattern) and 
oropharyngeal infections, with s. constellatus mostly 
associated with dental abscesses, Gomez-Garces, Alos and 
Cogollos (1994) found that s.anginosus predominated in 
abdominal areas, while s.intermedius was isolated mainly 
from hepatic abscesses. Jacobs et al (1995) found 
S.anginosus to be recovered more often from the genito­
urinary tract and s. constellatus from the thorax. 
s. intermedius was mostly found in the head and neck area.
but was also isolated from the abdomen, skin,bones and 
soft tissue.
1.2.3 BACTERIOLOGICAL CHARACTERISTICS
The SMG are commensals commonly isolated from the mouth, 
oropharynx, gastrointestinal tract and vagina, and are 
responsible for a variety of infections. They form 
minute colonies ( less than 0.5 ram diameter), may require 
CO2 for isolation (Kambal 1987) and have a distinct 
caramel odour (diacetyl), which has been suggested as a 
presumptive identification method (Chew and Smith 1992), 
when cultured on agar plates. Gram staining reveals 
spherical cells forming chains or pairs.
They are a heterogeneous group exhibiting various 
haemolytic, Lancefield and biochemical reactions, Kambal 
(1987) found 54% non haemolytic, 29% beta haemolytic and 
17% alpha haemolytic s.miiieri among 80 strains, while 
Jacobs et al (1995) found one third of 518 SMG isolates 
to be # haemolytic. Lancefield serological reactions are 
of little use in identifying the SMG, as a variety of 
antigens can be expressed, mainly groups A, C, F and G. 
Whiley et al (1990) found that in strains of s. constellatus 
and S.anginosus belonging to Lancef ield group F, the former 
were nearly all beta haemolytic and the latter were all 
non haemolytic. Similarly Jacobs et al (1995) found that
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the majority of s.anginosus strains were non haemolytic and 
carried Lancefield group F or were nongroupable, while 
most of the s.constellatus isolates were # haemolytic, 
along with 16.6% of s.intermedius strains.
1.3 THE STREPTOCOCCUS MILLERI GROUP AS PATHOGENS
1.3.1 CARIES
Unlike streptococcus mutans, Streptococcus miiieri is not 
recognised as a primary agent in production of dental 
caries, despite being reported in high numbers in deep 
areas of carious dentine by Edwardsson (1974), However, 
Poole and Wilson (1979) found s.miiieri in similar numbers 
on normal and carious teeth,though they probably sampled 
whole teeth, not specific lesions as described by 
Edwardsson (1974).
s.miiieri strains have been used in attempts to induce 
caries in gnotobiotic rats. The first published 
investigation showed an endocarditis strain of 
S.intermedius to cause more severe caries than s.mutans 6175 
(Rosen and Kolstad 1977). Other studies have similarly 
found organisms of the SMG to be cariogenic, but less 
severely than s.mutans, Drucker and Green (1978) showed 
four plaque isolates of s.miiieri to produce moderate (4-8
lesions) fissure caries in gnotobiotic rats, with two of 
these also causing moderate approximal carles. Two 
isolates from dental abscesses and another plaque isolate 
induced little or no caries (less than 4 lesions), A 
series of studies on the cariogenicity of SMG organisms 
have been reported by investigators from Aichi-Gakuin 
University in Japan. Yoshizaki (1983) and Hosoi (1985) 
both consider s. intermedius ATCC 27335 to cause caries in 
rats and hamsters, with Bessho (1985) showing that it was 
capable of producing lesions in extracted human teeth in 
v i tro • Caries produced in this fashion was shown to be 
less severe than that caused by s.mutans in the presence 
of sucrose, but significantly more severe than that found 
in uninoculated controls with an indigenous oral flora. 
Caries development was Independent of sucrose or any 
other carbohydrate, suggesting that SMG may be 
responsible for some sucrose-independent caries in 
humans. Horton et al (1985) found s.miiieri NCTC 11169 
produced fissure caries in gnotobiotic rats fed on diets 
high in sucrose, glucose and maize starch, with ranking 
of caries incidence in relation to diet in that order. 
Willcox, Drucker and Green (1987) found s. oralis and 
s.miiieri induced similar levels of caries in gnotobiotic 
rats fed a high sucrose diet. Willcox, Drucker and 
Hi 1 lier (1988) found that s.miiieri was less cariogenic 
than mut ans streptococci and s. salivarius but induced more 
fissure caries than s. sanguis, s.faecalis, s.mitis and
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s .iac tis . Some investigators have tried to assess the 
properties of SMG organisms which allow them to induce 
caries. Ogawa (1989) found that s.intermedius OE-1 
produced fissure caries (scored 22.3 using the Konig 
method), having chondroitinase activity and producing 
lactic acid as a metabolic end product. Kobayashi et al 
(1992) inoculated gnotobiotic rats fed on a diet 
containing 25% sucrose with a strain of s. intermedius and 
found the destruction of the dentine was similar to that 
caused by s.mutans. They suggested that this was due to 
proteolytic activity of the test strain rather than their 
acidogenic activity. Smalley et al (1994) investigated 
the mucin-sulphatase activity of oral streptococci, 
suggesting this activity may contribute to the 
destruction of salivary mucins and therefore may aid in 
the development of dental caries. However, little or no 
such activity was found in 4 strains of s. constellatus and 
3 s . anginosus strains tested.
1.3.2 PERIODONTAL DISEASE
A series of studies by Moore et al found SMG organisms 
isolated frequently in association with experimental 
gingivitis (1982a), severe periodontitis (1982b) and 
severe generalized periodontitis (1983). Further to this 
Moore et al (1983) suggested that s.anginosus may be
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implicated in a model of episodic destructive activity in 
periodontal disease, caused by periods of aggressive 
pyogenic activity. No pathological significance could be 
attributed to s.miiieri by Crawford and Russell (1983) who 
found no significant differences in numbers of viridans 
streptococci isolated from healthy sites,or from cases of 
gingivitis, early or moderate periodontitis, or severe 
periodontitis.
Haffajee et al (1985) examined the f1ora of periodontal 
pockets of 16 people undergoing surgical and antibiotic 
treatment for periodontal disease. In the group showing 
poor response to treatment there were significantly 
elevated proportions of s. intermedius as well as f. nucieatum 
and p.micros. Topoll, Lange and Muller (1990)found that 
patients with advanced periodontal disease, in whom 
s. intermedius was a prevalent isolate from subgingival 
plaque samples, developed multiple periodontal abscesses 
after taking a course of broad spectrum antibiotics. 
They suggested that with advanced periodontal disease, 
systemic antibiotic therapy without subgingival 
debridement may change the composition of the subgingival 
microbiota, favouring the development of multiple 
abscesses. Socransky et al ( 1991 ) found 25% of 2299 
sites sampled to be colonised with s.intermedius amongst 13 
other organisms, while Haffajee et al (1992) found 
s. intermedius in 80% of the same 90 subjects. Magnus son
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and Walker (1996) reported on refractory periodontal 
disease, which is characterised by low plaque scores and 
low responsiveness to periodontal therapy. They stated 
that in this case the subgingival microflora can be 
either predominantly Gram positive with elevated levels 
of s. intermedius or Gram negative, containing classical 
periodontal pathogens.
Periodontal disease has also been implicated as a 
predisposing factor for other SMG infections. 
Christiansen et al (1993) reported a septic pulmonary 
embolism where s. intermedius was isolated from the pus. 
The only predisposing factor was toothache and 
periodontal disease, and the authors suggested the 
gingiva as the source of s.intermedius, leading to 
bacteraemia, seeding of the lungs and abscess formation. 
This is supported by Wong, Donald and MacFarlane (1995) 
who found predisposing factors, including periodontal 
disease, in 80% of 25 cases of pulmonary disease.
1.3.3 ODONTOGENIC ABSCESSES
Originally s.miiieri was described by Guthof ( 1956) as an 
organism isolated from dental abscesses, illustrating its 
association with purulent lesions. This has been 
confirmed by more recent studies, with s.miiieri being 
frequently isolated from dental abscesses, often in pure 
culture ( Sabiston et al 1976; Bartlett and O 'Keefe 1979;
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Aderhold et al 1981 ) . A recent study by Lewis et al 
(1986) to quantify bacteria in pus aspirated from 50 
acute dento-alveolar abscesses found s.miiieri to 
predominate, isolating it from 20 cases, in two of which 
it was the sole organism. This correlated with Von Konow 
and Nord (1983) and Fisher and Russell (1993) who 
similarly found s.miiieri to be the commonest facultative 
anaerobe in orofacial infections. With the recognition 
of three species of SMG, s. constellatus has been reported 
as the most common of the group associated with dental 
abscess formation (Whiley et al 1992). Although the 
pathogenic role of s.miiieri in abscess formation is not 
clear, Aderhold et al (1981) suggested that the early 
phase of abscess formation involves a mixed aerobic- 
anaerobic infection where streptococci utilise oxygen and 
prepare the environment for anaerobic growth. This is 
supported by Lewis et al (1986) whose pure cultures of 
s.m iiieri were obtained when samples were obtained from 
patients on the first day of clinical symptoms, with an 
anaerobic flora predominating in 2-3 day old infections.
s.miiieri isolates have been used to induce abscesses in 
mice with some success, Flynn and Lynes (1986) used 
s.miiieri type 1 injected into the subcutaneous and 
submandibular spaces of Swiss white mice and examined the 
inoculation sites at different time intervals. A 72% 
incidence of abscess formation was obtained.
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submandibular space abscesses 62%, subcutaneous space 
abscesses 78%, with abscesses resolving at 19.2 (+/- 1,1 
SD) days, Lewis et al ( 1988) also used s.miiieri, both as 
the single inoculating organism and in combination with 
another species, to induce abscesses in male albino mice. 
s.miiieri alone produced either a Type A reaction, a 
diffuse inflammatory infiltrate, or Type B, a localized 
abscess without peripheral necrosis. Combination with 
Bacteroides intermedius (now Prevotella intermedia) gave a more 
severe group C reaction in most cases (localized abscess 
with peripheral necrosis), indicating synergistic 
interaction with the anaerobic Gram negative bacilli 
which may be important in abscess development in man.
1 . 3 . 4  ENDOCARDITIS
Like other dental plaque bacteria, those belonging to the 
SMG can cause infective endocarditis. Parker and Ball 
(1976) found 5.4% of 317 isolates from patients with 
endocarditis to be s.m iiieri. They further suggested that 
SMG are a less common cause of endocarditis than other 
dental plaque bacteria because they do not produce 
dextran, which allows adherence to heart valves. This 
may be discounted for two reasons. First, a study by 
Facklam (1977) showed that the proportions of s.miiieri in 
plaque and endocarditis were almost identical i.e. low. 
Secondly, extracellular dextrans require sucrose for 
synthesis and since this is not present in blood it seems
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unlikely to be of importance (Gosling 1988). It may be 
more likely that fimbriae present on some SMG bacteria 
are involved in attachment (Handley et al 1985), In a 
study of streptococci from the blood and internal organs 
of patients with specified systemic infections, Parker 
and Ball (1978) found 21% of 173 patients from whom 
s.miiieri was isolated to have endocarditis, but only in 
those over 35 years old. Seven of the patients had 
previous valvular damage. Herzberg et al (1992) found 
that the SMG accounted for between 9-15% of all infective 
endocarditis cases. Glauser and Francioli (1982) 
successfully induced endocarditis in rats using 
S.intermedius. Willcox et al (1994) attempted to explain 
some pathogenic determinants of the SMG which may be 
involved in endocarditis, namely the ability to aggregate 
human platelets. Endocarditis results from infection by 
a microorganism of a platelet/fibrin vegetation that is 
located on the endothelial surface of the heart (Whiley 
and Hardie 1989). The ability of bacteria to aggregate 
platelets is considered to be important in the induction 
and progression of endocarditis, with Willcox and 
investigators finding that Lancefield group C SMG strains 
did aggregate platelets (Willcox et al 1994). In a 
further study, Willcox (1995) found that the SMG bound 
fibronectin and bound to platelet/fibrin or fibrin clots 
and fibrinogen, while s. constellatus species produced 
thrombin-like activity. He suggested that these in vitro 
pathogenic properties may be involved in both production
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of abscesses and endocarditis.
s.miiieri has also been implicated in cases of myocardial 
abscesses associated with endocarditis (Wallis et al 
1986) and has been isolated from cases of purulent 
pericarditis (Akashi et al 1988).
1.3.5 BACTERAEMIA
Viridans streptococci may enter the circulation after 
vigorous toothbrushing, with more significant bacteraemia 
resulting from trauma, surgical procedures or purulent 
lesions in various body sites, Parker and Ball (1976) 
found 14% of patients with bacteremia to have serious 
underlying disease such as leukaemia, Hodgkin's disease 
and diabetes mellitus. Bacteremia due to s.miiieri 
following dental extraction is well reported (Shanson et 
al 1978; Barnham et al 1989). Bacteraemic infections due 
solely to s.miiieri are very infrequent and Murray et al 
(1978) and Shlaes et al (1981) concluded that s.miiieri 
seldom infects an otherwise healthy individual in the 
absence of trauma, Jacobs et al (1994) analysed 19 cases 
of bacteraemia involving the SMG, where eleven patients 
had underlying disease, with local trauma to the mucosal 
barrier an important risk factor. s.anginosus was found to 
be the most common (16/20) while 8 of 20 strains carried 
the Lancefield group C antigen.
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1.3.6 CENTRAL NERVOUS SYSTEM INFECTIONS
Reports of s.miiieri isolated from infections of the 
central nervous system and meninges are numerous. Indeed 
this gives it its reputation for pathogenicity. Of 
streptococci associated with intracranial pus, s.miiieri 
is the commonest of all isolates (De Louvois 1980). De 
Louvois et al (1977) carried out a multicentre study of 
organisms isolated from abscesses of the central nervous 
system and found 20 of 36 streptococcal isolates were 
s.miiieri Lancefield group F, Ottens and Winkler type O 
III. Fourteen were from brain abscesses and 6 from 
subdural or extradural empyemas. Melo and Raff (1978) 
reported 3 cases of brain abscess in which s.MG-intermedius 
was isolated in pure culture. Where studies considered 
location of infection or underlying disease, it was shown 
that SMG organisms did not have a strong predilection for 
any area of the brain or that any particular infection or 
condition preceded formation (Shlaes et al 1981;Hendrix 
et al 1982;Puthecary and Rapport 1982). Considering the 
rarity of brain abscesses, the evidence of their 
association with SMG organisms suggests that it may be 
one of the commonest bacterial agents of such infections. 
Indeed animal experiments have shown that s.miiieri has a 
well defined affinity for the central nervous system of 
mice (De Louvois et al 1974). Whiley et al (1990) found 
S.intermedius to be the most common of SMG organisms in
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brain abscesses (21/25- 84%),and suggested that as
s.intermedins is the most common of SMG isolates in plaque 
this may be the source. Homer, Whiley and Heighten 
(1994) found that an isolate of s.intermedius from a brain 
abscess produced specific glycosidase activities and 
suggested that these may allow the persistence and growth 
of s.intermedius at sites anatomically removed from its 
normal habitat.
Other than brain abscesses, SMG organisms are 
infrequently associated with other CNS infections, often 
requiring a history to show trauma or antecedent purulent 
infection. Parker and Ball ( 1976) found s.miiieri in 8 of 
65 (12%) cases of streptococcal meningitis. Two patients 
in a study by Shlaes et al (1981) infected with Group F 
streptococci developed meningitis following cervical 
osteomyelitis, one developing an epidural abscess. 
Blayney et al (1984) list 3 cases of subdural empyema 
complicating sinusitis. Meningitis following tooth 
extraction has been reported (Wu and Tsung 1983) and 
following nasal malignancy and sinusitis (Plotkin 1982). 
These indicate infection secondary to trauma or 
infection, but Tescon-Turaang et al (1982 ) reported a 
fatal case of purulent meningitis which showed presence 
of s.MG-intermedius where there was no preceding trauma or 
infection.
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1.3.7 ABDOMINAL INFECTIONS
This is another area where the SMG has gained a 
reputation for pathogenicity. A review of clinical 
isolates of the SMG by Gosling (1988) showed that between 
7% and 40% of clinical isolates were from the abdomen, 
with liver abscesses, purulent appendicitis and post- 
surgical Infections most frequently reported.
SMG organisms have been associated with appendicitis by 
many workers (Murray et al 1978; Madden and Hart 1985; 
Kambal 1987), Poole and Wilson (1977) cultured 121 
appendices and found a significantly higher level of 
isolation of s.miiieri in inflamed appendices than normal 
(58% vs 26%). There was a pronounced connection between 
the presence of s.miiieri in the appendix and purulent 
manifestations of appendicitis, and it was also isolated 
from other abdominal sites associated with appendicitis. 
Madden and Hart (1985) reviewed appendectomy cases over 
1 year in a childrens’ hospital. Preoperative cultures 
from unknown sites from 33 patients gave growth of 
s.miiieri in 9 cases (27%), Postoperative cultures from
the infected site where an abscess or purulent wound 
discharge developed gave a 69% isolation rate of 
s.miiieri > McAllister et al (1988) administered
cefotaxime in an attempt to reduce postoperative sepsis 
following append!cectomy. Sixteen wound infections 
occurred among 401 patients, with s.miiieri being a
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predominant isolate.
There are several case reports of liver abscess 
associated with the SMG (Bateman et al 1975;Allison et ai 
1984). Chua et al (1989) reviewed 33 cases of s.miiieri 
liver abscess, 15 of which had detailed case notes. 
Among them, males predominated (only 1 woman) and single 
and multiple abscess cavities were observed, 4 of 7 with 
single sites being under 40 years of age, and 6 of 8 with 
multiple sites over 40 years. Nine ( 60%) had an 
underlying illness, predominantly gastrointestinal 
disease, but also present were dental infections and 
diabetes. Another review by Moore-Gillon et al (1981) 
similarly found predisposing factors, 10 of 16 having had 
abdominal surgery or disease.
Other abdominal Infections which have yielded s.miiieri 
include peritonitis (McCue 1983), subphrenic abscess 
(Ball and Parker 1979), cholangitis, splenic abscess and 
pelvic abscess (Murray et al 1978) and infected aortic 
aneurysm (Fox 1979 ) - In these reports one or few cases 
are detailed and other intestinal bacteria are involved.
1.3.8 LUNG INFECTIONS
A significant proportion of SMG-associated infections are 
thoracic infections, empyema most commonly, though lung
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abscesses and purulent pneumonia are also reported 
(Shlaes et al 1981; Prankish and Kolbe 1984) . Parker and 
Ball (1975) studied streptococci from 22 purulent 
thoracic infections. Six (27%) isolates were s.miiieri 
with only s.pyogenes found more frequently (7). Of 23 
cases of empyema or lung abscess studied by Waitkins et 
al ( 1985) 13 (57%) yielded s.miiieri, with 8 strains
isolated in pure culture. Wong, Donald and MacFarlane 
( 1995) reviewed 25 cases of pulmonary disease due to the 
SMG, where 16 had empyema, 5 had a lung abscess and 4 had 
both. There was a strong male predominance (84%) and 
predisposing factors were present in 80% of patients. 
The mouth and upper respiratory tract have frequently 
been regarded as the source of s.miiieri and it is thought 
that infections are preceded by aspiration (Shlaes et al 
1981). The SMG has also been isolated from purulent 
pericarditis (Reder et al 1984) and from myocardial 
abscesses (Wallis et al 1986).
1.3.9 EAR, NOSE AND THROAT INFECTIONS
Bannatyne and Randal1 (1976) isolated only 8 strains of 
group F streptococci in mixed culture from the external 
auditory canal of patients at a childrens‘ hospital from 
1970-1975, suggesting s.miiieri is rare in ear infections.
The SMG has been repeatedly isolated from cases of 
sinusitis both acute and chronic, sometimes in pure
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culture (Wort 1975;Blayney et al 1984). Van Der Auwera 
(1985) found 7 isolates of s.miiieri from acute maxillary 
sinusitis, with 4 of these in pure culture. Whitworth 
(1990) suggested the role of the SMG in sinusitis to be 
similar to its suggested role in dental abscesses i.e. 
autogenic succession. The major complication of SMG 
sinus infections is CNS infection.
SMG organisms have been found in the tonsils (Brook et al
1980) and aspirates of peritonsillar abscesses (Brook
1981) in children. They have also been reported in 
throat swabs from adults and children (Wort 1975),but 
their pathogenic significance is disputed. Poole and 
Wilson (1976) showed a trend of heavier growth from 
throats of those with symptoms than from asymptomatic 
carriers. Of 25 patients with pharyngitis and 
tonsillitis, 21 (84%) had heavy growth compared to only 
5 (31%) symptomless carriers. Yamashiro (1991) also 
found a higher incidence of SMG in patients with purulent 
respiratory disease (24.7%) compared to healthy controls 
(11.7%), whereas Fox, Turner and Fox (1993) found similar 
levels of isolation from controls (11%) and patients with 
pharyngitis (11.1%). This may support the previous 
suggestion that s.miiieri is not generally regarded as an 
important pathogen in the throat, with studies by Bucher 
and Von Gravenits (1984) and Ruoff et al (1985) stressing 
the importance of distinguishing p-haemolytic SMG of 
Lancefield Groups A,C and G from the more pathogenic,
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large zone |3-haemolytic members of the group. However, 
Mitchelmore et al (1995) found s.miiieri one of the most 
common isolates from pus aspirated from peritonsillar 
abscesses.
1.3.10 SKIN AND SUBCUTANEOUS INFECTIONS
Isolates of the SMG from superficial abscesses and wound 
infections have been reported by a series of 
investigators. Skin and subcutaneous isolates made up 8% 
of Poole and Wilson's (1976) SMG isolates from a 
reference laboratory and 30% of a collection at the Mayo 
Clinic Hospital (Libertin et al 1985) amongst others. 
Miller et al (1983) reported a very high incidence of 
subcutaneous sepsis caused by s.miiieri following human 
bites. A similarly high incidence of small distal 
extremity abscesses after trauma was found by Libertin et 
al (1985), There have also been isolations of s.miiieri 
from cellulitis (Murray et al 1978; Flanagan and Mills 
1994) and rarer conditions of necrotising fasciitis 
(Shlaes et al 1981), where Imamura at al (1995) found 
s. intermedius as the causative species, and hydradenitis 
suppurativa (Highet et al 1980), Brook and Walker (1985) 
amongst others have been successful in inducing 
subcutaneous abscesses in experimental animals using 
s.miiieri alone and in combination with other bacteria. 
Lewis et al (1988) investigated the capacity of bacterial
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species isolated from human acute dentoalveolar abscesses 
to induce subcutaneous tissue reactions in mice. 
Injection of s.miiieri alone produced either type A 
(diffuse inflammatory infiltrate) or type B (localised 
abscess without peripheral necrosis) reactions. When 
combined with b . intermedius^ a type C (localised abscess 
with peripheral necrosis) reaction occurred, and there 
was a high incidence of recovery of the 2 organisms. 
This suggests a synergistic effect in abscess formation.
1.3.11 OBSTETRIC AND NEONATAL INFECTIONS
As the SMG are common inhabitants of the vagina it is 
hardly surprising that they have been found in these 
infections. Keay et al (1995) examined the prevalence of 
s . consteiiatus in urine of controls and patients with 
interstitial cystitis, with significantly greater 
isolation in IC patients (6/11) versus controls (0/7). 
With neonatal and obstetric infections, onset was 
associated with premature rupture of the membranes and 
consequent ascending infection, but it is unclear whether 
infection follows rupture or causes it. s.intermedius was 
found in 30% of cervical cultures from patients with 
premature membrane rupture but from only 7% of healthy 
controls (Evaldson et al 1980). Cox et al (1987) 
reported 2 cases of fatal infection of neonates of 26 
weeks gestation due to s.m iiieri, suggesting in these
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cases that an inadequately functioning cervix allowed 
ascending infection, s.intermedius endocervically
inoculated into five pregnant ewes spread to the amniotic 
fluid and placenta (Evaldson et al 1983) illustrating 
that ascending infection can occur while the membranes 
are intact. Bergman et al (1995) described a strain of 
s . anginosus associated with neonatal infection, which 
exhibited a gliding type of motility, expressed as 
spreading growth on certain agar, which may aid in 
ascending infection.
1.3.12 INFECTION OF THE BONES AND JOINTS
There have been reports of the association of s.miiieri 
with septic arthritis (Lever et al 1982; Ortel, Kallianos 
and Gallis 1990) and osteomyelitis (Shlaes et al 1981). 
In many cases these have been mixed infections and in an 
immunocompromised host or an individual with a number of 
predisposing factors present. Balantine, Papasian and 
Burdick (1989) reported a case of arthritis due to 
s . anginosus where the only predisposing factors were 
osteoarthritis of the knee and an acute men!seal tear, 
this case being the fifth found due to s. anginosus. 
Furthermore, Mateo et al (1991) described a case of 
pyogenic arthritis due to s. anginosus in a non­
immunocompromised host, and suggested that problems with 
identifying the SMG may account for the rarity of reports
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on its involvement in articular infections.
1,4 TREATMENT OF SMG INFECTIONS
Surgical drainage is central to the management of 
abscesses, augmented by antibiotics (Whitworth 1990). 
All but a few strains of s.miiieri are very sensitive to 
penicillin, with Jacobs and Stobberingh (1996) finding 
only 1.4% of 423 strains of SMG to be of intermediate 
susceptibility to penicillin. However, Bantar et al 
(1996) found penicillin resistance rates of 12.5% and 
suggested emerging resistance to antibiotics may present 
a potential problem in therapeutic management of 
infections caused by the group. Alternatives are 
erythromycin, clindamycin and the cephalosporins. 
However, sensitivity to tetracyclines is variable 
(Tillotson and Ganguli 1984). Sulphonamides are inactive 
against the SMG, possibly promoting their growth (Mirick 
et al 1944), and they have been used as a selective agent 
for isolating these organisms from the mouth (Mejare and 
Edwardsson 1975).
Certain other antibiotics have been implicated in 
contributing to the pathogenicity of the SMG, 
specifically metronidazole and gentamicin in combination. 
Tresadern et al (1983) reported the development of 13 
post-operative SMG infections in patients after 
colorectal surgery. In 6 of the 13 cases metronidazole
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and gentamicin had been administered as prophylaxis for 
surgery, and the author suggested that the suppression of 
anaerobic and enteric Gram negative organisms, and the 
lack of activity of these two antibiotics against the 
SMG, allowed their expression as a pathogen. Piscitelli 
et al ( 1992 ) also suggested that suppression of the rest 
of the normal flora in this way can give an ecological 
advantage to the SMG with resultant disease.
1.5 POTENTIAL VIRULENCE FACTORS OF SMG ORGANISMS
From the preceding evidence it is clear that the SMG is 
capable of producing infection in a range of sites, and 
that compared with other viridans streptococci these 
organisms have an enhanced ability to produce purulent 
disease (Table 1.1). An important question is whether 
this ability is possessed uniformly by all members of the 
group or whether there are well defined subgroups with 
individual sites and modes of act ion. Possible virulence 
factors have been rarely studied hitherto.
1.5.1 HAEMOLYSINS
The fact that streptococci can cause several types of 
haemolysis on blood agar has long been known, and served 
as the basis for early classification of these
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Table 1.1 Frequency of Isolation of streptococcal 
species in purulent disease
1 MICROORGANISM : : % FREQUENCY ÔP ISOLATION FROM PURULENT
disease
CLINICALLY
RECOGNISED
BACTERIOLOGICALLY
CONFIRMED
15.1% 12.9%
; GROUPS ; 22,4% 25.9%
3.3% 1.7%
dï^tiPG, 3.3% 1.7%
5.3% 3.4%
2.6% 3.4%
1 ' rDncla8alfi«ij'''-f* 2.6% 1.7%
S,.àlivarlu. 2.6% 3.4%
28.3% 29.3%
' '" A il-l» . ' . 0% 0%
S.faecalis 2,0% 2.6%
Adapted from Parker and Ball (1976)
microorganisms. Many strains causing human infections 
produce f3-haemolysis. Todd (1932,1938) and Weld (1934) 
described the production of two distinct haemolytic 
toxins - Streptolysin 0 and Streptolysin S.
STREPTOLYSIN O (SLO)
SLO is an oxygen labile, antigenic bacterial toxin 
produced by most Group A and some Group C and G 
streptococci, with all strains producing an 
immunochemical1y and functionally identical toxin 
(Halbert 1970). It can be found in culture filtrates of 
complex media such as Todd Hewitt broth and also may be 
synthesised in a chemically defined medium as shown by 
Bernheimer (1982). Peak SLO synthesis usually occurs 
between 6 and 12 hours Incubation, with titres falling 
rapidly after this time. SLO oxidised to its inactive 
form may be reactivated by a variety of sulphydryl 
compounds which restore the initial high activity 
(Herbert and Todd 1941). Hewitt and Todd (1939) showed 
that its activity could be irreversibly inhibited by low 
concentrations of cholesterol. Cholesterol was found to 
be the binding site for the toxin, being illustrated by 
the activity of SLO on the membranes of mycoplasma. 
Parasitic strains whose membranes contained cholesterol 
were sensitive to SLO, whereas saprophytic strains 
containing carotenol instead of cholesterol were 
insensitive (Bernheimer and Davidson 1965), Alouf and
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Raynaud (1968) showed that the first step in SLO activity
involves irreversible binding of the reduced form to
membrane cholesterol. Further insight into the mode of
action was gained when Dourmashkin and Rosse (1966)
examined, by electron microscopy, the effect of SLO on
erythrocyte membranes, and reported scattered holes of 
0500 A diameter which allowed rapid release of 
haemoglobin. More recent investigations using electron 
microscopy showed that SLO forms arc or ring-shaped
structures on erythrocyte membranes after binding to 
cholesterol molecules (Bhakdi et al 1985), Two
haemolytic forms of SLO have been reported. The first is 
an acidic type with a molecular weight of 69,000 +/-
3.000 with a pi of 6.0 to 6.4 (Bhakdi et al 1984). The 
second is a neutral and degraded type of molecular weight
57.000 +/- 5,000 and a pi of 7.0 to 7.5 (Bhakdi et al 
1984). Sekiya et al (1993) detailed a ring shaped
structure with a crown formed by SLO on erythrocyte
membranes, observed by electron microscopy. Numerous 
researchers have reported a multiplicity of toxic effects 
of SLO on animals as reviewed by Halbert (1970), while 
Hamburger and Lemon (1953) and Quinn (1957) confirmed 
these in man. SLO has been shown by Halbert et al 
(1961a, 1961b) to be the streptococcal factor responsible 
for the pathogenesis of rheumatic fever. It has been 
shown to stimulate light emission by human neutrophils 
(Andersen and Duncan 1980), to suppress chemotaxis and 
mobility of neutrophiIs (Andersen and van Epps 1972), to
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inhibit phagocytosis by macrophages (Ofek et al 1972) and 
suppress lymphocyte responses to phytohemagglutinin 
(Andersen and Cone 1974).
STREPTOLYSIN S (SLS)
Streptolysin S is the oxygen stable, non-antigenic 
haemolysin responsible for 0 haemolysis around colonies 
on aerobic blood agar plates. It is produced by 
streptococci of Groups A,C,G and others, especially 
pyogenic strains, Expression of SLS activity depends
upon contact between the microorganism and one of many 
agents like serum albumin, ribonucleic acid and Tween and 
Triton detergents. These different inducers give rise to 
different forms of SLS, acting also as carrier molecules 
for the haemolytic moiety, allowing it to be transferred 
from one carrier to another, as shown by Ginsburg and 
Harris (1963). SLS is sensitive to streptococcal 
proteinase (Wannamaker 1983) and its activity is 
inhibited by several phospholipids (Elias et al 1966) and 
trypan blue. Haemolysis is also inhibited by zinc ions, 
apparently by interfering with the attachment of SLS to 
erythrocyte membranes (Avigad and Bernheimer 1978), It 
is sensitive to heat and acid.
Koyami and Egami ( 1963) purified SLS and found it to 
consist of an oligonucleotide and polypeptide in the
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ratio 3.3 to 1, with amino acids glycine, glutamic acid 
and serine in large amounts. A stable preparation of 
RNA-core SLS was reported by Lai et al (1978). Both 
moieties of the polypeptide-oiigonucleotide complex were 
in a dimeric form, with the molecular weight of the 
complex 15,000 and that of the oligonucleotide carrier 
7,100.
SLS has a broader spectrum of action than SLO. It is 
lytic or toxic to all those cells being sensitive to SLO, 
and has activity against wall-less forms of some bacteria 
and L forms of two strains of streptococcus pyogenes. SLS 
is also responsible for the leukotoxic property of group 
A streptococci, where PMNLs are killed after ingestion of 
the streptococci (Ofek et al 1972), while lower 
concentrations of SLS inhibit phagocytosis.
Dourmashkin and Rosse (1966) found that,unlike SLO, SLS 
does not cause holes in erythrocytes, but subtly alters 
the lipid and/or protein organization in the membrane 
which allows free passage of ions. The retained 
haemoglobin exerts osmotic pressure, drawing water into 
the cell and causing it to rupture.
Weissmann et al (1965) showed that repeated intra- 
articular injection of Streptolysin S caused chronic 
osteoarthritis in rabbits, while Ginsburg (1970) showed 
repeated SLS injections to cause myocarditis. Ofek et al
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(1972) illustrated that sublethal amounts of SLS 
suppressed phagocytosis of mouse peritoneal macrophages, 
suggesting that this contributed to the invasiveness and 
pathogenicity of microorganisms. Studies on human and 
mouse lymphocytes indicate that T cells are more 
sensitive than B cells to SLS (Hyrniewicz and Pryjma 
1977). In vivo studies indicated that SLS suppressed T 
cell-dependent antibody responses, and suggested that SLS 
can suppress helper T cells (Hyrniewicz and Pryjma 1979).
1.5.2 INTERMEDILYSIN
Nagamune et al (1996) detailed a novel cytotoxin specific 
for human cells produced by s.intermedius ÜNS46 isolated 
from human liver abscess. This toxin, named
intermedilysin, consisted of two proteins of 54 and 53 
kDa, and its pattern of activity caused the investigators 
to distinguish it from all known bacterial cytolysins.
1.5.3 HYALURONIDASE
Poole and Wilson (1979) showed a positive association 
between hyaiuronidase production in the SMG and 
haemolysis, production being most marked in 0 haemolytic 
strains of Lancefield groups A, C and F. Steffen and 
Hentges (1981) failed to find hyaiuronidase production 
whereas Unsworth et al (1980) found 4 distinct serotypes 
which correlated with the source of the strain. Isolates
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from dental plaque and purulent lesions produced type IV 
hyaiuronidase suggesting an oral origin for abscess 
strains. High titres of antibodies in blood donor sera 
to type III and IV hyaiuronidase also suggest a greater 
invasiveness for strains producing these types (Unsworth 
1980). Unsworth (1989) showed significant hyaiuronidase 
production in 50%-100% of s.miiieri strains isolated from 
abscess sites, with higher frequency in deeper sites. In 
contrast, strains from normal flora sites showed low 
frequency of production (4%-52%). Jacobs and Stobberingh 
(1995) also found that hyaiuronidase activity correlated 
significantly with infection-related strains when they 
examined 518 isolates of SMG. Homer et al (1993), using 
a sensitive spectrophotometric assay, showed that 
hyaiuronidase was produced only by s.intermedius and 
s. consteiiatus in accordance with previous observations by 
Killper-Balz et al (1984). This was also found by Jacobs 
and Stobberingh (1995) and Willcox, Patrikakis and Knox 
(1995) and has been suggested as a further point of 
species identification within the group. This strong 
association between hyaiuronidase production and s.miiieri 
from abscesses suggests that the enzyme has an important 
role in their formation.
It has also been suggested by Homer et al (1994) that 
production of hyaiuronidase may play a role in nutrition 
and replication of s.intermedius at abscess sites. They 
detected growth of a strain of s.intermedius when
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hyaluronic acid was supplied as the sole carbohydrate 
source, due to depolymerisation of the substrate by 
hyaiuronidase and internalisation of the resultant 
disaccharides.
1.5.4 NUCLEASES
Extracellular DNAse is found in about one half of strains 
tested (4l%-67%) and RNAse in about two thirds (67%-80%) 
(Marshall and Kaufman 1981;Drucker and Lee 1983). Jacobs 
and Stoberringh (1995) found RNAse activity to be equally 
distributed among the 3 species, while DNAse activity was 
more frequently present in s.intermedius and s. consteiiatus 
and was associated with infection-related strains (p< 
0.001).
1.5.5 CAMP FACTOR
The CAMP phenomenon was first reported in 1944 by 
Christie, Atkins and Munch-Peterson, providing the 
acronym. The haemolytic activity of staphylococcal 0- 
lysin is enhanced by an extracellular factor produced by 
group B streptococci, called the CAMP factor, and this is 
routinely used in laboratory identification of these 
streptococci (McFadden 1980).
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1.5.6 PROTEOLYTIC ENZYMES
Some researchers have failed to find the tissue 
destroying enzymes collagenase (Ottens and Winkler 1962), 
gelatinase, caseinase, (Lutticken et al 1978) 
fibrinolysin, chondroitin sulphatase and lecithinase 
(Steffen and Hentges 1981). Steffen and Hentges (1981) 
did find gelatinase and collagenase activity in one of 
two clinical isolates examined. A strain of s.MG- 
intermedius from infective endocarditis produced several 
extracellular proteins with proteolytic activity (Strauss 
et al 1977). Growth of this strain in conditions 
mimicking the conditions in a fibrotic heart lesion gave 
a 4-8 fold increase in these proteins, sufficient to 
damage tissues. Willcox, Patrikakis and Knox (1995) 
investigated the degradative enzymes of oral streptococci 
and found that strains of the SMG had aryl ami dase 
activity and degraded casein. No strains were able to 
degrade bovine serum albumin or produced chondroitin 
sulphatase, glycosyltransferase or dextranase (Willcox, 
Patrikakis and Knox 1995).
Homer et al (1993) found that strains of s.intermedius 
produced chondroitin sulphate depolymerase when the 
organisms were grown in the presence of 
glycosaminoglycan, suggesting that the enzyme is 
inducible. As well as a role in tissue degradation, 
Shain et al (1994) suggest an additional role of
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nutrition at sites of infection, after showing that a 
strain of s.intermedius grew on chondroitin sulphate A. In 
further investigation of this strain of s.intermedius UNS 
35, an isolate associated with brain abscess, Shain, 
Homer and Beighton (1996a) found it produced chondroitin 
sulphate (CS) depolymerase A and C. This property was 
inducible with little activity produced in the presence 
of glucose, which was consistent with the low level of 
production of polysaccharide degrading enzymes by other 
bacteria when a more readily catabolisable substrate is 
available (Salyers and Kotanski 1980). As chondroitin 
sulphate is distributed throughout connective tissues, in 
most cases as a hybrid structure, Shain et al (1996) 
suggested the ability of s.intermedius UNS35 to produce CS 
depolymerase A and C may play a role in destruction of 
host connective tissues and bacterial nutrition at an 
otherwise nutritionally compromised infection site. On 
further investigation Shain et al (1996b) purified this 
glycosaminoglycan depolymerase with SDS-PAGE analysis 
yielding a single band of molecular weight 83 000.
However, their previous assumption that the enzyme was a 
chondroitin sulphate depolymerase was revised as it 
exhibited greatest activity against hyaluronic acid, with 
degradation rates of CS-A and CS-C at 8% and 2% of the 
rate with HA, It could therefore be considered a 
hyaiuronidase, rather than a CS depolymerase. The pH 
optimum was around neutral similar to peptostreptococcal 
hyaiuronidase (Tam and Chan 1985), but it was unusual in
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having a high pi of 9.3,
Byers, Homer and Beighton (1996) reported strains of 
s. anginosus, S. consteiiatus and S. intermedius were able to use 
sialic acid efficiently as a sole carbon source 
independently of production of sialidase. They suggested 
this may play a role in survival in vivo in extra-oral 
diseases.
1.5.7 RUTINASE
Some s.miiieri Strains from the mouths of healthy 
individuals were shown by Farisis and Pritchard (1983) to 
release carcinogenic substances by the hydrolysis of 
common foodstuffs. Hydrolysis of rutin, a common 
component of food and drink, liberated quercetin, a 
genotoxic substance which may be involved in production 
of epithelial carcinoma. The rutinase was constitutive, 
partly inducible, cytosolic and most active at pH 6.5, 
The authors suggested that the reaction is likely to 
occur in vivo due to the constitutive nature of the 
rutinase, the intra-oral availability of rutin and the pH 
range of activity which closely resembled that of the 
mouth.
1.5.8 BACTERIOCINS
The ability of the SMG to colonize in the presence of a
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mixed flora may be aided by production of substances 
antagonistic to other microorganisms. Dajani at al 
(1976) demonstrated bacteriocin-like activity in 78% of 
alpha haemolytic streptococci. Drucker and McKillop 
(1982) described widespread production of antagonistic 
substances in the form of production and bacteriocin- 
like activity among s.miiieri strains from various 
sources. Virtually all of these isolates were in turn 
sensitive to the bacteriocin-like activity of s.mutans 
NCTC 10832. Dajani (1991 ) suggested a low rate of 
bacteriocin-like activity among a haemolytic s.miiieri 
strains. Kanamoto et al (1996) found strains of 
S.intermedius produced a bacteriolytic substance which 
lysed M. luteus.
1.5.9 SYNERGY
Shinzato and Saito (1994) have suggested synergy between
S. consteiiatus and Prevotella intermedia • Whilst each alone 
caused pneumonia in mice, in combination they resulted in 
more severe pneumonia, often associated with lung abscess 
formation or empyema. Acute pneumonia with mixed 
infection resulted in a 60% mortality rate, while there 
was only 10% mortality and mild pneumonia in each 
separate infection. Additionally, enhancement of growth 
of s. consteiiatus occurred when cultured with p. intermedia, 
with growth also stimulated by a culture filtrate of
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p. intermedia. This filtrate also inhibited the
bactericidal activity of human PMNL, and was shown in vivo 
to be responsible for a 20% mortality rate and delayed 
clearance of s. consteiiatus. The investigators suggested 
that p. intermedia may act with S. consteiiatus in the 
production of pulmonary infections by stimulating its 
growth and suppressing bactericidal activity of the host.
1.5.10 INTERACTION WITH THE HOST IMMUNE SYSTEM
Higerd et al (1978) found that gentle washing of 
S.intermedius liberated a crude extracellular product named 
EP-Si which suppressed fibroblast proliferation and 
altered lymphocytic responses in vitro. Further work by 
Arala-chaves et al (1979) revealed a strongly immuno­
suppressive, non-cytotoxic substance in this crude 
extract. When purified, it gave a 90 Kd protein named 
F3' EP-Si which was shown to induce T-suppressor 
lymphocytes and to have B-cell mitogenic activity (Arala- 
chaves et al 1981). Lima et al (1992) further studied 
F3'EP-Si (renamed P90) and its role in the survival of 
S.intermedius in the host. They demonstrated that P90 
treated mice were 50 times more susceptible to infection 
with s.intermedius than untreated mice. This was believed 
to be due to mitogenic and immunosuppressive effects of 
P90 on B cells. Experiments showed that B cells obtained 
from P90 treated mice were less able to respond to
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antigenic challenge, even in the presence of normal T 
cells, and T cells obtained from P90 treated mice could 
actively suppress the specific immune response of normal 
B cells. The authors suggested that even though these 
experiments were performed using a larger amount of P90 
injected Into mice than s.intermedius can produce in vivo, 
the effect on the survival of s.intermedius in the host 
would still be marked.
Toyoda, Kusano and Saito (1995) found a virulent strain 
of s. consteiiatus exerted a substantial inhibitory effect 
on phagocytic killing compared to an avirulent strain 
from the normal flora, and suggested it was mediated by 
a structural component of the organism. This would also 
contribute to delayed bacterial clearance.
1.5.11 CAPSULE
Encapsulation is a well established virulence factor for 
other bacteria, conferring varying degrees of resistance 
to phagocytosis. For example in Group A streptococci 
capsule has for many years been investigated for its role 
in virulence of these organisms via resistance to 
phagocytosis (Kass and Seastone 1943, Whitnack, Bisno and 
Beachey 1981, Dale et al 1996). Encapsulation has been 
suggested as playing a role in the pathogenesis of 
infections caused by a mixed bacterial flora such as 
acute dentoalveolar abscesses, Lewis et al (1993a)
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isolated capsulate bacteria from acute dentoalveolar 
abscesses, having previously shown s.miiieri to be 
particularly prevalent among facultative anaerobes in 
such infections (25/43 isolates) (Lewis et al 1986). Of 
the s.miiieri isolates 2 were acapsulate and 25 were 
capsulate, with the authors suggesting a role in 
pathogenicity (Lewis et al 1993a). Brook and Walker 
(1985) demonstrated capsule on some s.miiieri strains and 
found that only those strains possessing capsule could 
cause subcutaneous abscesses when injected alone into 
mice. However, when the unencapsulated strains were 
injected together with other capsulated organisms, 
encapsulation and pathogenicity were often restored. 
Lewis et al (1988) also demonstrated the ability of 
encapsulated s.miiieri strains to produce abscesses in 
pure culture. Therefore, if SMG bacteria are to cause 
purulent disease, a polysaccharide capsule may be a pre­
requisite, Lewis et al (1993b) investigated a possible 
role of SMG capsule in pathogenicity, that was resistance 
to phagocytosis. Of 10 s.miiieri strains (8 capsulate, 2 
non-capsulate) there was no significant difference in the 
percentage uptake by human PMNL, As resistance to 
phagocytosis did not appear to be a function of capsule 
the authors suggested it may play a role in pathogenicity 
by influencing functioning in cells or acting in synergy 
with other species in mixed infections.
The nature of the capsular material of the SMG is not
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known but the typing antigen present in Group F and 
related streptococci has been regarded as antiphagocytic 
(Huis int Veld and Linns sen 1973). It may be similar in 
structure to the capsule of other streptococci, but this 
has not been investigated.
1.5.12 SURFACE APPENDAGES
M protein fimbrial structures have been studied on 
s.pyogenes and similar structures have been observed on 
some oral strains of the SMG (Handley et al 1985). These 
may be Important in adherence to surfaces or other 
organisms of a mixed mucosal flora, although no work has 
been done to indicate their role in the SMG. Bergman et 
al (1995) found isolates of s.anginosus exhibited a gliding 
type of motility, expressed as spreading growth on 
certain types of agar media. These strains lacked any 
observable organelles of motility and were negative when 
tested in conventional motility test stab cultures. 
Electron microscopy revealed that motile strains produced 
more extracellular glycocalyx than non-motile strains.
1.5.13 CELL WALL ASSOCIATED PROTEINS
Lutticken et al (1978) found one or two protein antigens 
(sm antigens) in hydrochloric acid extracts of s.miiieri 
strains from pyogenic infections. These sm antigens were 
thought to be situated at or near the cell surface and a
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role in virulence similar to M protein of s.pyogenes was 
suggested.
1.5.14 SURFACE ASSOCIATED PROPERTIES
Willcox and Knox (1990) studied a variety of 
characteristics of the SMG that could be associated with 
pathogenicity and compared these with type strains of 
s. sanguisf s.mutans and S.pyogenes • Recent abscess isolates 
had a significantly greater ability to adhere to buccal 
epithelial cells than did other strains, with values for 
abscess strains similar to those of s.saiivarius, which 
preferentially binds to epithelial surfaces. Compared to 
s.sanguis the SMG were generally not aggregated by human 
saliva. They co-aggregated weakly with strains of 
Veiiionelia spp. and actinomycetes. The generally low 
level of adherence to saliva-coated hydroxyapatite 
correlated with its observed low levels in dental plaque.
It has been suggested that ability of s.pyogenes to bind 
fibrinogen enables it to escape the host defence 
mechanisms (Whitnack et al 1984). In the study of 
Willcox and Knox (1990), 22% of the fibronectin added to 
the assay bound to test strains of s.pyogenes^ SMG strains 
had a corresponding value of >2%, which although not high 
still represented a significant level of binding (10^  
molecules per bacterial cell) and, therefore, may aid
44
pathogenicity. Binding of fibronectin may also aid
pathogenicity, as it is found on the surface of many 
mammalian cells. Conversely, Yang et al (1988) suggested 
that bacteria coated in fibronectin are more readily 
opsonized and ingested by polymorphonuclear leucocytes. 
Fresh isolates from infections bound fibronectin to a 
significantly greater extent than others, suggesting that 
binding of fibronectin may contribute to pathogenicity.
Hydrophobicity and surface charge may also play a role in 
pathogenicity. Absolora (1988) stated that the more
hydrophobic the bacterial cell the more likely it is to
be phagocytosed. SMG strains varied in the degree of
their hydrophobicity with no relation to source (Willcox 
and Knox 1990). The authors suggested localized regions 
of charge on the cell surface, as strains with a high 
cell surface hydrophobicity were also able to possess a 
high cell surface charge. Alternatively, ability to 
display both hydrophobicity and negative cell surface 
charge may indicate that molecules such as lipoteichoic 
acid are involved. In addition, cell surface proteins 
may undergo conformational changes dependent on 
environment, which expose different regions. A cell may, 
therefore, have a charged cell surface and be 
hydrophobic. Later, Willcox,(1995) found that cell 
surface hydrophobicity of the SMG increased by 3% - 36% 
after binding fibronectin, but not proportionally.
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Willcox et al (1994) found that Lancefield group C SMG 
strains could aggregate human platelets mediated by cell 
surface protein(s). The ability of bacteria to aggregate 
platelets is considered to be important in the induction 
and progression of endocarditis. It also may play a role 
in abscess formation where bacteria are localized in a 
platelet/fibrin clot. Lancefield group C SMG aggregated 
human platelets within 10 minutes of mixing (Willcox et 
al 1994), Addition of substances which chelated cations, 
inhibited the cycloxygenase pathway in platelets, reduced 
the availability of ADP or disrupted platelet membrane 
stability reduced this aggregation, Willcox et al (1994) 
suggested the platelet interacting substance on the 
surface of the SMG to be proteinacious, as treatment with 
protease inhibited aggregation, whereas treatment with 
lipase, periodate and antisera to Lancefield group C 
polysaccharide had no effect. Group C SMG strains had 
previously been shown by Willcox et al (1993) to bind 
large amounts of albumin to their cell surface. A cell 
surface protein of 24000 which was liberated by 
lysozyme treatment was shown to be the cel1-surface 
receptor on s. intermedius strain C5. This receptor was 
physically dissimilar from protein G, an albumin and IgG- 
binding protein of "large colony" Lancefield group C and 
G streptococci. Combination of these findings led them 
to suggest a potential role in pathogenesis for albumin 
binding and a novel mechanism of platelet aggregation for 
SMG Group C isolates,
46
Willcox (1995) examined potential pathogenicity features 
of the SMG which may be involved in production of 
endocarditis and abscesses. All strains were able to bind 
fibronectin, ranging from 12-198 mol/cell, with strains 
within each species showing wide variation. Binding of 
fibronectin increased the cell surface hydrophobicity of 
strains by 3-36%, though the amount of fibronectin bound 
did not correlate with the increase in hydrophobicity. 
Organisms bound to plateiet-fibrin or fibrin clots and 
fibrinogen, with maximum adhesion values of 16.5%, 21.8% 
and 151 mol/cell respectively, with the two former 
relating to two strains of s.consteiiatus associated with 
abscesses and the latter a strain of s.intermedius isolated 
from the throat . s.consteiiatus strains produced thrombin­
like activity, and Lancefield group C SMG aggregated rat 
platelets. Binding of fibronectin has previously been 
shown to be related to adhesion of SMG to saliva-coated 
hydroxyapatite and the isolation of strains from 
infections (Willcox and Knox 1990), Binding of 
fibronectin may aid the ability of an organism to invade 
the body and can also help bacteria to adhere to 
fibronectin associated with fibrin clots, therefore 
contributing to endocarditis (Manning et al 1994). 
Fibronectin may also promote the ingestion of bacteria by 
host PMNL as it has been shown that bacteria coated with 
fibronectin are more readily phagocytosed (Yang et al 
1988). Willcox et al (1995) characterised the cell- 
surface receptor for fibronectin on strain s.anginosus F4
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and found it to be a protein of 14000 which was 
released from cells after mutanolysin digestion. The 
binding was specific, with cells having a maximum number 
of binding sites per cell of 770* They reported that 
fibronectin binding to cells increased the association of 
the bacteria with PMNL, but did not increase killing. The 
production of thrombin-like activity may also be involved 
in causing endocarditis and abscesses as thrombin converts 
fibrinogen to fibrin and is one of the major enzymes in 
the blood coagulation pathway. Therefore coagulation of 
plasma can seal off bacteria in a platelet-fibrin clot, 
and this may protect bacteria from elements of the host 
defence system (Willcox 1995), Willcox (1995) found that 
these in vitro pathogenic factors did not correlate with 
each other, except for a correlation between binding of 
large amounts of fibrinogen and the ability to aggregate 
platelets, suggesting fibrinogen binding may aid in 
platelet aggregation.
1.6 INTRODUCTION TO THE PRACTICAL WORK
It is therefore clear that the SMG possess a wide variety 
of pathogenicity factors which help them to cause disease. 
Although there have been more studies into the pathogenic 
determinants of the SMG since the clarification of 
taxonomy of the group and improved isolation and 
identification methods have been employed, much further 
work is required in order to fully characterise the group.
The aim of the practical work was therefore to address 
some of the issues suggested by the literature which may 
contribute to the pathogenicity of the SMG. In light of 
the ability to identify the three species of the group, 
could any significance be attributed to their site of 
isolation or toxin and enzyme profiles, allowing certain 
species to predominate in specific infections? Cell 
surface characteristics were investigated, especially 
possession of capsule, as these were implicated in the 
literature as possible virulence factors. Furthermore 
does the possession of capsule affect the interaction of 
the SMG with host cells? Willcox and Knox (1990) found 
dental abscess isolates of SMG had a proclivity for 
adherence to buccal epithelial cells, and their work was 
expanded in the current investigation. Finally the 
reaction of the body's immune response to the SMG was 
investigated via phagocytosis by human polymorphonuclear 
leukocyteso Were any species or isolate type resistant? 
Is capsule antiphagocytic?
It is hoped that in addressing these questions the 
understanding of the virulence of the SMG may be forwarded 
a stage and further work will be stimulated.
The following chapter is concerned with the isolation, 
identification and characterisation of a range of SMG 
isolates, in order that a heterogeneous group was 
available for further study.
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Chapter Three examines the surface properties of the SMG, 
namely possession of capsule and cell surface 
hydrophobicity. Capsule plays an important role in the 
pathogenicity of other streptococcal strains, and 
therefore this was examined for the SMG. Similarly, cell 
surface hydrophobicity can contribute to ability to cause 
disease, for example preventing opsonisation and therefore 
phagocytosis, and so this was also examined.
Chapter Four investigates adherence of the SMG to buccal 
epithelial cells. This expands on the experimental work 
of Willcox and Knox (1990) which showed that abscess 
isolates adhered more readily than other SMG isolates to 
BEC. This finding was examined and the results related to 
species. Further to this the data were also analysed with 
respect to influence of capsule or cell surface 
hydrophobicity.
Chapters Five and Six are both concerned with ability of 
the SMG to resist phagocytosis, The interaction of SMG 
with PMNL was examined using chemiluminescence and the 
effect of serum opsonisation on this process was 
investigated. Chapter 6 explored this interaction further 
by measuring directly, using a radiometric assay, the 
number of organisms ingested by PMNL. In both chapters the 
influence of species or isolate type on phagocytosis was 
assessed, as well as the possible conferring of resistance 
by either capsule or hydrophobicity.
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CHAPTER TWO ISOLATION, IDENTIFICATION AND
CHARACTERISATION OF 'STREPTOCOCCUS MILLERI 
GROUP’ (SMG) STRAINS
2.1 INTRODUCTION
2.1.1 AIMS OF THE INVESTIGATION
The aim of the work in this thesis was to investigate 
whether there are specific virulence factors which allow 
the SMG to cause disease. In order for any organism to 
be considered pathogenic it must be able to : 1] adhere 
to the host, 2] multiply within the host, 3] produce 
damage to the host and 4] avoid the host * s defence 
mechanisms long enough to cause disease. The oral 
streptococci have often been considered opportunistic 
pathogens, as certain of these pathogenicity factors were 
absent. The following chapters will examine some of 
these features in relation to the SMG,
The first stage was to gather a collection of strains 
representative of the three species. These were 
collected from dental abscesses, clinical infections and 
supragingival plague. This allowed re-examination of 
the evidence described in the literature review which 
suggested that isolates of the SMG from different 
infections have different properties. These were then 
characterised for Lancefield grouping, toxin production 
and degradative enzymes, to determine whether
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distribution of these attributes correlated with either 
isolate type or species. Indeed throughout the 
experimental work results were analysed for any 
relationship with species or isolate.
Therefore, the identification of specific virulence 
factors of the SMG which may explain its ability to cause 
purulent infections provided an underlying rationale for 
the research. In the absence of these factors, SMG may 
still be considered an opportunistic pathogen requiring 
the correct environmental conditions or interaction with 
other organisms to be effective in causing disease.
2.1.2 STRAIN SELECTION
To allow for meaningful comparisons, three groups of 
isolates were collected. These were isolates from dental 
abscesses, non-oral isolates from unspecified clinical 
infections and a commensal group of plaque isolates from 
healthy mouths. NCTC strain 11325 was also included to 
represent a type strain of s.consteiiatus, isolated from a 
case of purulent pleurisy (Hoideman and Moore 1974). 
These groups allowed examination of the distribution of 
the three species, s.anginosus, s.consteiiatus and 
S.intermedius, in different ecological situations. Similar 
studies have revealed an association of s.consteiiatus 
species with dental abscesses (Whiley et al 1992). It 
also allowed investigation of factors which may aid
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proliferation and spreading, as discussed earlier (P28- 
39), indicating whether these are peculiar to a 
particular species or isolate type. For example, 
production of certain enzymes such as sialidase, 
hyaluronidase and chondroitin sulphate depolymerase by 
specific species may account for their increased 
prevalance in certain infections, such as the association 
of S.intermedius with brain abscessas (Beighton 1994).
2.2 MATERIALS AND METHODS
2.2.1 CONFIRMATION OF PURITY OF STRAINS
Both the strains from dental abscesses and the isolates 
from non-oral infections had been isolated previously by 
other workers and were stored in a lyophilized state. 
These were reconstituted with 0.5 ml of Anaerobic Blood 
Broth (ABB), then plated out onto blood agar plates to 
check for viability and purity. They were then Gram- 
stained and confirmed as Streptococcus mil1eri group 
organisms by API 20 Strep kits (API Laboratory Products, 
Hampshire, England), which gave a biochemical profile and 
identified the SMG as Biotypes I, II or III. This was 
later replaced by the API RAPID 32 STREP (API Laboratory 
Products, Hampshire, England) test kit as this identified 
the SMG as either s.anginosus, S.consteiiatus or s.intermedius.
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2.2.2 ISOLATION OF THE SMG FROM PLAQUE
Samples of supragingival plaque were taken from 20 
trainee dental hygienists, all of whom had excellent 
oral hygiene and healthy mouths. The plaque was 
transferred into Transport Medium (Difco, Detroit, 
Michigan) and dispersed in the medium by mechanical 
agitation (Whirlimixer, Fisons, Leicestershire, England). 
A loopful of the suspension was plated out for single 
colonies on a semi-selective medium consisting of 
Sensitivity Test Agar (STA Lab 12, Lab M, Amersham) 40 
g/1, sulfamethazine (4-amino-N-[4,6-dimethyl-2-
pyrimidinyl]-benzene-suIphonamide) (Sigma, Poole, Dorset, 
England) 1000 pg/ml, nalidixic acid (Sigma, Poole, 
Dorset, England) 30 pg/ml and defibrinated horse blood 5% 
v/v. This allowed growth of s.anginosus, S.consteiiatus, 
S.intermedius and S.mutans, but no other Oral Streptococci 
(Whiley et al 1993). Single colonies were further plated 
out for purity on blood agar and identified using the 
Rapid ID 32 STREP test (API Laboratory Products, 
Hampshire, England),
2.2.3 STORAGE OF CULTURES
Pure cultures of all strains were stored on Protect beads 
(Technical Service Consultants, Bury, England) at - 70°C 
and - 20°C. Those stored at - 70°C were kept as a back up 
culture, while those held at - 20°C were routinely used
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as starter inoculae. When strains were required for 
testing, a bead was removed and plated onto blood agar, 
incubated and cultures used from this plate. This 
allowed for minimal subculturing of strains and ensured 
properties as close to the original isolate as possible.
2.2.4 PLATE HAEMOLYSIS
Haemolysis produced on Columbia base agar 4- 5% sterile 
defibrinated horse blood was recorded as alpha (greening 
of blood around colonies), beta (lysis of blood) and no 
haemolysis (no change in blood). Colonial morphology was 
also noted at this point, particularly in reference to 
rough or smooth appearance.
2.2.5 LANCEFIELD GROUPING
This was determined using the Oxoid Streptococcal 
Grouping Kit (Oxoid), a latex agglutination test for 
groups A,B,C,D,F and G.
2.2.6 PHENOTYPIC DIFFERENTIATION
Strains were assigned to species streptococcus anginosus, 
Streptococcus constellatus or streptococcus intermedins by the 
method of Whiley et al (1990). Ten milligrams of the 4
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methylumbelliferyl (4MÜ)™linked substrates, 4 MU-p-D 
fucoside, 4 Mü-N-Acetyl p-D galactosaminide, 4 MU-ot-D 
glucoside and 4 MU-p-D glucoside (Sigma) were each 
dissolved in 0.15 ml dimethylsulphoxide (DMSO) and 
diluted in 100 ml of 50 mM TES buffer (Sigma), giving a 
final concentration of 100 ug/ml. Strains were grown on 
blood agar for 2 days in 5% CO^  at 37“ C, harvested by 
swabbing the plate surface and suspended in TES buffer. 
This suspension was adjusted to an optical density at 620 
nm of 0.1, representing approximately 1 x 10 ® organisms 
per ml, and 50 pi of this suspension was mixed with 20 pi 
of each substrate solution in the wells of a flat 
bottomed microtitration plate (Titertek, Flow 
Laboratories Ltd, Irvine, Scotland), This was incubated 
at 37“ C for 3 hours, after which presence of enzyme 
activity could be visualised by use of an ultraviolet 
transilluminator; a positive result was indicated by 
blue fluorescence,
The three species reacted thus :
SubatratiO ' s  ; 'iib.srinosu» , ' is ' S , IntttruwKiiv*
OR OR
1 - —
2 - - + -j.
3 Hf- + - -
4 + + -f
(From Whiley et al 1990)
Where degradation of numbered substrates indicated
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1= p-D fucosidase activity 2= p-D galactosarainidase 
activity
3= p-D glucosidase activity 4= a-D glucosidase activity
2.2.7 STREPTOLYSIN 0 MEASUREMENT
Production of streptolysin O was tested in 20 ml cultures 
grown in Todd-Hewitt Broth (Oxoid) and Brain-Heart 
Infusion Broth (Oxoid) using the method of Abdul-Amir 
(1980)
Organisms were grown overnight at 37“C, after which SLO 
could be recovered from the culture supernate. The 
supernatant was saturated with sodium thioglycollate to 
provide -SH groups and act as a reducing agent to prevent 
SLO from being oxidized to its inactive state.
Assay Procedure
Serial doubling dilutions of the supernate were prepared 
with isotonic phosphate buffered saline (PBS). Red blood 
cells were washed three times with saline and resuspended 
to give a 2% w/v solution. One millilitre of each 
dilution was mixed with 1ml of 2% RBC (either sheep, 
horse or human) and incubated for 1 hour in a 37“C water 
bath along with a control tube containing PBS + RBC. The 
tubes were agitated to resuspend sedimented RBC's and 
then centrifuged for 2 minutes at 1 OOOg. The absorbance 
of the supernatant at 540 nm was measured and the value
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of the control subtracted. The level of SLO activity was 
determined, where 1 haemolytic unit was defined as the 
amount of haemolysin in 1ml of PBS which caused 50% 
haemolysis of 1ml of RBC after 60 minutes, the titre 
being the highest dilution showing activity.
Positive samples were confirmed by adding anti­
streptolysin O (Wellcome, Dartford, England) to show
specific neutralization of the haemolysin.
2,2.8 STREPTOLYSIN S SCREENING
Horse serum (20 % w/v) was added to 100 ml of THE and BHI 
broth and organisms incubated as before. Cells were then 
harvested by high speed centrifugation (15 000 g for 30 
minutes at 4°C) and the resultant pellets were 
resuspended in 8 ml of undiluted inactivated horse serum 
(heated at 56°C for 30 minutes) and shaken for 60 minutes 
with large glass beads (ballotini 12) in a Mickle 
disintegrator (Mickle Engineering, Gomshall). The
resulting suspension was centrifuged (15 OOOg for 10 
minutes) and the supernatant retained. Cell contents 
were further extracted by suspension in 8 ml of horse 
serum and centrifugation (15 OOOg for 30 minutes) after 
which the supernatant s were pooled and filtered to 
provide the assay fluid. The assay procedure was the
same as that described for SLO,
Anti-streptolysin O was added to positive samples and
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they were then assayed. This tested that the haemolytic 
effect was not neutralized, and thereby confirmed that 
the haemolytic activity was due to SLS.
2.2.9 SCREENING FOR PROTEASE
A 250pl aliquot of a 1% solution of Azocoll (Sigma) was 
mixed with 250pl of culture supernate and the mixture was 
incubated at 37°C for 30 minutes. Two volumes of ice- 
cold 5% TCA were added and mixed and the solution 
centrifuged for 5 minutes at high speed in a centrifuge 
( Micro centrifuge, MSE). The resulting supernatant was 
mixed with an equal volume of 0.5M NaOH and the 
absorbance at 440 nm was read after a 5 minute 
development time at room temperature. 1 protease unit = 
change in 00 440 of 0.1. A known positive strain of 
Clostridium perfringens was used as a control .
2.2.10 SCREENING FOR HYALURONIDASE
The method of Unsworth (1989) was used. Strains were 
grown overnight in 20ml of Todd-Hewitt broth with added 
Neopeptone 2% w/v, NazH^PO^. ZH^O 0.13 g/1 and Na^HPO^. 2HgO 
0.74 g/1, which prevented proteinase production. The 
broth cultures were centrifuged until the supernate was 
clear (1 000g/15mins) and 0.025ml was added to the first 
and second wells of one row of a microtitre plate
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(Titertek, Flow Laboratories Ltd, Irvine, Scotland). 
From these first two wells, doubling dilutions were made 
with cold distilled water. A further 0.025 ml of cold 
distilled water was added to each well followed by 0.05ml 
of potassium hyaluronate (Baeto AHT Substrate,Di fco) 
which was reconstituted with 8ml of cold diluted India 
ink (4%), The tray was shaken to mix its contents and 
incubated for 20 minutes at 37“C, after which it was 
cooled at 4“C for 30 minutes, Finally, 0,025ml of cold 
1 N acetic acid was added to each well and the tray again 
shaken to allow mixing. Presence of a black clot 
indicated intact hyaluronate substrate which clotted by 
addition of acid. Absence of a clot showed presence of 
hyaluronidase activity, as the hyaluronate substrate had 
been digested. The titre of hyaluronidase activity was 
the lowest dilution showing a negative reaction.
2.2.11 SCREENING FOR DNAse
The method of Porschen and Sonntag (1974) was used. 
DNAse agar (Oxoid) was supplemented with 0.3% yeast 
extract and cultures grown overnight. Plates were then 
flooded with 1 N HCl, Production of DNAse was 
demonstrated by a clear zone surrounding the colonies due 
to hydrolysis of DNA into nucleotide fractions which were 
not precipitated by the acid. Intact DNA formed a cloudy 
precipitate in the medium.
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2.2.12 CAMP TEST
A single streak of the test strain was made perpendicular 
to a streak of beta lys in-producing staphylococcus aureus on 
sheep blood agar plates, and the plate incubated in CO^
at 37° C. A positive result, enhancement of the
staphylococcal beta lysin by CAMP factor, was Indicated 
by the development of an arrowhead at the junction of the 
two streak lines. A positive control of group B
streptococcus, s.agaiactiae was included.
2.2.13 HAEMAGGLUTINATXON
Strains were grown overnight in BHIB 4^ 0.3% YE then
washed with PBS and suspended to an OD 660 nm of 1.0 ( 5 
X 10“ cells/ml). Suspensions (2 % w/v) of sheep, horse 
and human RBC ' s in PBS were used to measure
haemagglutination. The PBS was supplemented with 1% BSA 
to act as a non specific protein blocker which prevented 
autoagglutination of the RBC's. Phosphate buffered 
saline (50 pi) was placed into the wells of a round 
bottomed microtitration tray. An equal volume of 
bacterial suspension was placed in the first well and 
double diluted across the tray. To each well was added 
25 pi of the suspension (2%) of RBCs, The tray was then 
shaken for 30 seconds and left at room temperature for 3 
hours, after which the trays were examined. 
Haemagglutination appeared as a mat of erythrocytes
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covering the bottom of the wells, while absence of 
haemagglutination was indicated by a red button of 
sedimented RBCs, A negative control of RBCs plus PBS was 
included, while Bacteroides fragiiis strain NCTC 9344 acted 
as a positive control. The titre of activity was 
indicated by the last dilution showing a positive 
reaction.
2.3 RESULTS
2.3.1 STRAIN IDENTIFICATION AND CHARACTERISATION
Tables 2.1, 2.2 and 2.3 show the strain number, species, 
pattern of haemolysis and Lancefield grouping of the 
dental abscess, clinical and plaque isolates. The 
letters O, C and P liave been used in the strain numbering 
system to denote oral, clinical or plaque origin of the 
strain.
All three species were represented within each of the 
three groups of isolates. Dental abscess isolates 
comprised s.anginosus 13/26, S.consteiiatus 8/26 and 
S.intermedius 5/26. Of the clinical isolates, 5/20 were
S.anginosus, 9/20 S.consteiiatus and 6/20 S.intermedius « Among 
the plaque isolates, 5/13 were s.anginosus, 2/13 
S.consteiiatus and 6/13 S.intermedius respectively.
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TABLE 2.1 DENTAL ABSCESS ISOLATES
STRAIN HAEMOLYSIS: LANCEFIELD SPECIES '
002 (R) a F S.consteiiatus
003 a F S .intermedius
006 Of NT S .anginosus
007 NONE F S .intermedius
008 a NT S .anginosus
009 NONE F S .intermedius
010 NONE C S .anginosus
016 (R) NONE NT S ,conste1Iatus
018 3 F S .constellatus
019 Of F S .anginosus
020 3 F S .constellatus
021 Of NT S.anginosus
023 NONE NT S .anginosus
024 NONE A S .anginosus
025 (R) 3 NT S ,constellatus
025 3 NT S.consteiiatus
030 Of NT S.anginosus
031 Of NT S -anginosus
034 3 A S.anginosus
035 NONE NT S .intermedius
039 NONE F S .anginosus
040 NONE F S .anginosus
041 NONE NT -.... ...... ....S .anginosus
042 NONE NT S .constellatus
043 3 NT S .constellatus
044 3 NT S .constellatus
045 3 F S .constellatus
046 NONE NT S .intermedius
Lancefield grouping NT = non-typeable with antigens A,B,C,D,F and G.
(R) = Rough "star shaped" colony appearance as opposed to smooth pinprickcolonies common to the other strains.
TABLE 2.2 CLINICAL ISOLATES
.... .
HAEMOLYSIS LÂHCÈEIELD  ^ ' SPECIES
COl 0 NT S .constellatus
C02 a NT S .intermedius
C03 a NT S .intermedius
C04 NONE A S .anginosus
C05 0 F S .constellatus
006 . . . 0 ...... F S .intermedius
007 0 C S .intermedius
008 .... 0...... F S♦constel1atus
009 0 NT S .constel1atus
CIO NONE C S .anginosus
Oil NONE 0 S .anginosus
012 0 NT S ,constellatus
013 NONE NT S .intermedius
014 a NT S.intermedius
015 0 F S .constellatus
016 0 F S .constellatus
017 0 NT S.constellatus
018 NONE F S .anginosus
019 NONE F S .anginosus
020 .- _ 0....... NT S .constellatus
Lancefield grouping NT = non-typeable with antigensA,B,C,D,F and G.
(R) = Rough 'star shaped' colony appearance as opposed to smooth pinprick colonies common to the other strains.
TABLE 2.3 PLAQUE ISOLATES
: STRAIN HAEMOLYSIS LANCEFIELD ; ' ' SPECIES ‘ '
POl a C S .anginosus
P02 a F S .anginosus
P03 <x F S .anginosus
P04 0 NT S .constellatus
P05 (R) NONE NT S .anginosus
P06 (R) NONE NT S .anginosus
P07 (R) NONE NT S .intermedius
P08 NONE NT S .intermedius
P09 NONE NT S .intermedius
PIO NONE NT S .intermedius
Pll NONE NT S .intermedius
P12 NONE NT S.intermedius
P13 6 NT S .constellatus
NCTC11325 NONE NT S .constellatus
Lancefield grouping NT = non-typeable with antigensA,B,C,D,F & G.
(R) = rough ’star shaped' colony appearance as opposed to smooth pinprick colonies common to the other strains.
Colonies were of two appearances, the most common being 
the typically reported small, pinpoint, smooth mucoid 
colonies. The second type were rough "star shaped" 
pinpoint colonies which were less coiranon and indicated by 
(R) in Tables 2.1 - 2.3. All gave the distinctive 
caramel odour of diacetyl on blood agar plates incubated 
for 18 hours at 37“C.
Haemolytic strains, either a or 0 type haemolysis, and 
non haemolytic strains were found in each group of 
isolates, with a fairly even spread of the three types in 
dental abscess isolates. Beta haemolysis dominated in 
clinical isolates and an absence of haemolytic activity 
was common amongst plaque isolates.
Lancefield Groups A, C and F were found, with group F 
predominating, but most commonly there was no reaction to 
Lancefield grouping sera.
2.3.2 STREPTOLYSINS
Results of streptolysin O and 8 screening are shown in 
Tables 2.4, 2.5 and 2.6. Positive strains gave similar 
results and titres with sheep, horse and human red blood 
cells, with the exception of strain C13 which was SLO 
positive only with human RBC. As was expected most Group 
A strains were SLO positive (2/3) along with two Group F 
and one non-typable strain. All beta-haemolytic strains
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TABLE 2.4 STREPTOLYSIN AND ENZYME TITRES OF ABSCESS
ISOLATES
. SLS (TITRE)' STRAIN (TITRE)
002
003
006
007
008
009 +(1/16)
010
016
018 +(1/8)
019
020 +(1/64)
021
023
024
02 5R
025S +(1/16) +(1/8 )
030
031
034 +(1/8 )
035
039
040
041
042
043
044
045
046
TABLE 2.5 STREPTOLYSIN AND ENZYME TITRES OF CLINICALISOLATES
STRAIN SLO(TITRE) .HYALDRONXDASE
COl
C02
C03
004
C05 +(1/16)
+(1/32)C06 +(1/8 )
C07 +(1/64) +(1/128)
C08 +(1/32)
C09 +(1/16)
CIO
Oil
C12 +(1/128)
€13 +(1/8 )
€14
015 +(1/32) +(1/64)
€16 +(1/8) +(1/16)
+(1/16)€17
€18
€19
€20
TABLE 2.6 STREPTOLYSIN AND ENZYME TITRES OF PLAQUEISOLATES
DNASEHYALURONIPASE(TITRE]STRAIN
POl
P02
P03
P04 + ( 1 / 4 )
P05 +(1/16)
P06
P07
P08
P09
PIO
Pll
P12
P13
showed SLS activity.
2,3.3 PROTEASE ACTIVITY
All strains failed to show protease activity. This 
activity had been found by Steffen and Hentges (1981), 
but not by others (Mergenhagen, Thonard & Scherp, 1958 , 
Ottens & Winkler, 1952).
2.3.4 HYALURONIDASE ACTIVITY
Tables 2.4, 2.5 and 2.6 illustrate hyaluronidase
activity, which was exhibited by 16/28 dental abscess 
isolates, 11/20 clinical and 2/13 plaque isolates of 
species s.constellatus and s,intermedivs<^ One strain of 
s.angino&us was positive for hyaluronidase (P05). Titres 
ranged from Vz to 1/128 with no recognisable pattern of 
distribution of theses titres.
2.3.5 DNASE ACTIVITY
DNase activity is illustrated in Tables 2.4, 2.5 and 2.6. 
This activity was shown by a variety of strains, 
consisting of 71% of dental abscess isolates, 60% of 
clinical and 38% of plaque isolates.
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2.3.6 CAMP FACTOR
All strains tested negative for CAMP factor. Therefore 
the test strains did not produce the extracellular CAMP 
factor which enhances the haemolytic activity of the 
staphylococcal p lysin.
2.3.7 HAEMAGGLÜTINATION
No strain was able to haemagglutinate sheep, horse or 
human RBC, Ability to haemagglutinate RBCs is often used 
as an indicator of whether bacteria can attach to host 
cells, as it is a simple experiment to perform. 
Attachment to eukaryotic cells can be an important 
virulence determinant in a number of bacteria, and the 
inability of the SMG to haemagglutinate may indicate an 
Incapacity to adhere well to certain host cells.
2.3.8 SIGNIFICANCE OF SPECIES IN DISTRIBUTION OF
HAEMOLYSIS, HYALURONIDASE AND DNASE ACTIVITY
Table 2.7 illustrates the distribution of selected 
characteristics in relation to species. s. anginosus 
strains showed a low incidence of p-haemolysis, SLS, 
hyaluronidase (4.3% for all three) and SLO activity 
(8.7%), while they were moderately positive for
6 5
Table 2.7 ASSOCIATION or HAEMOLYSIS, TOXIN AND ENZYME CHARACTERISTICS WITH SPECIES
Characteristic s.anginosus S .constellatus S .intermedins
cx-haemolysis 9/23
(39%)
1/21(4.7%) 4 /1 7(23.5%)
0-haemolysls 1/23(4.3%) 18/21(85.7%) 2 /1 7(11.7%)
No haemolysis 13/23(56.5%) 2/21(9.5%) 11/17(64.7%)
SLO 2 / 2 3(8.7%) 2/21(9.5%) 1 /1 7(5.9%)
SLS 1 /2 3(4.3%) 18 /21(85.7%) 2/17(11.7%)
HYALURONIDASE 1 /2 3(4,3%) 17 /21(80.9%) 10/17(58.8%)
DNase 7 / 2 3(30,4%) 19/21(90.5%) 11/17(64,Z%J ...
haemolysis (39%), no-haemolysis (56,5%) and DNase 
activity (30.4%). In contrast, s, constellatus strains 
showed high incidence of (3-haemolysis and SLS activity 
(85.7%),hyaluronidase (80,9%) and DNAse (90.5%) 
production. Strains of s.intermedius showed average 
hyaluronidase (58.8%) and DNase (64.7%) activity, tended 
to be either a-haemolytic (23.5%) or non-haemolytic 
(64,7%) and had a low incidence of f3~*haemolysis and SLS 
activity (11.7%) and SLO activity (5.9%).
2.4 DISCUSSION
2.4.1 METHODS OF IDENTIFICATION
Use of the API 20 Strep test kit was an unsatisfactory 
method of identification of the SMG, as species were not 
distinguished, only Biotypes I, II or III which did not 
directly correspond to the three species. The Rapid ID 
32 Strep kit was a far more useful system, as it 
identified the three species. In most cases the reaction 
of the test strain produced an identification number 
corresponding to only one species, but on several 
occasions the identification was not definite, with a 
resulting ID of, for example, 96,3% likely as s,anginosus 
with 3.7% possibility of s.intermedius^ Therefore, to 
provide a conclusive yet rapid identification, the Rapid 
API 32 Strep test was used in conjunction with the 
fluorescence test of Whiley et al (1990). The
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fluorescence test provided good identification of 
s. intermedius strains, but as the essential difference 
between s. anginosus and s.constellatus is presence of p-D 
glucosidase activity in the former and absence in the 
latter, the discrimination between these two was 
occasionally inconclusive. Thus, combination of the two 
methods provided excellent identification to species 
level of the SMG. This was in agreement with the 
findings of Jacobs and Stobberingh (1994) who compared 
the Rapid ID 32 Strep kit with the fluorescence method of 
Whiley et al (1990). They found the systems agreed on 
70.2% of identifications, with the best agreement 
occurring for s. anginosus and most discrepancies with 
s. intermedius Strains, despite the latter being the most 
readily distinguished by the fluorogenic system.
From the biochemical profiles obtained, it can be stated 
that in general most strains fermented lactose, sucrose, 
trehalose and salicin, were Voges Proskauer positive 
(formed acetoin) and hydrolysed arginine and aesculin. 
They tended not to ferment raffinose, mannitol, sorbitol, 
inulin or arabinose or to hydrolyse starch or hippurate.
Kellens et al (1994) suggested another method for rapid 
characteri sat ion of the SMG, namely agglutination by 
lectins. They found that after boiling at pH 2, all 218 
isolates of SMG tested were agglutinated with 25 lectins, 
giving 45 agglutination patterns. They suggested that
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this could be an important assay in epidemiological and 
ecological studies of the SMG, potentially more useful 
than Lancefield grouping which only distinguishes 4 
groups (A,C,F & G),leaving almost 50% of strains 
ungroupable.
2.4.2 SPECIES DISTRIBUTION
Until recently, disagreement over the taxonomy and 
nomenc 1 ature of the SMG had led to the use of various 
naming systems for the group and different systems of 
identification being employed by American and European 
microbiologists. This made it impossible to illustrate 
any relationship between isolate type and the disease 
caused. However, with the recent classification of the 
SMG into 3 species, some reports have detailed 
significant differences in the distribution of these 
species. Whiley et al (1990 & 1992) found s.intermedius to 
be the most common of the SMG causing brain abscesses and 
also the most frequent isolate from supra gingival 
plaque, suggesting a plaque origin. They also noted that 
S.constellatus was the most common species isolated from 
dental abscesses, with s. anginosus tending to be found in 
the gastrointestinal and urogenital tracts and 
oropharyngeal infections. In the current work
S. intermedius was the most common plaque isolate ( 46% 
recovery), and of limited distribution in the other two 
groups (20% & 30% for abscess and clinical respectively).
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S.constellatus was not the most common isolate from dental 
abscesses, but this may have been due to insufficient 
numbers. These results suggest that particular species 
of the SMG do have a proclivity for certain infections.
2.4.3 CHARACTERISATION
When the 61 isolates are considered as a whole group they 
follow the trends noted by a number of previous studies 
performed before the SMG were divided into three species 
(Poole & Wilson 1979 ; Ball & Parker 1979 ; Shlaes et al 
1981 ; Ruoff, Kunz & Ferraro 1985). Most isolates were 
non-haemolytic (26/61 ; 43%) and many did not possess
Lancefield antigens (34/61 ; 54%). Among those that were 
haemolytic, {3 haemolysis was more frequent (21/35 ; 60%) 
than a haemolysis (14/35 ; 40%). Where Lancefield
grouping was determined. Group F was most common (19/27 
; 70%), followed by Group C (5/27 ; 19%), then Group A 
(3/27 ; 11%). No isolates of group G were found. There 
was a positive association between (3 haemolysis and Group 
F strains, with 8/19 (42%) showing (3 haemolysis, 5/19 
(26%) showing « haemolysis and 6/19 exhibiting no 
haemolysis. Whiley et al (1990) noted that Group F 
S.constellatus strains were nearly all (3 haemolytic, a 
result which is supported by the present work. They also 
reported that Group F s. anginosus strains were non 
haemolytic, though this was not shown conclusively in the 
present study.
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Therefore, the isolates collected represented a typical 
selection of SMG strains with characteristics similar to 
those reported previously.
2.4.4 POSSESSION OF TOXIN AND ENZYME ACTIVITY
Both the abscess and clinical isolates had similar 
numbers of strains possessing SLO, SLS, hyaluronidase and 
DNAse activity, SLO activity was present in 11% of 
abscess and 10% of clinical isolates, SLS in 29% of the 
former and 55% of the latter, hyaluronidase in 46% and 
55% and DNAse in 71% and 60% of the respective groups. 
Plaque isolates had a lower prevalence of all properties 
tested. Thus, none possessed SLO activity, 15% had SLS 
activity, 31% produced hyaluronidase and 38% produced 
DNAse. This illustrated that in the true commensal flora 
fewer strains possessed virulence factors. The few 
strains which did possess degradative and invasive 
activity may be important in initiating potential disease 
if the appropriate conditions arise.
2.4.6 HYALURONIDASE ACTIVITY
Whiley et al (1990) found that hyaluronidase activity was 
possessed by s.constellatus and s.intermedius but not 
s. anginosus and used this as a factor in identification. 
This was also found in the current study, with the
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exception of one s. anginosus strain, P05, which was 
positive for hyaluronidase at a titre of 1/16. The 
ability of this s. anginosus strain to exhibit hyaluronidase 
activity, when it is unreported by others, may be due to 
mis“identification of the species, although the 
identification was confirmed by both the API Rapid 32 
Strep test and the fluorogenic system reported earlier. 
It may also have been caused by a contaminant, although 
the result was obtained on two separate occasions using 
fresh inoculum, and on plating-out, only one colony type 
was present. Finally it may have been a mutant strain 
which does have hyaluronidase activity. Although the 
method used here was sufficient for a rapid screening, a 
more sensitive assay method for detecting hyaluronidase 
activity (for example the spectrophotometric assay used 
by Homer et al 1993) would be useful to help clarify the 
picture.
Poole and Wilson (1979) found a positive association 
between hyaluronidase production and haemolysis, which 
was also found in this study. Amongst those strains 
exhibiting hyaluronidase activity, 64% were a- or (3- 
haemolytic.
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CHAPTER 3 SURFACE PROPERTIES OF THE "STREPTOCOCCUS 
MILLERI GROUP"
3.1 INTRODUCTION
3.1.1 GENERAL INTRODUCTION
The bacterial cell surface is perhaps the most obvious 
site of interaction between the pathogen and host, and is 
important in many aspects of virulence. Attachment to 
host cells and the extracellular matrix is a necessity 
for bacteria colonising sites such as mucosal surfaces 
which are constantly being washed with host secretions 
(Beachey 1981). Attachment may also be advantageous for 
the bacterium which obtains nutrients by lysing host 
cells or digesting the extracellular matrix, where 
contact, then lysis, delivers nutrients directly 
accessible to the organism. Similarly, attachment may be 
required in order for the organism to deliver toxins to 
the host in order to cause disease. This was found by 
Satterwhite et al (1978), where a non-adherent strain of 
enterotoxigenic E.coil was unable to produce diarrhoea, 
despite retaining its toxin-producing ability. The 
authors suggested that attachment to the intestinal 
epithelium was essential for the toxin's effectiveness. 
At other stages of infection interaction of pathogenic 
bacteria with host cells can be a disadvantage, such as 
the need to avoid binding of complement and 
immunoglobulin molecules, and therefore retention of
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resistance to attachment to phagocytic cells. 
Silverblatt and Ofek (1978a) showed that fimbriated 
p.mirabilis adhered readily to urinary tract cells, causing 
pyelonephritis, but that these fimbriated cells also 
adhered well to phagocytic cells and were therefore more 
readily ingested and killed than their non-fimbriated 
counterparts (Silverblatt & Ofek 1978b). It can 
therefore be seen that the bacterial cell surface has a 
dual role to play in pathogenicity, the first being 
positive interaction with the host cell which aids the 
infection process, and the other in disguising its 
surface in order to avoid recognition by the host defence 
mechanisms.
This chapter will examine some surface characteristics of 
the SMG which may aid their pathogenicity, namely 
possession of capsule and bacterial cell surface 
hydrophobicity. The following two sections outline the 
possible significance of these.
3.1.2 RELEVANCE OF CAPSULE WITHIN THE SMG
The possibility that possession of capsule may be a 
pathogenic determinant for the SMG has been suggested by 
a number of investigators. Brook and Walker (1985) found 
that only strains of SMG in which > 50% of cells were 
encapsulated could cause subcutaneous abscesses in pure
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culture in mice. In addition, when unencapsulated 
strains, which previously could not induce abscesses, 
were injected into mice along with a capsulate strain, 
they could subsequently cause abscesses themselves (Brook 
and Walker 1985). Lewis et al ( 1988) also found pure 
cultures of SMG strains to induce abscesses in mice. 
These results suggest that a polysaccharide capsule may 
be required by the SMG for production of pyogenic 
infections, though it is not entirely clear how it 
contributes to their pathogenicity. Both papers
mentioned suggested that capsule may aid virulence by 
inhibiting phagocytosis, and this was investigated by 
Lewis et al ( 1993b). They found no difference in the 
degree of uptake of capsulate and non-capsulate strains 
of the SMG.
3.1.3 BACTERIAL CELL SURFACE HYDROPHOBICITY
The hydrophobic/hydrophilic nature of the bacterial cell 
surface affects subsequent interactions with other 
surfaces and particles, depending on their nature. In 
the absence of opsonin, the physico-chemical aspects of 
adherence are involved in phagocytosis of particles. The 
more hydrophilic the bacterial cell surface is in 
relation to the hydrophobicity of the phagocytic cell, 
the more likely it is to resist phagocytosis (Patrick and 
Larkin 1995) (Table 3.1).
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During the course of an infection,opsonins will override 
these physico-chemical interactions, but cell surface 
hydrophobicity should not be disregarded in this 
instance. Absolom (1988) stated that the more 
hydrophobic the bacterial cell the more likely it was to 
be opsonised with IgG and phagocytosed. This suggests 
that hydrophilicity may contribute to pathogenicity by 
facilitating evasion of the host defences.
Table 3.1 The hydrophobicity/ hydrophilicity of 
bacterial surfaces in relation to phagocytic cells
BACTERIUM/CELL CONTACT ANGLE
Hydrophilie; resistant to phagocytos i s by human PMNL
S .aureus S .typhimurium S .pneumoniae H.influenzae
Human PMNL
S.pyogenes
Guinea pig macrophages
16.517.017.017.6
18.0
21.3
21.3
Resistant to phagocytosis by guinea pig macrophages
Hydrophobic
E.coli 07 N .gonorrhoeas B .abortus
23.0 26.727.0
Figure adapted from Patrick & Larkin (1995) Ch 7 pl41
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3.2 MATERIALS AND METHODS
3.2.1 CAPSULE STAIN
The presence of capsule was assessed microscopically by 
negative staining using a modified India Ink wet mount 
method. India Ink (Pelican Black 9150,Osmiroid, England) 
(1 ml) was added to 1 ml of sterile water and centrifuged 
at 22 000 g for 20 minutes at 10° C . The pellet was then 
washed twice by suspension in 2ml of sterile water and 
centrifugation at 11 000 g for 15 minutes at 10° C . The 
pellet was finally resuspended in sterile water and mixed 
by sonication and mechanical agitation to give an aqueous 
preparation which was stored at 4° C .
Colonies were picked off an 18hr blood agar plate and 
mixed in a loopful of India Ink on a glass slide. A 
coverslip was applied and tapped into position using a 
wooden stick.
Preparations were examined under oil at x 1000 
magnification using a standard light microscope. The 
degree of encapsulation was recorded as capsule (+), 
small capsule + (s) and no capsule (-).
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3.2.2 EXAMINATION OF CAPSULE BY TRANSMISSION ELECTRON 
MICROSCOPY
Test strains of the SMG were grown overnight in BHIB +YE 
then centrifuged at 1 000 g for 15 minutes. The
resulting pellets were fixed for electron microscopy in 
Ruthenium red (Luft 1964 & 1971) using the following 
method. Primary fixative (Appendix ii) was added to the 
samples and incubated for 1 hour at 0“ C, followed by a 
rinse with buffer wash (Appendix ii). Post fixative was 
then added and the samples incubated for 3 hours at room 
temperature. Following fixation the specimens were 
dehydrated with graded alcohol and embedded in Araldite 
(Glauert 1965). Ultrathin sections were cut with a 
Diatome diamond knife and mounted on Formvar coated 
1000 pm aperture grids. The sections were examined using 
a Zeiss E.M. 109 electron microscope at 50 kV and 
electron micrographs taken on Ilford FP4 film.
All electron microscopy work was kindly performed by Dr 
Ian Montgomery of the Institute of Physiology, Glasgow 
University.
3.2.3 REMOVAL OF CAPSULE
(A) Physical
Initial attempts were made to remove the capsule by 
sonication. Bacterial suspensions were subjected to
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sonication of varying power and duration with a Microson 
XL ultrasonic cell disrupter (Heat Systems, New York). 
This machine is used within the Dental Hospital to 
emulsify plaque samples without damaging the organisms, 
and therefore was thought to be mild enough to remove 
capsular material, whilst leaving the organism intact.
(B) Chemical
Capsule was removed by treatment with hyaluronidase, a 
method which has been used to strip other streptococcal 
species of their capsule. 5 mg of hyaluronidase (Type 1- 
S from bovine testes / 340 units per mg) (Sigma) was 
added to 1 ml of sterile distilled water. This solution 
( 100 pi) was added to 1 ml of bacterial culture and 
incubated at 37°C for 20 minutes. After incubation a 
loopful was subjected to India ink capsule staining as 
previously described to check for absence of a capsule 
halo. A sample was also spun down into a pellet and 
processed for electron microscopy as detailed in the 
preceding section.
3.2.4 BACTERIAL CELL SURFACE HYDROPHOBICITY
The following two methods were used to measure cell 
surface hydrophobicity :
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(A) Hexadecane Partition Assay
Relative hydrophobicities were assessed by the method of 
Rosenberg et al (1980), Bacterial suspensions were 
adjusted to an OD 660 nm of 1.0 (5 x 10® cells/ml). An 
aliquot (0.86 ml) of bacteria was mixed with 0.14 ml of 
n-hexadecane (Sigma) and incubated for 10 minutes at 
30°C, after which the suspension was vortex mixed for 2 
minutes. The mixture was left for 15 minutes to allow 
the suspension to separate, the aqueous phase was removed 
with a pastette and the OD 660 nm recorded. Triplicate 
samples were set up in this way and the experiments were 
repeated three times. The percentage reduction in OD 
provided a measure of cell surface hydrophobicity.
A change in OD 660 nm of :
0% - 9% indicated a very hydrophilic surface 
16% - 49% showed moderate hydrophilicity 
50% - 79% showed moderate hydrophobicity 
80% - 100% denoted a very hydrophobic surface.
(B) Hydrophobic Interaction Chromatography
A modification of the method of Dahlback et al (1981) was 
used. Octyl Sepharose CL 4B (Pharmacia) was washed ten 
times with distilled water and then suspended 1:1 in 75%
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seven salts solution (Appendix I). This was then packed 
to a height of 50 mm into glass Pasteur pipettes 
(diameter 5 mm) which had been washed with ethanol and 
plugged with cotton wool. Bacterial suspension (1 ml) 
labelled with tritiated adenine (2 pCi/ml)(Amersham, 
England) at OD 620 nm 0.45 (1 x 10® cells/ml) was added
to the column and then eluted with 12 ml of 75% seven
salts solution. The eluate and gel were collected in 
scintillation vials, 3 ml of Ecoscint A (National 
Diagnostics) was added and counts obtained. The degree 
of hydrophobicity was indicated by the ratio g/e,
representing the radioactivity retained by the
hydrophobic gel(g) and that present in the eluate(e), 
The higher the g/e value the more hydrophobic the 
interaction, i.e. log g/e of less than 0 indicates a 
hydrophilic nature.
log g/e values of :
+0.51 - +2.0 very hydrophobic
+0.01 - +0.5 indicated a moderately hydrophobic surface
-0.01 - -0.5 denoted a moderately hydrophilic surface
-0.51 - -2.0 very hydrophilic
3.2.5 STATISTICAL ANALYSIS
Correlation between the two methods of assessing cell 
surface hydrophobicity was tested using a rank
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correlation test according to Spearman (Clarke 1980) 
which yielded a rank correlation coefficient, r^  within 
the limits ( -1 < r^  < 1  ) where 1 indicates exact
agreement and -1 complete disagreement.
3.3 RESULTS
3.3.1 DISTRIBUTION OF CAPSULE
The test strains of SMG showed varying capsule size, 
which was characterised as + denoting large and +(s) 
representing small capsule as determined visually by 
staining with India ink and shown in Figure 3.1. 
Characterisation of capsule in this way for the three 
groups of isolates is illustrated in Tables 3.2, 3.3 and 
3.4. Of the 61 strains tested, possession of + and +(s) 
capsule was evenly distributed, with 30/61 +, 30/61 +(s) 
and 1/61 having no capsule (025R). As would be expected, 
passage through an animal model increased capsule size. 
Strains used here were previously used by Lewis et al 
(1988) for abscess induction in mice and strains before 
and after animal passage retained. It was found that 
capsule size increased (pairs 016 & 020 and 018 & 021 
representing strains before and after passage), indeed 
016 changed from a rough to smooth colony appearance. An 
unexpected result was the change of 018 s. anginosus to 021 
s. constellatus after animal passage.
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FIGURE 3.1 INDIA INK STAINING OF + AND +(S) CAPSULE TYPES
■"S-v
(A) + CAPSULE (Mag. X500)
* ♦
I ■
(B) +(S) CAPSULE (Mag. X500)
TABLE 3.2 ENCAPSULATION OF DENTAL ABSCESS ISOLATES
' ' STPEAm  ^^ ‘ . CAPSULE ' SPECIES .
002 4- S .constel1atus
003 4- S .anginosus
006 ■Ks) S .anginosus
007 + S .intermedius
008 + S .anginosus
009 + S .intermedius
OlO + (s) S.anginosus
016 -ï* ( s ) S .constellatus
018 + (S) S .constellatus
019 + S .anginosus
020 f S .constel1atus
021 •f S .anginosus
023 S .anginosus
024 S .anginosus
025R S .constel1atus
025S + S,constellatus
030 + S .anginosus
031 S .anginosus
034 S .anginosus
035 S ,intermedius
039 + (S) S .anginosus
040 + S .anginosus
041 + (s) S .anginosus
042 + S .constel1atus
043 + S .constellatus
044 + S .constellatus
045 ■F S .constellatus
046 S-intermedius
Capsule : ^+ (s) large capsule present small capsule present no capsule present
TABLE 3.3 ENCAPSULATION OF CLINICAL ISOLATES
STRAIN; : ', \ CAPSULE SPECIES
COl + (s) S .constellatus
C02 4* S .intermedius
C03 + (s) S .intermedius
C04 + (s) S .anginosus
C05 + (s) S .constel1atus
C06 + (s) S .intermedius
C07 ■Ks) S.anginosus
C08 + S .constellatus
C09 + (s) S.constellatus
CIO 4 S .anginosus
Cll 4 S .anginosus
C12 , Ks) S .constellatus
C13 ...... +(8) S.intermedius
C14 + (S) S.intermedius
CIS + (S) S .constel1atus
C16 + S .anginosus
C17 + (s) S .constel1atus
018 + (s) S .anginosus
C19 4 S .anginosus
C20 4- S .constel1atus
NCTC 11325 4 S .constel1atus
Capsule : ++ (s) large capsule present small capsule present no capsule present
TABLE 3.4 ENCAPSULATION OF PLAQUE ISOLATES
............. ' CAPàUUÈ _ . .... ^ . SPECIES '
FOI S .anginosus
P02 + (s) S .anginosus
P03 _ +.(s) S .anginosus
P04 + (s) S .constellatus
P05 + (s) S .anginosus
P06 + (s) S,anginosus
P07 + (s) S .intermedius
P08 + (s) S .Intermedius
P09 ..... +(8) S .intermedius
PIO + (s) S .intermedius
Pll + S.intermedius
P12 + (s) S .intermedius
P13 -......+ Cs) S.constellatus
Capsule ;  ^•f(s) large capsule present small capsule present no capsule present
When capsule distribution was considered in relation to 
species (Figure 3.2a), each species had similar 
proportions of large and small capsules. As table 3.5(a) 
shows, s.anginosus had 11/26 (42%) of strains with +(s) and 
15/26 (58%) with + capsule, s. constellatus had 1/21 with no 
capsule, 10/21 (48%) +(s) and 10/21 with + capsular type, 
while s.intermedius strains showed 9/15 (60%) +(s) and 6/15 
(40%) + capsule. However, in relation to source of
isolates, both clinical and plaque isolates tended to 
have smaller capsules, while abscess isolates possessed 
more extensive capsular material (Figure 3.2b). Twenty 
one out of 28 abscess isolates had + capsular type, while 
only 7/20 clinical and 2/13 plaque isolates had larger 
capsule type.
3.3.2 EXAMINATION OF CAPSULE BY TRANSMISSION ELECTRON 
MICROSCOPY
TEM photographs of test strains (Table 3.5b) revealed two 
types of capsular material stained with ruthenium red. 
The first was a dense, dark- staining, thick layer of 
material and the second a more wispy, lightly-stained 
material (Figure 3.3). These corresponded respectively 
to strains showing + and +(s) encapsulation from light 
microscopy. The exception was strain 025R which was 
negative for capsule with India ink staining, but which 
showed a large, deep-staining capsule-like mass under TEM 
(Figure 3.4).
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Table 3.5(a) Distribution of Capsule in Relation to Species
B m c i m "
+ (S) +
S .anginosus 0/26 (0%) 11/26 15/26(42%) (58%)
S .constellatus 1/21 (4%) 10/21 10/21(48%) (48%)
S .intermedins 0/15 (0%) 9/15 6/15(60%1 _
Capsule : -f- - large capsule present +($)= small capsule present - = no capsule present
Table 3.5(b) Strains Subjected to Transmission Electron Microscopy
STRAIN' STRAIN * m  (NT &T1
00$ . + S.anginosus YES
00$ % + S .intermedins YES
: 0 1 6 + (8) S .constellatus YES
' OaSR — S .conste11atus YES
 ^ 0250 S,constellatus YES
COl + (s) S .constellatus YES
, Cl# . + (s) S.anginosus YES
NCTO 11325 + S.constellatus YES
m + (s) S.anginosus YES
311 + S .intermedins YES
*EM (NT & T) = electron micrographs of strains both before and after treatment with hyaluronidase to remove capsule.
w+ +□ ■
g3O(0s
ü2O)c1o
<
oS(0wO)c01c01 3 (/> Q.ScLUO>*uca>3a-o>
CM
ci23O)
lO o
s3)e|OS| *o jisquinN
FIGURE 3.3 ELECTRON MICROSCOPY OF CAPSULAR MATERIAL
Micrographs show two capsule types ; The first being thick capsule 
(+) and the second smaller capsule (+(S)).
1
(A) LARGE CAPSULE : STRAIN 025S
0 Sum
(B) SM ALL CAPSULE : STRAIN COl
FIGURE 3.4 CAPSULE REACTION OF STRAIN 025R
Photograph (A) shows the negative capsule stain with India ink, 
while Micrograph (B) shows capsular material.
. 'À/
\ A ,
% \ 
«^ ' X -
(A) STRAIN 025R SHOWING NEGATIVE CAPSULE STAIN (Mag. x 500)
O Sum
(B) 025R SHOWING CAPSULAR MATERIAL WITH RUTHENIUM RED 
STAIN UNDER TRANSMISSION ELECTRON MICROSCOPY
3.3.3 REMOVAL OF CAPSULE (A) BY SONICATION AND (B) BY 
TREATMENT WITH HYALURONIDASE
(A) Sonication
Electron microscopy performed on test strains which had 
been sonicated as described showed that removal of 
capsular material was patchy and left some areas of the 
cell stripped of capsule, while others retained a thick 
capsular layer.
(B) Hyaluronidase
Treatment of strains of the SMG with hyaluronidase gave 
rise to three different outcomes. The first resulted in 
the test strain being completely denuded of capsule. 
This occurred with those strains exhibiting wispy 
extracellular material (Figure 3.5). The second outcome 
was partial removal of capsular material from those 
strains with the thicker gelatinous material (Figure 
3.6). Finally, in the case of strain 025R,designated 
non-encapsulated due to India ink staining, no change 
took place (Figure 3.7).
3.3.4 HYDROPHOBICITY
The selected SMG strains exhibited both hydrophobic and 
hydrophilic characteristics as shown in Tables 3.6, 3.7, 
3.8 and 3.9. There was a statistically significant 
correlation between the two methods used to determine the
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FIGURE 3.5 ALMOST COMPLETE REM OVAL OF CAPSULE BY
TREATMENT W ITH  HYALURONIDASE
(A) STRAIN NCTC 11325 WITH CAPSULE (UNTREATED)
^ 1 ^
0 5
(B) STRAIN NCTC 11325 WITHOUT CAPSULE (HYALURONIDASE
TREATED)
FIGURE 3.6 PARTIAL REM O VAL OF CAPSULE BY TREATMENT
W ITH  HYALURONIDASE
O Sum
(A) UNTREATED STRAIN 025S
(B) STRAIN 025S TREATED W ITH  HYALURONIDASE
FIGURE 3.7 FAILURE TO REMOVE CAPSULE BY TREATMENT W ITH
HYALURONIDASE
0-5|jm
(A) UNTREATED STRAIN 025R
#
(B) STRAIN 025R TREATED W ITH HYALURONIDASE
TABLE 3.6 HYDROPHOBICITY OF SMG USING THE HEXADECANE PARTITION ASSAY
% CHANGE IN CD 660 nm
STRAINr RUN,1 : RUN 2 ' RUN 3 MEAN % CATEGORY
008 72% 61-6% 64% 65.8% HYDROPHOBIC (M)
009 56.3% 54,5% 60% 56.9% HYDROPHOBIC (M)
016 81.5% 94% 91% 88.8% HYDROPHOBIC (V)
02 5R 50% 87.5% 63.2% 66.9% HYDROPHOBIC (M)
0258 55.3% 46% 60.3% 53.8% HYDROPHOBIC (M)
046 84% 78% 81% 81% HYDROPHOBIC (V)
COl 87% 87.6% 80.6% 85% HYDROPHOBIC (V)
C02 40.3% 34.6% 33.3% 36% HYDROPHILIC (M)
C06 33.3% 26.6% 38.3% 32.7% HYDROPHILIC (M)
C08 44,6% 24% 24.3% 31% HYDROPHILIC (M)
CIO 5% 7.3% 2.3% 4.8% HYDROPHILIC (V)
C18 94% 78.6% 92% 88.2% HYDROPHOBIC (V)
NCTC 48% 42% 46-6% 45.4% HYDROPHILIC (M)
POl 15% 7% 10.3% 10.7% HYDROPHILIC (M)
P02 21% 42% 58.4% 40,4% HYDROPHILIC (M)
P04 62% 57% 69.3% 62.7% HYDROPHOBIC (M)
P08 74% 64% 84.1% 74% HYDROPHOBIC (M)
Pll 86% 38.6% 86.9% 87.1% HYDROPHOBIC (V)
P13 64% 56.6% 74.3% 64.9% HYDROPHOBIC fM)
Change in CD of0%““9% very hydrophilic - HYDROPHILIC (V) 10%~49% moderately hydrophilic = HYDROPHILIC (M) 50%*"79% moderately hydrophobic = HYDROPHOBIC (M) 80%-100% very hydrophobic ~ HYDROPHOBIC (V)
TABLE 3.7 HYDROPHOBICITY OF ABSCESS ISOLATES USING
HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC)
STRAIN RUN'd RUN. 2 RUN 3: RUN 4 MEAN CATEGORY
008 0.63 1.46 1.017 1.02 1,031 HYDROPHOBIC
-0.2 0.165 0.0073 0,008 0.0135 (M)
009 0.114 0.179 0.0706 0.057 0.105 HYDROPHILIC
“0.944 -0.746 -1.15 -1.24 -0.978 (V)
016 0.476 3.24 0.943 1.226 1.47 HYDROPHOBIC
-0.322 0.51 -0.025 0.088 0.167 (M)
025R — 3.27 0.323 0.6 1.397 HYDROPHOBIC
— 0.515 -0.49 -0.22 0.145 (M)
025S 0.14 0.225 0.218 0.53 0.278 HYDROPHILIC
-0,85 -0.646 -0.66 -0.28 -0.555 (V)
046 0.814 1.114 1.755 2.04 1.43 HYDROPHOBIC
-0.089 0.047 0.244 0.42 0.155 (M)
First row figures represent value of g/e Second row represent log g/e.A log g/e value of less than 0 indicates hydrophilicity
CATEGORY : Hydrophobic (V) Hydrophobic (M) Hydrophilic (M) Hydrophilic (V)
log g/e 0.51 - 1.5 log g/e 0.01 - 0.5 log g/e -0.01 - (-0.5) log g/e -0.51 - (-1.5)
TABLE 3.8 HYDROPHOBICITY OF CLINICAL ISOLATES USING
HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC)
STRAIN RUN 1 RUN 2 RUN 4 MEAN CATEGORY
COl 1.4 1.52 0.478 0.422 0.955 HYDROPHILIC
0.146 0.18 -0.32 -0.375 -0.02 (M)
C02 0.41 0.995 0.128 0.516 0.512 HYDROPHILIC
-0.38 -0,002 -0.89 -0.287 -0.29 (M)
C06 0.03 0.29 0.235 0.135 0.172 HYDROPHILIC
-1.5 -0.54 -0.629 -0.87 -0.764 (V)
C08 0.027 0.152 0.038 0.048 0.066 HYDROPHILIC
-1.57 -0,81 -1.42 -1.31 -1.18 (V)
CIO 0.011 0.272 0.106 0.092 0.12 HYDROPHILIC •
-1.96 -0.566 -0.97 -1.03 -0.92 (V)
C18 1.18 3.145 0.932 0.806 1.515 HYDROPHOBIC
0.07 0.497 -0.03 -0.094 0.18 (M)
NCTC 0.76 0.526 0.758 0.887 0.733 HYDROPHILIC
-0.135 -0.274 -0.12 -0.052 -0.135 ....  (M)
First row figures represent value of g/e 
Second row represent log g/e.
A log g/e value of less than 0 indicates hydrophilicity
CATEGORY : Hydrophobic (V) = log g/e 0.51 - 1,5
Hydrophobic (M) ~ log g/e 0.01 - 0.5
Hydrophilic (M) = log g/e -0.01 - (-0.5)
Hydrophilie (V) - log g/e -0.51 — (—1,5)
TABLE 3.9 HYDROPHOBICITY OF PLAQUE ISOLATES USING
HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC)
STHAIÎ^ RUN 1 ,'PtUN '2 ' RUN' 3 RÙN 4 . 'MEAN- CATEGORY"
POl 0.535 0.57 0.37 0.525 0.525 HYDROPHILIC
-0.19 -0.244 -0.49 -0.288 -0.28 (M)
P02 0.136 0.236 0,32 0.23 0.2305 HYDROPHILIC
-0,86 -0.62 -0.49 -0.656 -0.637 (V)
PÜ4 0.234 0.188 0.078 0.166 0.1665 HYDROPHILIC
-0.63 -0,72 -1.1 -0.81 -0.778 (V)
P08 0,907 0.373 0.98 0.75 0.752 HYDROPHILIC
-0.04 -0.42 -0.008 -0.156 -0.123 (M)
Pll 0.193 0.242 0.68 0.37 0.371 HYDROPHILIC
-0.71 -0.61 -0.16 -0.49 -0,43 (M)
P13 0.358 0.08 0,22 0.219 0.219 HYDROPHILIC
-0.44 -1.08 -0.65 -0.72 “0.659 CV) ...
First row figures represent value of g/e 
Second row represent log g/e.
A log g/e value of less than 0 indicates hydrophilicity.
CATEGORY Hydrophobic (V) 
Hydrophobic (M) 
Hydrophilic (M) 
Hydrophilic (V)
log g/e 0.51 - 1.5 
log g/e 0.01 - 0.5 
log g/e -0.01 - (-0.5) 
log g/e -0.51 - (-1,5)
cell surface hydrophobicity of the SMG (r^  = 0.7193), 
Abscess isolates were hydrophobic in nature (all 6 
strains with hexadecane partition assay and 4/6 with 
HIC), while clinical isolates were predominantly 
hydrophilic (4/6 with the hexadecane partition assay and 
5/6 with HIC). However, plaque isolates gave conflicting 
characteristics between the two methods in 4/6 strains, 
making characterisation difficult.
Possession of capsule provides the cell with a 
hydrophilic surface. As table 3.10 shows, the extent of 
capsular material does not correlate with the cell 
surface hydrophobicity. Five of seven hydrophilic 
strains do show + type capsule, but 5/12 hydrophobic 
strains also exhibit a greater extent of capsular 
material.
3.4 DISCUSSION
3.4.1 DISTRIBUTION OF CAPSULE
Dental abscess isolates had larger capsules than the 
other two groups. This may have been expected as 
previous work showed that possession of a capsule was 
necessary for dental abscess isolates to cause a purulent 
infection (Lewis et al 1993a). As all these strains were 
isolated from the pus of dental abscesses a large capsule 
was to be anticipated. Successful pathogens must be
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Table 3.10 Effect of Capsule on Hydrophobicity
CAPSULE .'■.SyèÉdPHOBfCITŸ- ■
008 4" Hydrophobic
009 4 Hydrophobic
016 + (s) Hydrophobic
02 5R Hydrophobic
0258 4 Hydrophobic
046 4- Hydrophobic
COl ___  ti s )______ Hydrophobic
002 + Hydrophilic
C06 + (s) Hydrophilic
C08 f Hydrophilic
CIO + Hydrophilic
018 + (S) Hydrophobic
NCTC 11325 -f Hydrophilic
POl 4* Hydrophilic
P02 4-{S) Hydrophilic
P04 +(8)... .. Hydrophobic
P08 + (s) Hydrophobic
Pll 4 Hydrophobic
P13 ____  ___ Hydrophobic.......
* Hydrophobicity as determined by HIC
Capsule : + ^( s ) large capsule present small capsule present no capsule present
adaptable in order to survive and produce disease, 
exhibiting surface adhesins in order to adhere, but on 
invasion of deeper tissues they may produce capsules to 
mask their surface in order to avoid attachment to 
phagocytic cells. This situation occurs in s.p n e u m o n i a e  
and s.p y o g e n e s  (Beachey 1981) and may occur in the SMG, 
thus going some way to explaining the differing extent of 
possession of capsule within the SMG. There is no
evidence in the literature to suggest capsule is needed 
for clinical isolates to cause infection, but results 
here, where all isolates possessed a degree of capsular 
material, may indicate that it is important, perhaps in 
avoiding phagocytosis. Plaque isolates may have smaller 
capsules to allow their surface structures to interact 
with other bacteria in the plaque mass, allowing them to 
persist in the mouth.
3.4.2 VISUAL AND ELECTRON MICROSCOPIC INVESTIGATION OF 
CAPSULE
Examination of India ink stains under light microscopy 
showed capsular halos which could be distinguished by 
size. Wilkinson (1958), described capsule as having a 
thickness of over 200 pm, which allows it to be 
visualised under light microscopy .
There was a good correlation between the capsule viewed 
via negative staining with India ink and electron
8 5
microscopic examination of ruthenium red stained 
sections. Two varieties of capsule appeared to be
present. The first type showed a small halo stained with 
India ink which appeared as a corresponding wispy 
material under EM. The second gave a larger halo under 
light microscopy and correspondingly thicker material 
under EM. However, strain 025R showed no halo with India 
ink, but did have a layer of material stainable by 
ruthenium red. This may be a similar situation to that 
suggested by Patrick et al (1986), who found that a 
strain of b . f r a g i l i s  (A334) showed no halo by the India ink 
method, but possessed a layer of material which stained 
with ruthenium red, designated the Ruthenium Red layer 
(RRL). They suggested that the two techniques do not 
detect the same structure. In this case strain 025R may 
possess a RRL and not capsule.
3.4.3 CAPSULE REMOVAL
As hyaluronidase randomly cleaves p-N acetyl hexosamine 
(1 -> 4) glycosidic bonds in hyaluronic acid, chondroitin 
and chondroitin sulphates, it can be suggested that the 
SMG capsule as for Group A and C streptococci, consists 
of hyaluronic acid which was removed by treatment with 
hyaluronidase (Figures 3.5, 3.6 and 3.7). Strains with 
the wispy material were completely denuded after 
treatment, while in the case of the denser material only 
partial removal occurred. This may have been because
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more material was present and therefore either a longer 
exposure to hyaluronidase was needed to completely digest 
it, or a more concentrated solution of the enzyme was 
required. Another explanation may be that all the 
hyaluronic acid capsular material present had been 
removed and the residual material was of a different 
composition, remaining undigested, and so termed, as 
before, the RRL. In the case of strain 025R the fact 
that little change occurred after treatment with 
hyaluronidase supports the suggestion that the material 
here is RRL and not capsule as defined in the other 
strains, perhaps having a constitution other than 
hyaluronic acid. This could be investigated by stripping 
the capsule and assaying it for hyaluronic acid content. 
Preliminary investigations like this were carried out, 
but the assay system used was not specific for hyaluronic 
acid, just pentoses and hexoses which encompasses a 
number of substances. Another explanation for the patchy 
nature of removal may be impurity of the hyaluronidase 
enzyme, thus being contaminated with other enzymic 
activity, Confirmation of a purely hyaluronic nature for 
capsule of SMG strains would negate this problem.
3.4.4 HYDROPHOBICITY
A number of techniques are currently used to estimate 
cel 1 surface hydrophobicity, with the two methods used 
here relying upon binding to a hydrophobic 1igand. The
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Chemical composition of both octyl-sepharose and 
hexadecane leads us to expect that both assays would 
correlate well (Van der Mei et al 1987), which indeed was 
the case. Investigators have also found that other 
methods of assessing cell surface hydrophobicity 
correlate well, both when comparing different strains of 
the same species and with Gram positive and Gram negative 
species ( Lindahl et al 1985 ; Clark et al 1985) .
However, others have found a lack of correlation between 
the methods (Dillon et al 1986 ; Mozes & Rouxhet 1987) 
and have suggested that it is not possible to define the 
surface 'hydrophobicity' of a bacterium other than on a 
comparative level with closely related strains of similar 
surface structure (Van der Mei et al 1987).
As this work only characteri sed SMG organisms, and 
therefore a similar cell surface composition would be 
expected, it was likely that the two methods would 
correlate with each other. However, this does not 
address the discrepancies obtained with the two methods 
used to characterise the plaque isolates. There may be 
some aspect of their composition which is peculiar to 
plaque isolates which makes these strains react 
differently in the two tests. Perhaps the possession of 
smaller amounts of capsular material amongst plaque 
isolates allows other surface structures which may be 
present such as pili to interact in a different manner 
than in the well encapsulated strain where similar
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structures may be masked. There were also variations in 
results between runs, although every effort was made to 
standardise both growth and assay conditions. Expression 
of cell surface hydrophobicity can be affected by growth 
conditions and nutrient availability which may explain 
differences between runs.
Capsule provides the cell with a hydrophilic surface, yet 
some strains of SMG with large capsules were hydrophobic. 
It may be the case that these organisms have other 
surface structures, such as fimbriae, responsible for 
hydrophobicity, as occurs in the case of E . c o l i  (Sherman 
et al 1985). Fimbriae have been reported in the SMG 
(Handley et al 1985), but their presence or absence in 
the present study cannot be commented upon as the 
sectioning procedure for EM examination makes it highly 
unlikely that these would remain visible. Negative 
staining with whole bacterial preparations would be 
necessary instead.
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CHAPTER 4 ADHERENCE OF THE "STREPTOCOCCUS MILLER! GROUP" 
TO BUCCAL EPITHELIAL CELLS
4.1 INTRODUCTION
4.1.1 GENERAL INTRODUCTION
Many bacterial infections are initiated by adherence of 
the microorganism to the mucosal surfaces of the 
respiratory, gastrointestinal or urogenital tracts 
(Gibbons 1977). For colonisation to result the organism 
must adhere strongly in order to avoid being swept away 
by mechanical forces and cleansing mechanisms such as 
sneezing, coughing and peristalsis. For colonisation of 
mucosal surfaces organisms must not only adhere, but 
multiply rapidly in order to recolonise newly exposed 
epithelial cell surfaces as old ones and their adherent 
bacteria are exfoliated and swept away (Beachey and 
Courtney 1987), Certain bacteria adhere more readily in 
particular locations, where they are likely to cause 
infection, for example streptococci causing pharyngitis 
(Stollerman 1975) and coliform bacteria causing urinary 
tract infections (Silverblatt 1974). Indeed amongst the 
SMG, Willcox and Knox (1990) found that isolates from 
dental abscesses adhered more effectively than other 
strains to buccal epithelial cells (BEC),
Colonisation of the oral cavity requires that in order to
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avoid being removed by saliva flow and the mechanical 
action of chewing, microorganisms adhere to the surfaces 
of the mouth. The strength of adhesion to various oral 
surfaces differs widely among oral bacteria and is a 
major reason for their different intraoral sites of 
localisation (van Houte 1983). Most pathogenic bacteria 
are capable of expressing multiple adhesins, each with a 
distinct receptor specificity and with an independent 
mechanism of regulating adhesin expression (Ofek & Doyle 
1994), Hogg and Manning (1988) found that lipotechoic 
acid (LTA) inhibited adherence of viridans streptococci, 
including s.miiieri, to fibronectin coated hydroxyapatite, 
suggesting it may be one adhesin for the group. Eifuku 
et al ( 1990) found that 60% of s.miiieri strains tested 
could coaggregate with some actinomycetes. This was not 
inhibited by lactose and the patterns of inhibition of 
coaggregation suggested this reaction belonged to 
streptococcus coaggregat i on group 2, as detailed by 
Ko1enbrander and Williams (1983), Three basic kinds of 
coaggregation are distinguishable on the basis of the 
assortment of heat or protease sensitivities with six 
groups of streptococci (coaggregation groups 1-6) and six 
groups of actinomyces ( groups A to F) having been 
identified (Ko1enbrander, Xnouye and Hoideman 1983). 
Further work by Eifuku et al (1991) found some s.miiieri 
strains exhibited lactose-inhibitable coaggregation with 
actinomycetes and streptococcus coaggregation groups 3, 
4 or 5, suggesting that a number of adhesins may be
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involved. Willcox et al (1994) found that Lancefield 
group C SMG strains aggregated human platelets due to a 
proteinaceous substance on the surface of SMG. Douglas 
et al (1990) reported on the ability of other oral 
streptococci to aggregate platelets, as this is one 
proposed mechanism in the pathogenesis of infective 
endocarditis. They found that among s.sanguisr a common 
causative agent of infective endocarditis, the ability to 
aggregate platelets was confined to certain biotypes, 
while other oral streptococci such as s.mitior and s.mitis 
did not aggregate platelets. They concluded that ability 
to aggregate platelets is not essential for an organism 
to cause infective endocarditis, but may still be an 
important virulence factor.
Lancefield group C SMG were also shown to bind albumin, 
with the receptor of s. i n t e r m e d i u s  C5 characterised as a 
cell surface protein of M^  24000 dissimilar from protein 
G (Willcox et al 1993). The SMG were also found to bind 
fibronectin via a cell surface receptor of 14000, and 
binding increased the association of strains with PMNL 
(Willcox et al 1995) . These studies clearly indicate 
that the SMG has a number of adhesin molecules on its 
cel 1 surface which participate in the adherence of 
strains to both host cells and other microorganisms, 
which can aid in pathogenicity in a number of ways.
The SMG regularly occur in the oral cavity, being found
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in plaque, saliva and on the surfaces of the tongue and 
cheek (Mejare & Edwardsson 1975). Although more numerous 
in plaque than on the mucosal surfaces of the mouth, 
Willcox and Knox (1990) found that isolates of the SMG 
from dental abscesses adhered more effectively than other 
strains to buccal epithelial cells (BEC). As enhanced 
ability to adhere in the mouth would aid pathogenicity, 
the adherence to BEC for a range of isolates derived from 
oral abscesses, non-oral infections and dental plaque 
(commensal isolates) was measured. Viridans
streptococci, including the SMG, as part of the normal 
oral flora can enter the bloodstream as a result of 
dental procedures. This may lead to infective
endocarditis with reports implicating dental procedures 
in 14 to 19 percent of cases (Mostaghm & Millard 1975, 
Bayliss et al 1986). Therefore, dental procedures can 
produce a bacteraemia leading to infective endocarditis 
in at risk patients, and strains which adhere to surfaces 
in the mouth like BEC may be able to enter the body and 
cause disease in such a manner.
4.1.2 MICROBIAL ADHESION
The process which results in microbial adherence to a 
host cell can be considered as two distinct events. 
First, when the two bodies are situated at a distance 
from each other, non-specific attractive forces act 
between the two in order for them to approach close
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enough for the second stage of adherence to occur, that 
is, specific interaction between adhesins and receptors 
on the two surfaces. Each of these stages will be 
discussed in the following sections.
4.1.2.1 Physico-chemical Aspects of Microbial Adhesion
Prior to the specific interactions between host cell and 
organism, interaction of a number of non-specific factors 
will have resulted in the two surfaces becoming close 
enough for specific adhesins to operate. The physical 
chemistry underlying these phenomena is complex, and this 
section will outline some of the basic principles to be 
considered in the analysis of microbial adherence. 
Figure 4.1 shows a diagrammatic representation of some of 
the aspects discussed.
Contact between two immiscible bulk phases creates an 
interface, which in terms of microbial adhesion is that 
between a solid collector and the aqueous system in which 
it is immersed. In a liquid milieu, the solid acquires 
a surface charge, either by ionisation of surface groups 
or by adsorption of ions. Once the charge is acquired 
the surface attracts counter-ions from the surrounding 
aqueous medium, this process being opposed by the thermal 
motion of the counter-ions. The net effect of these two 
opposing processes is the formation of a zone next to the
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FIGURE 4.1 PHYSICO-CHEMICAL ASPECTS OF MICROBIAL
ADHERENCE
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Figure shows the effect of the electrical double layer on bacterial adhesion, with 3 distinct interaction regions depicted, (a) >50 nm reflects van der Waals attractions, (b) a closer region, 10-20 nm, involves both van der Waals and Coulombic forces. The diameter of the electric double layer is 1-5 nm in physiological buffers, so bacteria are generally repulsed from substrata at distances of < 8-12 nm. (c) At < 2 nm complementary binding sites which may involve hydrophobin-hydrophobin, lectin-carbohydrate and charge-charge interaction. The presence of hydrophobic sites may stabilize other interacting sites, with the result being a virtually irreversible adhesion, (d) illustrates 2 extreme cases,A where there is a sufficiently high energy barrier preventing deposition and B where such a barrier has dissappeared.
charged surface, referred to as the "Gouy-Chapman diffuse 
electric double layer", where the concentration of 
counter-ions is greater than in the rest of the aqueous 
phase. It is usual for both the bacterial and collector 
surfaces to be negatively charged in aqueous 
environments, and therefore a bacterial cell will 
experience a repulsive force when its diffuse double 
layer approaches that of a collector (Fletcher et al 
1980).
Analysis of long range forces between cells and between 
cells and surfaces is based on the DLVO theory of 
colloidal stability (Derjaguin & Landau 1941, Verwey & 
Overbeek 1948), For the model of microbial adhesion, 
contact interactions between bacteria and a collector may 
be considered in terms of the balance of electrostatic 
repulsion, and attractive forces of the van der Waals 
type.
At short distances between surfaces there is a very high 
potential energy barrier which must be crossed to allow 
direct interaction. This requires an energy supply, 
either from the particle itself or from bombardment by 
other molecules (producing Brownian motion of bacteria). 
Both produce insufficient energy (Brooks et al 1967), and 
it appears cells are incapable of passing the barrier. 
However, an attractive secondary energy minimum exists at 
a greater distance between bodies, which is relatively
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weak. Although it does not account for adhesion, it may 
play a role in halting a cell long enough to allow other 
adherent interactions to take place.
4.1,2.2 Specific Interactions
Once an organism has penetrated these nonspecific forces, 
the interaction at the mucosal surface is highly 
selective, depending on whether or not the surface 
presents the receptors required for the adhesive 
structures on the surface of the invading organism 
(Beachey and Courtney 1987). The preference of 
particular bacteria for certain tissues over others 
(tissue tropism) was illustrated by Gibbons (1977). For 
example s t r e p t o c o c c u s  m u t a n s  was found in high numbers in 
dental plaque, but sparsely on the epithelial cells of 
the tongue. In contrast, s t r e p t o c o c c u s  s a l i v a r i u s  attached 
in large numbers to tongue epithelial cells, but was 
absent from plaque.
The specific binding between unique adhesins on the 
bacterial cell and receptors of the host cell is common 
to all bacteria and the interaction can be compared to 
the combination which occurs between an enzyme and its 
substrate (Ofek and Beachey 1980). In general, bacterial 
adhesins are conposed of proteins in the form of fimbriae 
or fibrils, while host cell receptors consist of
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carbohydrate moieties of glycolipids or glycoproteins 
(Beachey, Giampapa and Abraham 1988).
Characterisation of adhesin and receptor molecules 
involved in adherence illustrates the highly specific 
nature of binding, and s.p y o g e n e s  will be considered here 
as an example, s. p y o g e n e s  initially adheres to and 
colonises the epithelial cells of the skin and pharyngeal 
mucosa (Wannamaker 1970). Exogenous fibronectin was 
shown to inhibit this adherence, and the organism adheres 
preferentially to fibronectin-coated epithelial cells 
(Abraham, Beachey and Simpson 1983), suggesting 
fibronectin binding has a major role to play in the 
adherence of this organism. Identification of the 
surface structure responsible for binding fibronectin has 
been problematic. Lipotechoic acid (LTA) has been 
implicated (Simpson and Beachey 1983), while Ofek, 
Simpson and Beachey (1982) suggested M protein played a 
role by forming a complex with LTA. This binding 
oriented LTA to expose the lipid moiety on the 
streptococcal cell surface and thus facilitated binding 
of the bacterium to fibronectin (Simpson, Courtney and 
Ofek 1987).
More recent studies have demonstrated that the high 
affinity fibronect in-binding property of s.p y o g e n e s  is 
mediated by a surface protein, named protein F (Hanski 
and Caparon 1992). They illustrated that when protein F
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production was lost, s.p y o g e n e s  strains lost their ability 
to bind fibronectin, Sela et al (1993) identified two 
binding domains and suggested these bind to two different 
regions on the fibronectin molecule.
4.2 MATERIALS AND METHODS 
ASSAY OF ADHERENCE OF SMG TO BEC
A modification of the method of Willcox and Knox (1990) 
was used, where incubation time was cut from 120 minutes 
to 45 minutes, and incubation was carried out in a 
titration plate of diameter 1 cm which allowed for 
greater mixing than that allowed in the microtitration 
plate used by the aforementioned authors.
4,2.1 COLLECTION OF BUCCAL EPITHELIAL CELLS
Buccal epithelial cells (BEC) were collected by agitating 
10 ml of PBS in the mouth for 1 minute and returning it 
to a sterile universal. This was left to stand for 10 
minutes to allow large particles to sediment, after which 
the suspension was decanted off into fresh universels. 
BEC from 4 donors were pooled and washed twice in PBS by 
centrifugation (110 g / 10 minutes) to remove loosely 
attached commensal flora. These were then resuspended to 
an OD 550 nm of 0.2 (1-2 x 10^  BEC/ml).
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In order to minimize interference of the normal flora 
with adherence, the BEC were screened in two ways. After 
washing, BEC from each donor were smeared onto a glass 
slide, the preparation Gram stained and examined under 
oil at xlOOO magnification, where a count of bacteria 
adherent to 20 BEC was made. Any donor with levels of 
colonisation greater than a mean of 20 bacteria per BEC 
was not included in the pool of donors. On the day of 
collection and use of BEC a check was again made on the 
levels of adherent commensal bacteria after washing. 
Levels of colonisation of > 20 bacteria per BEC excluded 
that sample.
Variation was minimized by collecting BEC at the same 
time of day and pooling cells from four suitable donors.
4.2.2 PREPARATION OF BACTERIA
Bacteria were grown overnight in BHl + 0.3% w/v yeast 
extract, to which 3H adenine at 2 pCi/ml (Amersham, 
Buckinghamshire, England) was added. These cultures were 
incubated at 37° C for 18 hrs in an anaerobic jar, after 
which they were washed three times with PBS (1 OOOg for 
15 mins) and resuspended to give an OD 660 nm of 1.00 
(5 X 10® cfu /ml ). The %ef f iciency of labelling (measured 
automatically by the LSC) with 3H ranged from the lowest 
value of 31.9% to the highest of 63.2%, but in most 
instances the efficiency of labelling was around 45%.
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4,2.3 ASSAY PROCEDURE
Bacteria (0.1 ml) + 0.1 ml BEC were mixed in round 
bottomed wells (1 cm diameter)of a micro-titration plate 
and incubated at 37° C in an orbital incubator 
(Gallenkamp, East Kilbride) at 100 rpm for 45 minutes. 
Cells were then harvested by means of a vacuum pump onto 
polycarbonate filters of 8.0 pm pore size (Nucleopore) 
which were supported on a funnel in a conical flask. 
Unattached bacteria were removed by washing with 30 ml 
PBS in 5 ml aliquots. The filter was then placed into a 
scintillation vial and 3 ml of Ecoscint A (National 
Diagnostics, Atlanta, Georgia) added, after which the 
radioactive emission was measured on a Wallac 1409 liquid 
scintillation counter (Wallac, Turku, Finland), Controls 
of bacteria alone were also filtered and these background 
counts subtracted from counts of the samples. An 
unfiltered sample count (5 x 10 ® cfu) was also made to 
represent 100% adherence. Each strain was tested in 
quadruplicate on four occasions.
The formula used to determine adherence was as follows :
Sample count - Background count
% Adherence =       % 100
Total count
100
4.2.4 TIME COURSE OF BACTERIAL ADHERENCE
In order to define the optimum incubation time, a poorly 
adherent strain and a strain which bound well (found by 
following the exact method of Willcox and Knox, 1990) 
were incubated in the assay system for two hours, and 
sampled every 15 minutes up to 1 hour and 30 minutes 
thereafter. This was repeated three times and the 
optimum time for adherence recorded.
4,2.5 ROLE OF CAPSULE IN ADHERENCE TO BEC
Capsule was removed from test strains by treatment with 
hyaluronidase as detailed in Section 3.2.3. In brief, 
300 p.1 of hyaluronidase solution ( 5 mg of type 1-8 
hyaluronidase from bovine testes added to 1 ml sterile 
water) was added to 3 ml of bacterial culture and 
incubated at 37° C for 20 minutes. Untreated samples had 
300 pi of distilled water added and were incubated in the 
same way, after which the bacteria were used in the 
adherence assay.
4.2,6 VISUAL COUNTS OF ADHERENCE
To confirm the results of the radiometric assay the 
adherence of a few strains was checked visually. After
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incubation and washing as normal the filter was smeared 
across a glass slide and once dry the preparation was 
Gram stained. The slide was examined microscopically at 
X 100 magnification under oil with a light microscope and 
the number of bacteria adherent to 20 BEC counted.
Photographs were taken using a Nikon FX-35 A camera 
connected to a Nikon optiphot microscope and attachments.
4,2.7 Statistical Analysis
A non parametric statistical test, the Mann-Whitney U 
test, was used for comparisons between data, with a value 
of p < 0,05 being considered significant.
4.3 RESULTS
4,3,1 KINETICS OF ADHERENCE TO BEC
The kinetics of adherence of two strains of SMG are 
illustrated in Figure 4,2. Strain 008 adhered well after 
5 minutes and stayed at a similar or lower value 
throughout, whereas 025R initially adhered poorly, but 
gradually increased over time. Strain 008 gave a peak 
adherence value of 2.2% (+/- 1.5%) and 025R gave one of 
15.4% (+/- 6.5%), both peaking at 45 minutes. Both then 
showed decreasing adherence over 45 to 90 minutes and 
then rose at 120 minutes, but not to the peak value.
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Thereforey instead of the 120 minutes incubation time used 
by Willcox and Knox (1990), 45 minutes was employed
throughout.
4.3.2 ADHERENCE OF THE SMG TO BEC
Values for adherence to BEC of strains from the three 
test groups, those from dental abscesses (9), those from 
clinical infections elsewhere (6) and plaque isolates 
(6), are shown in Tables 4.1, 4.2 and 4,3 respectively. 
Dental abscess isolates gave mean % adherence values 
ranging from 0.76% to 26.8%, clinical isolates 0,11% to 
0.95% and plaque isolates 0.16% to 3.55%. There is 
evidence that dental abscess isolates had a higher 
affinity for BEC than clinical and plaque isolates.
Indeed, there was a statistically significant difference 
between mean % adherence to BEC of dental abscess 
isolates compared to both clinical (p=0.0027) and plaque 
isolates (p=0.029), with no significant difference 
between the latter two. This may indicate that abscess 
isolates have different adhesin molecules on their 
surface than the other two species, which allow them to 
selectively bind to BEC,
4.3.3 ADHERENCE CHARACTERISTICS OF DIFFERENT SMG SPECIES
The ability of different species of streptococci of the
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TABLE 4.1 VARIATION OF ADHERENCE OF DENTAL ABSCESS
ISOLATES OF SMG TO BEC
' . " " ^ " ; 1 , . ,1. . ^ .... r ,% ADHERENCE OF STRAINS OF SMG
STRAIN RUN 1 RUN 2 RUN 3 RUN 4 MEAN S.D. SEM
4.1% 1.49008 8.1% 1.9% 7.74% 5.46% 2.98
009 0.39% 1.37% 1.19% 0.11% 0,76% 0.61 0.3
016 9.4% 37.2% 8.6% 29.6% 21.2% 14.3 7.15
018 3.27% 1.5% 3.3% 2,47% 1.06 0.61
020 1.05% 1.1% 1.3% «- 1.15% 0.13 0.07
021 2.3% 2.5% 3.08% 2.63% 0.40 0.23
025R 25.4% 37.8% 12.4% 31.5% 26.8% 10.8 5.42
0258 8.4% 10.4% 3.4% 5.68% 6.97% 3.07 1.53
046 5.7% 2.95% 0.85% 4.83% 3.6% 2.13 1.06
SD - STANDARD DEVIATION SEM = STANDARD ERROR OF MEAN
TABLE 4.2 VARIATION OF ADHERENCE OF CLINICAL ISOLATES OF
SMG TO BEC
% ADHERENCE OF STRAINS OF SMG .
STRAIN RUN 1 RUN 2 RUN 3 RUN 4 MEAN S.D. SEM
001 0.34% 0.29% 0.17% 0.83% 0.4% 0.29 0.14
C02 0.33% 0.6% 0.11% 0.24% 0.32% 0.2 0.1
C06 0.98% 0.22% 0.36% 0.17% 0.43% 0.37 0.18
C08 0.24% 0.22% 0.21% 0.25% 0.23% 0.02 0.01
CIO 0.004 0.065 0.28% 0.102 0.11% 0.12 0.06
C18 3.05% 0.29% 0.2% 0.27% 0.95% 1.4 0.7
NCTC
11325
1.06% 0,7% 1.15% 0.6% 0.88% 0.27 0.13
S.D, = STANDARD DEVIATION SEM = STANDARD ERROR OF MEAN
TABLE 4.3 VARIATION OF ADHERENCE OF PLAQUE ISOLATES OF
SMG TO BEC
n % ow STi^XH$ Ofism '
STRAIN RUN 1 RUN 2 RUN 3 RUN 4 MEAN S.D. SEM
POl 0.43% 0.13% 0.24% 0.46% 0.32% 0.16 0.08
P02 0.25% 0.01% 0.35% 0.04% 0.16% 0.17 0.08
P04 1.06% 0.33% 0.46% 0.19% 0.51% 0.38 0.19
P08 2.55% 1.9% 1.67% 5.78% 2.98% 1.9 0,95
Pll 2.18% 3.44% 3.69% 4.89% 3.55% 1.11 0,55
P13 0.15% 0.82% 0.19% 0.51% 0.42% 0.31 0.15
S.D. = STANDARD DEVIATION SEM = STANDARD ERROR OF MEAN
SMG to adhere to BEC is shown in Figure 4.3. From this 
graph it appears that s. consteiiatus strains have a higher 
mean % adherence to BEC than the other two species. 
However, there were insufficient numbers of each species 
used to draw any conclusions and there was no 
statistically significant difference between them. The 
two strongly adherent strains, 016 and 025R, resulted in 
an elevated mean % adherence for the s. consteiiatus group, 
whereas the other s. consteiiatus strains had similar 
adherence values to the other species. It is likely that 
the high adherence of these two strains is due to a 
factor other than difference in biotype (species),
4.3.4 ROLE OF CAPSULE IN ADHERENCE TO BEC
Adherence values of selected strains, representing 
members of the three species, with varying degrees of 
capsule, were examined before and after capsule removal, 
with results shown in Table 4.4. Treatment to remove 
capsule resulted in increased adherence, which was 
statistically significant (p < 0.05). The two strains 
showing comparatively high adherence (strains 016 & 025R) 
both had a rough colony appearance with no or little 
capsule surrounding individual cells.
4.3.5 VISUAL MEASUREMENT OF ADHERENCE TO BEC
Visual counts made of selected strains adherent to BEC
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TABLE 4.4 % ADHERENCE OF SMG TO BEC AFTER REMOVAL OF 
CAPSULE
STRAIN .
! (SPECIES)
RUN 1
.,1.-,..^..... "i « f V
------RUN 3 RUN 4 MEAN
009 (SI) 0,55% 0,007% 0,58% 0,57% 0.43%
009 T [P] 0,65% 0.28% 0.58% 1.92% 0,86%
COl (SC) 0.29% 0.46% 1.32% 0.21% 0,57%
COl T tfl 0.4% 0,47% 1.63% 1.3% 0.95%
C18 (SA) 0.34% 0,2% 0.38% 0.1% 0.255%
CIS T..IfJ... 0,55% 0,44% 0.53% 0.26% 0.445%
P02 (SA) 0.75% 0.6% 0.385% 0.72% 0.61%
P02 T m 1.2% 0.96% 0.89% 1.3% 1.09%
Pll (SI) 0.01% 2.15% 5,4% 9.3% 4.2%
Pll T [p]. 1.43% 3.58% 5,9% 10.7% 5.4%
02 5R (SC) 12.2% 13.5% 28,86% 26.3% 20.2%
02 5R T In] 13.67% 19.76% 37.95% 31.1% 25,6%
0258 (SC) 10.28% 5.62% 9.75% 11.5% 9.3%
0258 T [p] 19.04% 8.01% 12.14% 18.9% 14.5%
NCTC (SC) 2.7% 0,39% 0,69% 0.24% 1.005%
NCTC T.[f] 4,71% 0,59% 1.86% 1.24% 2.1%
T indicates treated with hyaluronidase to remove capsule. 
SA = S.anginosus SC = S .consteiiatus SI = S . intermedins 
[p] indicates partial removal of capsule after 
hyaluronidase treatment 
[f] indicates full removal of capsule after 
hyaluronidase treatment
[n] indicates no removal of capsule after hyaluronidase 
treatment
shown in Table 4.5 confirmed the results obtained in the 
radiometric assay. Photographs ( Figures 4.4 A & B, 4.5 
A & B and 4.6 A & B ) show a poorly, moderately and 
strongly adherent strain before and after capsule 
removal, confirming that adherence increases when capsule 
is removed,
4.3.6 EFFECT OF CELL SURFACE HYDROPHOBICITY ON ADHERENCE 
OF SMG TO BEC
Adherence to BEC related to hydrophobicity as determined 
by HIC (Section 3.2.3) is shown in Table 4.6. Four of 
seven strains showing moderate to high adherence were 
hydrophobic, while 11/12 poorly adherent strains were 
hydrophilic.
4.4 DISCUSSION
4.4.1 ADHERENCE OF SMG TO BEC
SMG organisms exhibited varying abilities to adhere to 
BEC, and examination of the adhesion kinetics (Fig. 4.2) 
suggests two types of interaction. First, the poorly 
adherent strain adhered after only five minutes 
incubation at a level which fluctuated throughout the 
assay, but was close to the maximum adherence achieved. 
This suggests that adherence is occurring as a result of
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TABLE 4.5 VISUAL COUNTS OF SMG ADHERENT TO BEC
s t r a i n '. (S.D, )% r  COUNT ASs^ %: , 
' ADHERENCE'
% ADHERENCE-*
025R NT 459.5 (268.6) 9.2 » IB.4% 13.5%
02 5R T 679.95 (512.3) 13.6 - 27.2% 19.75%
0258 NT 257.45 (163,1) 5.14 - 10.3% 5.615%
0258 T 320.25 (237.1) 6.4 - 12-8% 8-005%
NCTC NT 28.8 (18.99) 0.58 - 1.15% 0.3925%
NCTC T 36.85.(18.07) 0.74 - 1.47% 0.585%
1, MEAN Average number of organisms adherent to one BEC(mean count from 20 BEC)
2. COUNT EXPRESSED AS % ADHERENCEThe mean count of one BEC could be calculated as a percentage using the following formula :
Adherence = MEAN COUNT x 1 - 2 x 10^
5 X 10® X 100
Where 1 - 2 x 10^  is the concentration of BEC used in the assay, providing the range of the two values in the table, and 5 x 10® represents the concentration of SMG test strains in the assay.
3. % ADHERENCE as found using radiometric assay, NT " not treated with hyaluronidase (capsule intact)T = treated with hyaluronidase (capsule removed)
FIGURE 4.4 STRAIN NCTC 11325 ADHERENT TO BEC
(A) WITH CAPSULE (Mag. X 500)
M i
a*is««a
(B) WITHOUT CAPSULE (Mag. x 500)
FIGURE 4.5 STRAIN 025S ADHERENT TO BEC
(A) WITH CAPSULE (Mag. x 500)
% . .jmsà
(B) W ITHO UT CAPSULE (Mag. x 500)
FIGURE 4.6 STRAIN 025R ADHERENT TO BEC
(A) WITH CAPSULE (Mag. x 500)
(B) W ITHO UT CAPSULE (Mag. x 500)
TABLE 4.6 RELATIONSHIP OF ADHERENCE TO CELL
HYDROPHOBICITY
STRAIN .  ^ ADHERENCE. HYDROPHOBICITY
008 MODERATE HYDROPHOBIC CM)
009 LOW HYDROPHILIC (V)
016 HIGH HYDROPHOBIC (M)
025R HIGH HYDROPHOBIC CM)
0258 MODERATE HYDROPHILIC CV)
046 MODERATE HYDROPHOBIC CM)
COl LOW HYDROPHILIC CM)
C02 LOW HYDROPHILIC CM)
C06 LOW HYDROPHILIC CV)
C08 LOW HYDROPHILIC CV)
CIO LOW HYDROPHILIC (V)
CIS LOW HYDROPHOBIC CM)
NCTC 11325 LOW HYDROPHILIC CM)
POl LOW HYDROPHILIC CM)
P02 LOW HYDROPHILIC CV)
P04 LOW HYDROPHILIC CV)
P08 MODERATE HYDROPHILIC CM)
Pll MODERATE HYDROPHILIC CM)
P13 LOW HYDROPHILIC _ÜÜ
ADHERENCE 0,01% - 2.0% 2.1% - 15%15.1% - 30%
= LOW = MODERATE = HIGH
HYDROPHOBICITY : categorised as stated in Table 3.6
Change in OD of :
0 % - 9 % very hydrophilic 10% - 49% moderately hydrophilic 50% ™ 79% moderately hydrophobic 80% - 100% very hydrophobic
ionic and other physical forces of low specificity, which 
allow bacteria to become loosely associated with 
surfaces. This initial loose association results from 
attraction by van der Waal's forces, after which 
organisms are repelled by negative electrostatic charges 
as the two surfaces draw closer together. In this loose 
association bacteria are frequently located approximately 
10 nm from the surface, at which point hydrogen, 
hydrophobic and other bonding can occur (Gibbons 1984), 
In contrast, the strongly adherent strain does not adhere 
well at first, but binding steadily rises over time to a 
maximum and then tails off. This indicates specific 
permanent bonding between complementary receptor and 
adhesin molecules located on the two cell surfaces.
As can be seen in the tables of results there is a large 
standard deviation in some cases, due to large variation 
between runs using the same strains. This was due to 
variation in BEC caused by factors out with experimental 
control. Although BEC were collected and processed in a 
way that minimised variation, BEC may be affected by 
factors such as donor health and diet which may influence 
receptors on their surface (Gibbons 1984). The 
indigenous flora present on BEC may affect the adherence 
of test strains, and this has been shown to vary between 
different donors and samples from the same donor over a 
time period (Pichichero 1984). However the screening 
process used allowed elimination of heavily colonised BEC
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samples and Samaranayake, Hamilton and MacFarlane (1994) 
showed that the indigenous flora did not inhibit 
adherence of a strain of SMG to EEC. Therefore, 
comparisons between data are still valid as uniform EEC 
were used in each run and trends for levels of adherence 
can be observed. Tissue culture may have been used to 
provide uniform cells of oral epithelium, but this was 
not used for a number of reasons. First, as the aim was 
to compare results with the findings of Willcox and Knox 
(1990) it was important to use the same target cells. 
Secondly, the assay was intended to be a fairly quick and 
easy to run screening method which tissue culture would 
have complicated. Finally, as outlined previously, EEC 
can be affected by diet and health of the donor and 
therefore collecting them freshly for use in the assay 
would give results more reflective of the situation 
occurring in the mouth.
Visual counts of the number of bacteria adherent per EEC 
were significantly higher than those reported by other 
investigators, for example 10.6 per cell as found by 
Samaranayake et al (1994) and 11.6 - 12.8 per cell 
observed by Schollin (1988). When the counts were
converted to % adherence as detailed in Table 4.5 there 
was a good correlation between these values and those 
found with the radiometric assay system, and these in 
turn were comparable with values found by Willcox and 
Knox (1990) who used a similar assay system.
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4.4.2 THE POSSIBLE ASSOCIATION OF DIFFERENT SPECIES OF 
SMG OR THEIR SOURCE OF ISOLATION AND THEIR 
ADHERENCE TO EEC
In agreement with the findings of Willcox and Knox 
(1990), dental abscess isolates were found to adhere more 
readily to BEC than either extra-oral clinical or plaque 
isolates. They also stated that the values for adherence 
to BEC of these abscess isolates were similar to those 
found for s. salivariua, which is preferentially associated 
with epithelial surfaces (Sklavourion and Germaine 1980). 
In common with Willcox and Knox (1990), other strains of 
SMG were found to have a low level of adherence to BEC, 
which may have been expected as SMG are seldom cultured 
from the cheek (Mejare and Edwardsson 1975). Based on 
the evidence from other studies on adherence in the mouth 
it is likely that different strains of SMG have different 
surface structures which account for the range of 
adherence values. When considering a role for this in 
relation to pathogenicity of the SMG, it may be that 
enhanced adherence of abscess isolates allows 
proliferation, in order to allow sufficient numbers to be 
present to pass through the root canal to the tooth apex. 
Alternatively, colonisation of BEC may allow the SMG to 
persist in the mouth ready to take advantage of any local 
damage and enter the tissues, rather than being bound up 
in the plaque matrix.
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This work supports the suggestion of Willcox and Knox 
(1990) that the SMG have specific target cells to which 
they adhere depending on the infection they cause. The 
clinical and plaque isolates here adhered poorly to oral 
cells, but are likely to adhere well to others. For 
example Gosling (1988) suggested that fimbriae which have 
been observed on some SMG and other plaque streptococci 
(Handley et al 1985) may be important for attachment to 
heart valves, in the pathogenesis of endocarditis. The 
ability of streptococcal cells to interact with specific 
target cells can be illustrated by the ability of s. sanguis 
to aggregate human platelets, a virulence factor in 
infective endocarditis. Ford et al (1993) found s. sanguis 
strain NCTC 7863 aggregated platelets after incubation 
with platelet-rich plasma after a lag phase of 7-19 
minutes. Aggregation was prevented by aspirin and EDTA, 
and blocking the glycoprotein lb receptor with monoclonal 
antibody inhibited aggregation. Further work by Ford et 
al (1996) revealed platelet aggregation depended upon 
plasma constituents binding to the bacterial surface 
during the lag phase, and aggregation could be inhibited 
by depleting/inhibiting complement. The rate of assembly 
of the C5b“9 complex on s. sanguis NCTC 7863 bacterial 
surface correlated with the lag time, leading the authors 
to suggest a role for the complement pathway in platelet 
aggregation by the type strain of s. sanguis. Other 
investigators (Chen et al 1994) had reported complement 
receptors on the surface of platelets, suggesting a
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specific interaction between s. s a n g u i s ,  complement 
activation and aggregation of platelets. In the SMG, 
Willcox et al (1994) found Lancefield group C strains 
aggregated platelets, with substances reducing 
aggregation which chelated cations, inhibited the 
cycloxygenase pathway in platelets, reduced the 
availability of ADP and disrupted platelet membrane 
stability. Willcox (1995) found a correlation between 
binding large amounts of fibrinogen and the ability to 
aggregate platelets, suggesting it aids platelet 
aggregation.
There were no significant differences between the 
different species and their ability to adhere to BEC. As 
s.consteiiatus is the most common SMG isolated from dental 
abscesses it may have been expected that this species 
would adhere to a greater extent. Of all the isolates, 
3/5 S.consteiiatus abscess strains had the highest adherence 
values. Therefore, although all s.consteiiatus species 
cannot be said to adhere to BEC to a significantly 
greater extent than the other two species, it can be 
noted that a few s.consteiiatus strains do have a higher 
affinity for BEC, and this may be one aspect of their 
pathogenicity in dental abscess formation. Another 
reason for isolation of s. consteiiatus species most 
frequently from dental abscesses may be the finding of 
Toyoda et al (1995) that a strain of s.consteiiatus was
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resistant to ingestion and killing by PMNL due to a 
structural component which was not identified. They 
suggested that this may be a virulence factor of 
s. consteiiatus, predisposing it to survival at foci of 
infection.
4.4.3 ROLE OF CAPSULE IN ADHERENCE
Bacterial capsules may participate in adherence in two 
ways. They provide a means for bacteria and target cell 
to bind together owing to the capsule's gelatinous 
nature, but alternatively they may hinder adherence by 
masking specific adhesins on the bacterial cell surface. 
As removal of capsule increased adherence of SMG to BEC 
it is likely that specific binding occurs between 
adhesins and receptors, and that these have been masked 
by the presence of capsule. A similar situation was 
reported for s.pyogenes, where only after fully 
encapsulated strains were treated with hyaluronidase to 
remove their capsules did they adhere well to oral 
epithelial cells (Beachey 1981). On regeneration of the 
capsules, ability to adhere was lost. As detailed in the 
introduction to this Chapter, adherence of s.pyogenes to 
epithelial cells is a complex process involving specific 
interactions of adhesin and receptor molecules. A 
similar situation can be suggested for SMG adherence, 
with capsule hindering these interactions.
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As capsule removal did not increase adherence of all 
strains to the same extent it is clear this is not the 
only factor affecting adherence. This may also support 
our previous supposition that strains of SMG have 
specific target cells, as non-uniform levels of adherence 
to BEC may indicate either a difference in number of 
adhesins on the cell surface or different types of 
adhesins specific for other target cells.
By reference to the electron micrographs of strains after 
capsule removal illustrated in Chapter 3, an explanation 
may be found as to why treatment with hyaluronidase 
increased adherence at different rates. The isolates 
responded to hyaluronidase treatment in three ways : 1. 
virtually complete capsule removal, 2. partial removal 
and 3. no visible difference in surface structure. Where 
full capsule removal occurred, this presumably allowed 
all adhesins to be available to receptors on the BEC. 
When partial or little capsule removal occurred, parts of 
the cell surface, and therefore adhesins, remained masked 
by capsule, thus reducing the adherence.
As most of the test strains possessed capsular material, 
it is likely to make a positive contribution to 
pathogenesis in some way, which outweighs the negative 
effect on adherence found here. This may well be an 
involvement in resistance to phagocytosis. Whitnack et 
al (1981) demonstrated that the hyaluronate capsule of
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s.pyogenes interfered with the attachment step of 
phagocytosis, and capsule has also been shown to 
interfere with the opsonic process as detailed in Chapter 
6. Therefore, as stated by Beachey (1981), pathogens 
must be highly adaptable to survive and produce disease. 
On mucosal surfaces they must possess surface adhesins in 
order to adhere, then immediately after invasion they 
must either shed adhesin or produce masking capsules in 
order to avoid attachment to phagocytic cells. This may 
explain why the plaque isolates had smaller capsules as 
a group than the other two types of isolate. The latter, 
having been isolated from infections, will have generated 
capsules to avoid phagocytosis as suggested by Beachey 
(1981), while the plaque isolates, having yet to invade 
the tissues, have small capsules in order that they may 
adhere effectively without their surface structures being 
masked with capsule.
4.4.4 ROLE OF CELL SURFACE HYDROPHOBICITY IN ADHERENCE 
TO BEC
Most of the strains which adhered poorly were of a 
hydrophilic nature, which may contribute to their poor 
attachment. As discussed in section 4.1.2, before 
specific interaction between adhesins and receptors of a 
bacterium and its target cell can occur, they must be 
able to approach sufficiently close to one another. The 
ability to do this is affected by the relative surface
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forces of each cell, and owing to the net negative 
charges on both cells, repulsion occurs. However, this 
is overcome by the attraction of hydrophobic molecules on 
the bacterial surface to the hydrophobic phospholipid 
molecules in the lipid bilayer membrane of the target 
cell (Beachey 1981). This allows the two cells to 
approach and thus for stronger specific interaction to 
occur. In the case of hydrophilic strains the repulsive 
forces cannot be overcome by counteractive attractive 
forces between hydrophilic molecules and therefore these 
strains may be unable to approach sufficiently closely to 
allow specific adhesin/receptor interactions to occur. 
Also, Absolom (1988) found that the early attachment 
phase in bacterial adhesion depends on the relative 
surface tension of the interacting phases, and that the 
most hydrophobic bacteria adhered to the greatest extent 
to all surfaces when suspended in a liquid with a high 
surface tension.
Strongly adherent strains showed both hydrophobic and 
hydrophilic characteristics. In the case of hydrophobic 
cells the above scenario is likely, i.e. attraction 
between hydrophobic molecules precedes specific 
interaction. In hydrophilic strains other attractive 
forces (such as those outlined in the DLVO theory : 
Section 4.1.2.1) may be involved in drawing the two 
surfaces close enough to interact. Whether hydrophobic 
or hydrophilic in nature, it is likely that highly
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adherent strains of the SMG have more adhesins on their 
surfaces complementary to the receptors present on BEC 
than do poorly adherent strains. Those strains which 
adhere poorly to BEC may in turn have a proclivity for 
other cells of the body, having adhesins of a different 
specificity present on their surface.
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CHAPTER 5 OPSONIC REQUIREMENTS OF THE SMG AND INDUCTION 
OF RESPIRATORY BURST (CHEMILUMINESCENCE) OF 
PMNL
5.1 INTRODUCTION
5.1.1 GENERAL INTRODUCTION
The proceeding chapters have examined aspects of the SMG 
which assist the organism in causing infection. These 
aspects have included adherence to target cells in order 
to persist in the host, examination of toxin and enzyme 
production which may help provide nutrition for the 
organism or damage host tissues to allow spreading, and 
characterisation of surface structures which may aid 
virulence. In response to bacterial invasion the body 
will initiate its own defence mechanism, the immune 
system. The host has developed three major mechanisms 
for killing bacteria : complement-mediated lysis,
phagocytosis and cell mediated cytotoxicity, all of which 
the successful pathogen must evade. This and the 
following chapter will investigate the ability of the SMG 
to evade the host's first line of defence against 
bacterial invasion, that is, phagocytosis by white blood 
cells. This was examined by measuring the respiratory 
burst (chemiluminescence) induced when bacteria and PMNL 
interact. The effect of serum opsonization on
chemiluminescent response was also investigated. The 
data were then analysed in order to ascertain whether any
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significance could be attached to either species or 
source of isolate. The influence of both capsule and 
cell surface hydrophobicity on respiratory burst 
induction was also examined, as these factors have both 
been implicated in conferring resistance to phagocytosis 
as discussed previously (Chapter 3 : Surface Structures).
5.1.2 POLYMORPHONUCLEAR LEUKOCYTES
PMNL are characterised by a large nucleus with 3-5 lobes 
and presence of numerous granules in the cytoplasm. They 
develop in the bone marrow from multipotential stem cells 
over a period of 12-13 days, after which they are 
released into the bloodstream. Half remain adherent to 
the vessel walls and the other half enter the tissues 
within 12 hours. PMNL make up 40 % - 70 % of circulating 
white blood cells.
5.1.3 THE PHAGOCYTIC PROCESS
The phagocytic process can be divided into 3 stages, 
recognition, ingestion and killing (Fig. 5.1)
1. Recognition : in response to chemotactic stimuli from 
tissues, PMNL arrive at the site of infection and contact 
the invading organism. This only initiates ingestion if 
the PMNL recognise the intruders. Opsonization of the 
bacterium with immunoglobulin G (especially IgGl & IgG3) 
or complement factor C3b allows recognition. This leads
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FIGURE 5.1 THE PHAGOCYTIC PROCESS
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to adherence of the bacterium to the surface of the PMNL 
due to interaction of Fc and C3b receptors on the surface 
of the phagocyte corresponding to the opsonins,
2. Ingestion : after adherence, the PMNL surrounds the 
particle with pseudopodia which fuse around the object 
and internalise it in a phagolysosome,
3. Killing : cytoplasmic lysosomes present in the 
phagocyte migrate to the phagosome and fuse with it, 
forming a phagolysosome into which the lysosomes' 
contents, including enzymes and other chemicals which 
degrade bacteria, are released. Subsequent killing of 
the bacterium occurs due to production of superoxide 
anion, hydrogen peroxide, singlet oxygen and hydroxyl 
radicals.
5.1.4 CHEMILUMINESCENCE
The production of chemiluminescence, the emission of 
light by phagocytic cells while ingesting microorganisms 
and other particles, was first described by Allen, 
Stjernholm and Steele (1972). When PMNL come into 
contact with opsonized bacteria or other particles there 
is an increase in hexose-monophosphate shunt activity 
giving an increase in NADPH. In the presence of NADPH- 
oxidase and this produces and/or HOOH which then 
produce singlet oxygen in the presence of myeloperoxidase 
and Cl”, It is this which is responsible for light 
emission and bactericidal activity. This native
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chemiluminescence is very weak, requiring large numbers 
of cells and a sensitive light detector. However, the 
sensitivity of the technique can be increased by addition 
of the cyclic hydrazide 5-amino-2,3 dihydro-1,4- 
phthalazinedione (luminol). Oxidation of this compound 
by reactive oxygen species produced during phagocytosis 
gives increased light production at 425 nm (Allen and 
Loose 1976), due to the oxidising species raising the 
energy of the peripheral electrons of the molecule to an 
excited state, which on returning to the ground state 
release the energy as a photon of light. Monitoring of 
the chemiluminescence response allows measurement of 
opsonic activity and cellular function, although it is an 
indirect method of assessing bactericidal function as it 
does not directly differentiate between defects of 
ingestion and intracellular killing (Easmon, Cole, 
Williams & Hastings 1980). Incorporation of luminol to 
reduce the number of cells required allows investigation 
of phagocytic function in neonates and neutropenic 
patients (Stevens, Winston & Van Dyke 1978).
5.2 MATERIALS AND METHODS
5.2.1 PREPARATION OF POLYMORPHONUCLEAR LEUKOCYTES
Normal human blood was collected by venipuncture and 
added to tubes containing 10 units of heparin 
(Multiporin) per ml to prevent clotting. A 5% solution
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FIGURE 5.2 SEPARATION OF PMNL FROM WHOLE BLOOD
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of dextran in saline (2-3 ml) was added to conical tubes, 
the heparinised blood layered onto this and left to 
separate for 30 minutes. After this time the leucocyte- 
rich top layer was removed and carefully layered onto 2-3 
ml of Lymphocyte Separating Fluid (Tech Gen, London), 
maintaining two layers. This was then centrifuged for 30 
minutes at 160 g, after which time four fractions were 
apparent (Figure 5.2). The layer of PMNL was removed and 
washed in gel Hanks (Appendix I) by centrifugation at 
160g for 15 minutes, the supernatant discarded and the 
resultant pellet was resuspended in gel Hanks. From this 
suspension 10 pi of the PMNL were added to 90 pi of white 
cell diluting fluid (2% acetic acid) and 10 pi of this 
suspension was counted in a haemocytometer (Depth 0.2mm 
1/16 mra^ ) (Weber, Weber Scientific, Sussex, England), 
The yield of PMNL was calculated from the equation : Cell 
count (in 16 small squares) x 5 x l 0 ^ x l 0  . PMNL were 
used at a concentration of 1 x 10  ^PMNL/ml.
5,2,2 PREPARATION OF BACTERIA
Bacteria were grown overnight in BHIB + 0.3% YE then 
washed 3 times in PBS before being suspended to an OD at 
620 nm of 0.45 (5 x 10® cfu/ml ).
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5.2.3 SERUM PREPARATION
Normal pooled human serum was prepared by collecting 
blood from four volunteers and allowing this to clot for 
2-3 hours. A wooden stick was then run around the edge 
of the tube to loosen the clot and the tubes centrifuged 
at 220 g for 15 minutes. The serum was removed from the 
top and the clot subjected to centrifugation two more 
times, after which the serum was pooled, allquoted into 
0.5 ml volumes and stored at - 70°C.
5.2.4 OPSONIZATION
Bacteria used were opsonized with serum concentrations of 
1%, 5%, 10%, 15% and 20% v/v diluted in gel Hanks, Equal 
volumes of serum and bacteria were mixed and incubated at 
37° C for 15 minutes with shaking at 100 rpm. They were 
then centrifuged at 1 OOOg for 15 minutes, the 
supernatant discarded, and the bacteria resuspended in 
the original volume of gel Hanks.
5.2.5 ASSAY PROCEDURE
Opsonized bacterial suspension (100 pi) 100 pi of PMNL 
+ 50 pi of Luminol (Appendix I ) were added to polystyrene 
microcuvettes (Clinicon, Life Sciences UK Ltd., 
Basingstoke, England), mixed by shaking and quickly 
loaded into a Bio Orbit 1251 Luminometer (Bio Orbit,
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Turku, Finland). This was connected to a PC running a 
Bio Orbit Multiuse 1251-130 V 2.0 program in Windows, 
This measured chemiluminescence (mV) proceeding with time 
(seconds), and produced a graphical representation of 
these variables, from which peak values could be 
determined.
5.2.6 EFFECT OF HYALURONIDASE TREATMENT OF SMG ON THEIR 
CHEMILUMINESCENT RESPONSE TO PMNL
Cells of SMG were treated with hyaluronidase in an 
attempt to determine the role of capsule on bacterial 
susceptibility to phagocytosis. Capsule was removed by 
treatment with hyaluronidase as described in Chapter 3 
(3.2,3) and the effects of such treatment are fully 
examined there. In brief, hyaluronidase treatment
resulted in three scenarios. First, strains with small 
amounts of capsular material were almost completely 
denuded of material, secondly, those with a more densely 
staining mass under TEM had a proportion of the material 
removed, and finally, strain 025R showed no change in 
surface material after treatment. Treated and untreated 
strains were included in the assay
5.2.7 STATISTICAL ANALYSIS
The Mann-Whitney U test was used to compare data, with a 
value of p < 0.05 being considered significant.
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5.3 RESULTS
5.3.1 SERUM Opsonization
Initial tests with 3 strains showed that the SMG were 
phagocytosed without serum opsonization, but the 
chemiluminescent response was enhanced by opsonization 
(Table 5.1), This also dictated the use of serum 
concentrations between 1% and 20% for further work, as 
the optimum response was usually within these limits.
Mean peak chemi luminescent responses for the 20 test 
strains opsonized with serum concentrations l%-20% are 
illustrated in Tables 5,2, 5.3 and 5.4. A range of
values were found, with chemiluminescence increasing with 
% serum, indicating that the SMG are efficiently 
opsonized. Opsonization with 20% normal pooled human 
serum, an effective serum concentration of 10%, tended to 
give optimum response with nrast organisms, the exceptions 
being 016, P08, PI3 and NCTC 11325, all of which peaked 
at 15% (7.5% final concentration).
From the data obtained it can be seen that there may be 
a large variation in chemiluminescent response between 
runs performed with the same strain. Rather than this 
reflecting a change in the bacterium, it is due to the 
different donors of PMNL, among whom there may be high 
and low responders. The factors affecting the response
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TABLE 5.1 EFFECT OF OPSONIZATION ON ABILITY OF SMG TO 
INDUCE A CHEMILUMINESCENT RESPONSE IN HUMAN 
PMNL
\ V \ ' - 'IT'" . .........................CHEMI LUMINESCENCE (mV) AFTER. ST
.’.. opsoNtzmd iiiiTH sÈRmî sou,
RAINS
FTlON'STRAIN UNOPSONIZED X% 5% 10% 15% 20%
025R 42.4 43.3 61.9 73.9 71.3 74.9
025S 50.9 71.9 96.8 123 131 132
NCTC
11325
53.2 61.9 85.4 105 111 95.5
Figures represent mean peak chemiluminescent response of 
strains without opsonization and with opsonization at 
serum concentrations of 1% - 20%.
TABLE 5.2 CHEMILUMINESCENCE OF PMNL IN RESPONSE TO ORAL
(ABSCESS) ISOLATES
MEAN PEAK CHEMILUMINESCENCE (mV) 
AT SERUM CONCENTRATIONS:
.STRAIN SPECIES.  ^J 1% 5% " 10% „ 15% ,\ 20% 1
008 S anginosus 20.46 36.63 50.7 62.76 80.43
009 s intermedins 39.96 41.66 55.2 68.83 72.46
016 s consteiiatus 63,0 99.24 139.. 3 159.3 142.4
025R s consteiiatus 43.3 61.9 73.9 71.3 74.9
0258 s consteiiatus 72.0 97.2 123.6 131.0 133.0
041 s. anginosus 28.1 39.56 49.2 58.6 72.16
046 s. intermedins 7.14 7.4 11.18 13,04 14.1
Values are the mean of three separate experiments 
performed with three different PMNL donors.
TABLE 5.3 CHEMILUMINESCENCE OF PMNL IN RESPONSE TO
CLINICAL ISOLATES
MEAN PEAK CHEMILUMINESCENCE (mV) 
AT SERUM CONCENTRATIONS:
STRAIN y SPECIES 1% 5% ' ' 10%: :.15%.. 20%
COl S .constel1atus 191.6 237.0 236.0 266.0 274.6
C02 S .intermedins 26.63 35.4 43.16 49.96 60.9
C06 S ,intermedins 22.3 27.1 44.6 59.56 68.46
COS S .constel1atus 21.2 28.34 34.5 36.38 39.03
CIO S .anginosus 1.95 2.86 5.9 8,5 11.23
CIS S.anginosus 27.86 37.04 39,1 43.05 43.6
NCTC
11325
S .constel1atus 62.0 85.4 105.1 111.0 95.4
Values are the mean of three separate experiments 
performed with three different PMNL donors.
TABLE 5.4 CHEMILUMINESCENCE OF PMNL IN RESPONSE TO
COMMENSAL (PLAQUE) ISOLATES
MEAN PEAK CHEMILUMINESCENCE (mV) 
AT SERUM CONCENTRATIONS :
\ STRAIN % SPECIES: 1%. 5% ' 10% 15% ^ 20%
POl s.anginosus 3.68 5.63 6.7 10.9 13,77
P02 S.anginosus 45.8 57.56 62.4 64.76 67.9
P04 S .consteiiatus 50.56 58.06 66.8 81.9 84.2
P08 S .intermedins 10.28 12.6 13.08 13.61 13.25
Pll S .intermedins 4.16 5.25 7.7 8.37 9.94
P13 ™S...C.ons.t6l latus -27.96 -36.0 .45.13 -4.2«.l--
Values are the mean of three separate experiments 
performed with three different PMNL donors.
of PMNL to bacterial stimuli are numerous. For example, 
Olinescu et al (1994) found that levels of testosterone 
and oestrone lower than 10'^  M in donors increased the 
chemiluminescent response of their PMNL, while higher 
levels decreased it. Despite this variation between 
experiments, comparisons are still valid as each run was 
performed with PMNL from the same donor and therefore 
high and low chemiluminescence inducers amongst the SMG 
will be evident on each occasion.
5.3.2 RATE OF INDUCTION OF RESPIRATORY BURST 
(CHEMILUMINESCENCE)
As shown in Figures 5.3, 5.4 and 5.5 the rate of
chemiluminescence starts slowly, building to a peak 
generally between 10-25 minutes and thereafter begins to 
tail off as PMNL and bacterial concentrations become 
rate-limiting. Measurement of the initial rate of 
chemi luminescence is equivalent to quantification of the 
rate of phagocytosis (Allen 1977), therefore a less sharp 
incline to peak may indicate resistance to phagocytosis 
in that strain.
Fredlund (1993) calculated a chemiluminescence index (Cl) 
in order to standardise results, having found, as we did, 
that differing PMNL donors can cause large variation in 
peak values. This method uses the maximal rate constant
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(MRC) calculated as a function of CL (mV) and time (min)
i.e. [mV/min] during the highest acceleration of the 
response of PMNL, rather than peak values- This was 
calculated and a comparison of peak chemiluminescence 
against maximal rate constant (MRC) is illustrated in 
table 5.5. In 11 out of 19 cases the peak CL value and 
MRC concurred.
5.3.3 SIGNIFICANCE OF ISOLATE TYPE
There was no statistically significant difference in 
opsonic requirement or chemiluminescence produced by the 
isolates from different sites. Thus, rather than 
considering isolates from plaque, clinical infections and 
dental abscesses separately, the SMG as a whole can be 
said to have a common opsonic requirement and to elicit 
similar chemiluminescent responses.
5.3.4 SPECIES SIGNIFICANCE
There was no statistically significant difference between 
serum opsonization and chemiluminescent response of 
S.anginosusi S. constellatus or s . intermedius - Although strains 
of s. constellatus tended to give a higher response, the 
range of variation within the group resulted in this 
being statistically insignificant (Figure 5,6).
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TABLE 5.5 PEAK CHEMILUMINESCENCE (CL) COMPARED TO
MAXIMAL RATE CONSTANT (MRC) AS A MEASURE OF 
THE CHEMILUMINESCENT RESPONSE OF PMNL TO SMG
MRC" VALUE (mV/min) PEAK CL" VALUE (mV)
'STRAIN^ 1 2 \3 1  ^ ' /'3L
008 5. 5(M) 9.5(M) 6.5(H) 69 (M) 93 (M) 79 (M)
009 7 (M) 2 (M) 4.8(H) 101(H) 43 (M) 73 (M)
016 6. 5(M) 16 (M) 15 (M) 100(H) 196(H) 182(H)
025R 0. 5(L) 4.5(L) 6.8(H) 22 (L) 94 (H) 109(H)
02 5S 5 (L) 7 (M) 8 (M) 121(H) 145(H) 133(H)
046 0. 8(L) 0.9(L) 1.6(L) 10 (L) 11 (L) 20 (L)
COl 12 (H) 22 (H) 27 (H) 168(H) 320(H) 336(H)
C02 2. 9(L) 1.9(L) 3.3(L) 72 (M) 53 (M) 57 (M)
C06 3. 9(L) 3.9(L) 6.2(H) 60 (M) 63 (M) 82 (M)
COS 2. 3(L) 0,4(L) 5.9(H) 66 (M) 14 (L) 37 (L)
CIO 0. 5(L) 1.3(L) 0.2(L) 9 (L) 21 (L) 3 (L)
CIS 0. 2(L) 2.7(L) 8 (M) 4.9(L) 39 (L) 87 (M)
NCTC 5 (L) 8 (M) 5.5(H) 121(H) 132(H) 80 (M)
11325
POl 0. 5(L) 0.5(L) 0.8(L) 7.2(L) 19 (L) 15 (L)
P02 6 (M) 4 (L) 1.7(L) 85 (M) 62 (H) 59 (M)
P04 6 (M) 3.3(L) 5 (L) 97 (M) 67 (M) 88 (M)
P08 1 (L) 0.9(L) O.l(L) 21 (L) 17 (L) 2.2(L)
Pll 0. 4(L) 1.3(L) 1.3(L) 5 (L) 12 (L) 13 (L)
P13 1. 5(L) 1.8(L) 2.5(L) 23 (L) 57 CM) 55 (M)
1. MRC = MAXIMAL RATE CONSTANT (mV/ulin)Defined as :(L)-Low (0-5 mV/min),(M)-Medlum(5.1-10 mV/min),(H)-High (10.1 upwards)
2. CL = Peak chemiluminescence (mV)Defined as :(L)-Low (0-50 mV), (M)-Medium (51-100 mV), (H)-High (101 upwards)
o
Chemiluminescence (mV)
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5.3.5 ROLE OF CAPSULE IN BACTERIAL SUSCEPTIBILITY TO 
Opsonization AND INDUCTION OF CHEMILUMINESCENCE
Treatment with hyaluronidase had an unusual effect of 
both raising and lowering chemiluminescence for some 
strains (Table 5.6)« However, the differences between 
treated and untreated values were not statistically 
significant and so fluctuation in chemiluminescence, 
either up or down, was presumably due to experimental 
variation. Therefore capsule appears to play no part in 
serum opsonization or chemiluminescence,
5.3.6 EFFECT OF HYDROPHOBICITY OF BACTERIAL CELL 
SURFACE ON CHEMILUMINESCENCE
There was no relationship between the hydrophobic nature 
of the organism and its ability to elicit a 
chemi luminescent response in PMNL as shown in table 5.7. 
The peak chemiluminescent response was categorised as low 
(0-50 mV), medium (51-100 mV) or high (101 mV upwards), 
whilst the MRC was categorised as 0-5 mV/min low, 5.1-10 
mV/min medium and 10.1 mV/min upwards high. This was 
compared with cell surface hydrophobicity, categorised as 
moderate or very hydrophobic/ hydrophilic. As it is 
generally considered that the more hydrophobic a cell, 
the more easily it is phagocytosed, it would be expected 
that strains classed as moderate/very hydrophobic would 
induce a higher chemiluminescent response. Of 14
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TABLE 5.6 EFFECT OF HYALURONIDASE TREATMENT OF SMG ON THEIR ABILITY TO STIMULATE A CHEMILÜMINESCENCENT RESPONSE BY HUMAN PMNL
. ETRAIÜ \  RUN 1 C 'RUNfZ '. RUN 3 RUN 4 , " MEAN "
009 258 50.7 17.0 56.4 95.525
009 T [p] 236 58.2 17.5 47.4 89.775
025R 217 32.1 42.0 90.3 95.35
025R TCn] 159 30.4 27.0 76.7 73.27
0258 144 48,4 11.0 33.8 59.3
025S T[p] 95.5 25.5 7.5 26.7 38.8
NCTC 465 2.34 5.5 9,42 120.5
NCTC T[f] 504 1.56 3.5 8.05 129.27
COl 167 94.8 132 112 126.45
COl T [f] 198 115 116 110 134.75
C08 18.7 45 32.4 54.3 37.6
C08 T Cf] 18.7 55.0 18.7 46.5 34.75
P02 52.0 13.1 10.2 17.7 23.25
P02 T [f] 35.5 12.9 10.9 11.7 17.75
Pll 11.8 3.94 3.27 11.1 7,5275
Pll T roi 16.4 3.72 7.49 9.77 9.345
Chemiluminescence values in mV.
T denotes hyaluronidase treated strains removed. with capsule
[p] denotes partial capsule removal after treatment with hyaluronidase
[f] denotes full removal of capsule after treatment with hyaluronidase
[n] denoted no change after treatment with hyaluronidase
TABLE 5.7 RELATIONSHIP BETWEEN BACTERIAL CELL
HYDROPHOBICITY AND THE CHEMILUMINESCENT 
RESPONSE OF HUMAN PMNL.
* “^STRAIN ’ J . ..... .... . ......HYDROPHOBICITY CLi MRC*
008 HYDROPHOBIC (M) MEDIUM MEDIUM
009 HYDROPHILIC (V) MEDIUM LOW
016 HYDROPHOBIC (M) HIGH HIGH
02 5R HYDROPHOBIC (M) MEDIUM LOW
02 5S HYDROPHILIC (V) HIGH MEDIUM
046 HYDROPHOBIC (M) LOW LOW
COl HYDROPHILIC (M) HIGH HIGH
C02 HYDROPHILIC (M) MEDIUM LOW
C06 HYDROPHILIC (V) MEDIUM LOW
C08 HYDROPHILIC (V) LOW LOW
CIO HYDROPHILIC (V) LOW LOW
C18 HYDROPHOBIC (M) LOW LOW
NCTC HYDROPHILIC (M) MEDIUM MEDIUM
POl HYDROPHILIC (M) LOW LOW
P02 HYDROPHILIC (V) MEDIUM LOW
P04 HYDROPHILIC (V) MEDIUM LOW
P08 HYDROPHILIC CM) LOW LOW
Pll HYDROPHILIC CM) LOW LOW
P13 HYDROPHILIC (V) LOW LOW
HYDROPHOBICITY : Categorised as stated in Table 3.6
1. CL = Peak Chemiluminescence (mV):Defined as : 0 - 50 LOW51 - 100 MEDIUM 101 upwards HIGH
2, MRC = Maximal Rate Constant (mV/min) :Defined as : 0 - 5 LOW5 , 1 - 1 0  MEDIUM10.1 upwards HIGH
hydrophilic strains, 6 exhibited low chemiluminescence 
and 8 high, while of 5 hydrophobic strains 2 had low and 
3 had a medium/high respiratory burst. MRC values 
compared to hydrophobi city revealed that of the 14 
hydrophilic strains 11 exhibited low, 2 showed medium and 
1 had a high rate of ingestion. Hydrophobic strains had 
ingestion rates of 2 low, 2 medium and 1 high.
5.4 DISCUSSION
5.4.1 SERUM OPSONIZATION
As shown in figures 5.2 - 5.4, increasing the percentage 
serum concentration used for opsonization increased the 
mean peak chemiluminescent response. As the
concentration of serum increases, the deposition of C3b 
and IgG on the bacterial surface increases, so allowing 
for increased interaction between the cell and the 
receptors of the PMNL. At a certain concentration the 
cell surface becomes saturated with opsonins, as there 
are no more receptors, therefore increasing the serum 
concentration does not further enhance chemiluminescence. 
This concentration is 15% for strains 016, FOB, P13 and 
NCTC 11325, and 20% or greater for those remaining.
As shown by the three strains 025R, 025S and NCTC 11325 
the SMG also induce a chemiluminescent response when 
unopsonized. In this instance the PMNL must recognise
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and adhere to another aspect of the cell surface other 
than C3b and IgG, As this has not been studied in the 
SMG we can only look at this situation in other organisms 
and suggest a similar role in SMG. E.coil is phagocytosed 
in the absence of opsonins due to the presence of 
adhesins on its surface which mediate its direct 
adherence to PMNL (Sobel and Kaye 1990). One of these 
adhesins is mannose sensitive, and is recognised by 
mannose-binding receptors on the PMNL allowing subsequent 
phagocytosis. As mannose is a component of the cell 
surface of SMG, receptors on the PMNL may be able to 
recognise it and, in the absence of opsonins, allow 
ingestion.
The plasma glycoprotein fibronectin may facilitate 
phagocytosis of SMG in the body in the absence of 
specific opsonins. Both SMG (Willcox, Geyeiin & Knox
1992) and PMNL (Procter, Prendergast & Mosher 1984) have 
been shown to bind fibronectin, and so the molecule may 
act as a bridge between the two. Fibronectin could also 
enhance the opsonic and protective activities of 
antibodies and complement as it does in relation to Group 
B streptococci (Hill et al 1984).
Although capsule tends to be antiphagocytic, in the 
absence of opsonins it can contribute to adherence of the 
PMNL. The gelatinous nature of the capsule may allow the 
PMNL to 'stick' to the bacterial cell in the absence of
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specific adhesive reactions (Patrick & Larkin 1995). 
Indeed, results for 025R and 025S, unencapsulated and 
capsulated varieties of the same strain, show peak 
chemiluminescence values when unopsonized of 42.4 and 
50.9 respectively, which may indicate that capsule 
enhances ingestion.
As whole pooled serum was used, it cannot he said whether 
complement or antibody play a larger role in opsonization 
of the SMG. Complement activity can be destroyed by 
heating serum to 55°C for 30 minutes, while further 
treatment can block either the alternative or classical 
pathways. Specific antibody can be removed by 
absorption. Use of these altered sera for opsonization 
of strains for use in the chemiluminescence assay would 
allow greater understanding of the specific mechanism of 
opsonization.
5.4.2 RATE OF CHEMILUMINESCENCE
The curve produced of the chemiluminescent response over 
time corresponds to the events of phagocytosis. The 
early phase of around 0 to 8 minutes, when the response 
is steadily rising, corresponds to the initial adherence 
of the bacteria to the white cell. As engulfment occurs 
and the killing of the bacteria proceeds at between 10 to 
20 minutes, peak response occurs as release of superoxide 
anion, hydrogen peroxide, singlet oxygen and hydroxyl
129
radicals are at a maximum in order to kill the bacteria. 
The reaction then begins tailing off as the bacteria have 
been digested and PMNL activity returns to its resting 
rate. Most of the SMG reach their peak between 8 - 2 0  
minutes. Those which peak at a later time, for example 
025S and P13, may be more resistant to ingestion due to 
a factor such as capsule. The rate and magnitude of 
chemiluminescence should correlate with the radioactive 
ingestion assay, which is examined in the following 
chapter.
5.4,3 SPECIES AND ISOLATE TYPE SIGNIFICANCE
As some members of the SMG may remain part of the normal 
commensal flora and never cause infection, whilst others 
proceed to cause purulent infection at numerous body 
sites, it may be suggested that those which cause disease 
are perhaps aided by resistance to phagocytosis. Indeed, 
it has also been shown that certain species of SMG 
preferentially associate with specific infections, again 
suggesting some distinguishing virulence factor. 
However, there are no significant differences in 
chemiluminescence of the three species or in relation to 
the site of their isolation. Individual strains did show 
relatively high (COl (274.6)) or low (Pll (9.94)) values, 
but these specific strains are likely to have other 
contributory factors in relation to pathogenicity.
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5.4.4 ROLE OF CAPSULE
As has been discussed previously (Chapters 1 and 3), the 
capsule of the SMG has been implicated as a virulence 
factor. A high number of strains isolated from purulent 
infections possess capsular material, and those 
possessing capsule being able to induce subcutaneous 
abscesses in mice as the single infecting organism (Lewis 
et al 1988). In this work we have already seen that 
capsule hinders the adherence of SMG to BEC (Chapter 4) 
and suggested that the negative role it plays here must 
be counteracted by contributing a positive element to 
virulence, hypothesising resistance to phagocytosis. 
This supposition was made after considering the anti­
phagocytic role of capsule in other organisms.
Capsules associated with bacterial pathogens protect 
against ingestion by PMNL through interference with 
opsonization (Finlay and Falkow 1989). They can prevent 
complement deposition on the bacterial cell surface, with 
those of pathogens more effective than the capsules of 
non-virulent strains. Capsule is only weakly immunogenic 
and masks the more immunogenic bacterial cell surface 
structures which would directly activate complement.
In pneumococci, C3b is bound to the unencapsulated cell 
wall via an amide link, while a thiolester-reactive site 
binds it to the capsule. The amide-linked molecules are
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far more potent activators of phagocytosis than the 
thiolester-binding ones (Gordon, Johnson & Hostetter 
1986), providing capsule with another virulence 
mechanism.
In s. a u r e u s  the mechanism by which type 1 capsule (mucoid) 
is antiphagocytic has been elucidated by Verbrugh et al 
(1982). They showed that the capsule shields C3b 
molecules deposited on the cell surface making them 
inaccessible to receptors on the membrane of PMNLs. In 
contrast Xu et al (1992) found microencapsulated strains 
of s. a u r e u s  (capsule types 5 and 8) did not resist 
opsonophagocytic killing in vitro by normal serum. Dale 
et al (1996) suggested a similar function of the 
hyaluronate capsule of type 18 Group A streptococci, that 
is acting as a physical barrier preventing C3b bound to 
the cell surface from interacting with the phagocyte 
receptor. This was suggested as the amount and pattern 
of C3 deposition on the surface of encapsulated and 
unencapsulated type 18 streptococci were not 
significantly different, but the unencapsulated mutant 
was unable to resist phagocytosis. The authors however 
found this was not the case for type 24 streptococci, as 
this strain was more susceptible to phagocytosis and 
killing despite similar encapsulation to the type 18 
strain. They concluded that different mechanisms operate 
in preventing the opsonophagocytosis of Group A 
streptococci.
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As detailed in the results section (5.3.5), treatment to 
remove capsule both raised and lowered chemiluminescent 
response, with no statistically significant difference 
between treated and untreated. This unusual dual effect 
may be due to the treatment process which, as detailed in 
Chapter 3, resulted in a number of outcomes. It may be 
that when the chemiluminescence increased after treatment 
this corresponded to the complete removal of surface 
material, whereas incomplete removal may lower 
chemiluminescence, perhaps by reducing the 'stickiness' 
of the bacterium for the PMNL. Chemiluminescence 
indicates the activation of the PMNL myeloperoxidase 
system and reflects the functional state of the 
phagocytic cell, but is not a direct measure of ingestion 
(McKinley et al 1993). Therefore, bacterial adherence to 
the surface of the PMNL can induce chemiluminescence 
rather than specifically ingestion, and this adherence 
may be aided by capsule although the organism is not 
internalised.
Capsule of the SMG was found by Lewis et al (1993b) to 
have no effect on phagocytic ingestion. Although the 
method used by these investigators did directly measure 
ingestion it involved counting of ingested organisms in 
PMNL by microscopic examination of cytospin slides, and 
therefore may involve human error in distinguishing and 
counting organisms within only a specified number of PMNL 
(100). Thus a radiometric ingestion assay was employed
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(Chapter 5) to investigate the issues raised in the 
preliminary work described in the present chapter. This 
method has the advantage over chemiluminescence 
measurement of directly quantifying ingestion and is not 
affected by external factors such as endo/exo toxins 
(which can induce chemiluminescence). Also, unlike any 
microscopic examination, it provides a count of bacteria 
ingested by all the PMNL present in the assay system. 
This work will be described in the next chapter,
5.4.5 ROLE OF HYDROPHOBICITY
In the absence of opsonin, bacteria with greater surface 
hydrophobicity are more readily phagocytosed than those 
with hydrophilic characteristics. When opsonization is 
considered, the more hydrophobic a bacterial cell surface 
the more it absorbs the opsonin IgG (Absolom 1988), 
Indeed, opsonization with IgG is often accompanied by an 
increase in surface hydrophobicity and gives rise to 
increased phagocytic ingestion in vitro (Magnusson et al 
1985),
Therefore it might have been expected that hydrophobic 
strains of SMG would induce a higher chemiluminescent 
response. In fact three of five hydrophobic strains had 
medium to high chemiluminescence, but there are 
insufficient data to conclude whether the hydrophobic 
nature enhanced opsonization and therefore ingestion. It
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may also be argued that the difference between moderately 
hydrophobic and hydrophilic strains is very slight and 
may be altered by environmental factors. Galdiero et al 
(1993) found that s.pyogenes surface hydrophobi city 
decreased under prolonged starvation and this resulted in 
increased chemiluminescence, phagocytic ingestion and 
killing. A number of hydrophilic strains also showed 
high chemiluminescence, which suggests that other 
specific factors are more important in influencing the 
efficiency of opsonization, rather than the passive 
absorption of opsonins which is enhanced by 
hydrophobicity. Also, when considering surface
interactions the role played by the surface electrical 
charge is more determinant than that played by 
hydrophobic domains.
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CHAPTER 6 INGESTION OF THE SMG BY HUMAN PMNL
6.1 INTRODUCTION
As outlined in Chapter 5, resistance to phagocytosis may 
be an important aspect in the pathogenicity of the SMG. 
The host's first line of defence against bacterial 
invasion is phagocytosis and in order to cause disease a 
bacterium must be able to avoid ingestion and killing by 
the phagocytic cells. The ability to resist
phagocytosis, or to exist within a phagocyte, is an 
important aspect of the pathogenicity of a number of 
bacteria, with capsule playing a major role in this 
resistance, Lewis et al (1993b) investigated the 
phagocytosis of SMG from dentoalveolar abscesses and the 
role of capsule in this process. The capsule of the SMG 
has been suggested as a pathogenicity factor of the 
group, as a contributory factor in both abscess formation 
and resistance to phagocytosis (detailed in Chapters 1 
and 3), and was found in the previous chapter to have no 
effect on chemiluminescence. Some investigators believe 
that chemiluminescence is produced only by oxidation of 
the ingested organism (Allen 1977), while others state 
that luminol enhanced chemiluminescence reflects both 
extra- and intra-cellular generation of oxygen radicals 
(Fredlund 1993). It can also be Induced by other factors 
such as endotoxin and certain chemicals (McKinley et al
1993), Therefore, as chemiluminescence may not be
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measuring only internalised SMG, other methods must be 
employed. Lewis et al (1993) examined phagocytosis by 
microscopical examination of cytospin preparations and 
counted the number of organisms ingested by 100 PMNL. 
Using this method they found no difference in the degree 
of uptake between capsulate and non-capsulate SMG 
strains. A radiometric assay was used in this chapter to 
investigate the possible effects of isolate source or 
species, presence of capsule and relative cell surface 
hydrophobic!ty on ingestion of SMG strains by human PMNL. 
This assay allows the examination of the kinetics of 
ingestion as well as the percentage uptake of bacteria by 
measuring the PMNL-associated radioactivity of labelled 
bacteria released by lysis of the phagocytic cells.
6.2 MATERIALS AND METHODS
6.2.1 ISOLATION OF POLYMORPHONUCLEAR LEUKOCYTES
Separation of PMNL from blood was carried out by a 
slightly different method from that described in Chapter 
5. The separating medium was changed to one which gave 
more efficient separation with whole blood rather than 
the plasma layer. Normal human blood was collected by 
venepuncture and added to 10 units per ml of heparin 
(Multiporin) to prevent clotting. 5 ml of Polymorphprep 
(Nycomed) was added to conical tubes and 5 ml of whole 
blood was layered on top, maintaining two tiers. The
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tubes were centrifuged at 350 g for 30 minutes, resulting 
in the formation of 3 layers from which the PMNL layer 
was removed and washed with gel Hanks (500 g /lO mins). 
The resultant pellet was resuspended in gel Hanks, 
counted in a haemocytometer and diluted to a 
concentration of 1 x 10^  PMNL/ml.
6.2.2 PREPARATION OF BACTERIA
Bacteria were grown overnight in BHIB + 0,3% YE in the 
presence of H^ adenine 2 pCi/ml (Amersham, 
Buckinghamshire, England). They were harvested and 
washed three times with saline ( 1 OOOg / 15 mins), then 
adjusted to an CD 620 nm of 0.025 (1 x 10^  cells/ml),
6.2.3 OPSONIZATION
Bacteria were opsonized with 10% pooled normal human 
serum as described previously (5.2.5).
6.2.4 ASSAY PROCEDURE
A modification of the method of Peterson et al (1977) was 
used.
For each test 4 scintillation vials were required to 
which were added :
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TUBE 1 2 3 4
BACTERIA 0.1 ml 0.1 ml 0.1 ml 0.1 ml
PMNL
GEL HANKS
0.1 ml 0.1 ml
0.1 ml 0,1 ml
These were incubated in an orbital incubator (Gallenkamp, 
Glasgow) at 100 rpm for 10, 20 and 30 minutes after which 
they were processed as follows :
Tubes 1 & 3 :
Ice cold PBS (3 ml) was added and the tubes 
shaken, followed by centrifugation (110 g/ 5 mins). This 
procedure was repeated 2 times, followed by the addition 
of 3 ml of scintillation fluid.
Tubes 2 Sc 4 :
3 ml of scintillation fluid was added
Ingestion of SMG by PMNL was calculated from radioactive 
counts using the following formula :
%  DPM PMNL associated 
bacteria (Tube 1)
%  DPM total bacteria 
and PMNL (Tube 2)
T-Ï DPM non specific 
bacteria (Tube 3)
    _______   _ a
%  DPM total bacteria 
(Tube 4)
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6.2.5 ROLE OF CAPSULE IN DETERMINING BACTERIAL 
SUSCEPTIBILITY TO INGESTION
Capsule was removed by treatment with hyaluronidase as 
described previously (3.2.3). For treated samples 
hyaluronidase (100 pi) was added to 1ml of bacteria at CD 
620 nm of 0.025, while control samples of untreated test 
strains had 100 pi of PBS added. The time of incubation 
was increased from 20 to 30 minutes in an attempt to 
produce more effective capsule removal (see Chapter 3 for 
previous results). After incubation the samples were 
used in the assay.
6.2.6 MICROSCOPIC EVALUATION OF PHAGOCYTOSIS
Cytospin preparations were made of a selection of 
bacteria-PMNL mixtures for examination under the 
microscope. To permit this a second replicate of tube 1 
was included in the assay. After the washing stages, the 
contents of this tube were resuspended in 1 ml of PBS and 
spun onto silane-coated slides using a Cytotek centrifuge 
(Miles Scientific, Ames Division, Indiana, USA) at 500 
rpm for 5 minutes. After drying for 10 minutes the 
slides were Gram-stained and viewed.
Photographs were taken using a Nikon FX-35 A camera 
connected to a Nikon optiphot microscope and attachments.
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6.2.7 STATISTICAL ANALYSIS
The Mann-Whitney U test was used to compare data, with a 
value of p < 0.05 being considered significant.
6.3 RESULTS
6.3.1 INGESTION OF THE SMG BY PMNL
The mean % ingestion of strains of SMG after incubation 
times for up to 30 minutes are illustrated in Table 6.1. 
The kinetics of ingestion reveals that the rate rose 
rapidly from 0 to 10 minutes, continued to rise somewhat 
more slowly from 10 to 20 minutes and finally levelled 
off by 30 minutes, as shown in Figure 6.1. Strain 025R 
which is ingested well shows this pattern of ingestion, 
whilst strain P02, which is poorly ingested, shows a 
different profile.
Again, as found in the chemiluminescence experiments 
reported in the previous chapter, there was often a large 
inter-experimental variation resulting in large standard 
deviations. This was due to inherent differences in the 
activity of PMNL from different donors, with some having 
highly active PMNLs which ingested bacteria well, whilst 
others had relatively inactive PMNL which were 
inefficient at ingestion.
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TABLE 6. INGESTION OF SMG ISOLATES BY PMNL
. :Sf lOMrÀgTEæ. INOJfBATIok -'mæ. ■
' STRAIN ' ' 10'MIN ' : ''20‘kïN 30 MIN '
008 8.84 (4.4) 13.18 (7.7) 18.16 (6.9)
009 16.54 (3.1) 15.28 (4.9).. 19.6 (13.75)
016 26.0 (9.6) 33.2 (12.6) 43.7 (3.99)
025R 25.8 (10.2) 38.3 (11.8) 38.9 (12.5)
025S 7.2 (2.07) 10.5 (3.5) 9.9 (4.2)
041 8.78 (5.95) 14.96 (4.2) 20.32 (6.4)
046 5.98 (4.1) 11.32 (10.3) 14.52 (9,8)
COl 27.6 (21.7) 40.5 (14.1) 37.7 (9.7)
C02 4.5 (3.6) 11.9 (3.05) 19.6 (3.1)
C06 10.8 (7.45) 14.5 (7.9) 24.4 (11.2)
C08 1.8 (1.3) 3.55 (1.06) 5.7 (2.2)
CIO 21.7 (13.98) 29-7 (13.9) 36.8 (9.5)
CIS 8.2 (4.8) 15.3 (4.2).. 26.0 (3.6)
POl 5.84 (3.5) 10.8 (7.3) 16.41 (6.7)
P02 4.9 (1.9) 7.8 (1.8) 11.1 (1.7)
P04 10.64 (7.75) 19.79 (9.6) 28.42 (4.2)
P08 19.86 (13.7) 32.05 (14.7) 48.26 (8.9)
Pll 19.66 (15.9) 27.08 (15.5) 42.94 (10.6)
P13 14.6 (9.5) 20.7 (7.3) 37.02 (5.4)
NCTC11325 18.0 (8,9) 28.9 (6.8) 43.36 (8.9)
Figures in brackets represent the standard deviation
Mean % ingestion is average of 5 experiments performed with 5 different PMNL donors.
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6.3.2 SIGNIFICANCE OF SPECIES AND ISOLATE TYPE ON 
SUSCEPTIBILITY TO PHAGOCYTOSIS
As shown in Figure 6.2 (a & b) there were no significant 
differences between the ingestion of either the three 
species types or the different isolate types.
6.3.3 EFFECT OF CAPSULE ON BACTERIAL SUSCEPTIBILITY TO 
PHAGOCYTOSIS
When the data for mean % ingestion of strains were 
separated into two groups according to capsule type + or 
+ (s), as defined in Chapter 3, there was a significant 
difference (p-0.0304) between the two groups. Those 
possessing a larger capsule were ingested to a lesser 
extent than those with the smaller (or no) capsule, as 
illustrated in Figure 6.3.
In addition, when capsulate strains were treated with 
hyaluronidase, the results illustrated in Table 6.2 
showed a significant difference (p=0.0313) between the 
mean of untreated and treated cell suspensions. Figure
6.4 shows poorly-ingested strain P02 before and after 
hyaluronidase treatment, while Figure 6.5 shows well- 
ingested strain 025R under the same conditions. In both 
cases a significant increase in the percentage of 
ingested bacteria can be seen.
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TABLE 6.2 INGESTION OF SMG ISOLATES BEFORE AND AFTER TREATMENT WITH HYALURONIDASE
" ; STRAIN MEAN % INGESTION" OR .SMG WITHOUT HYALURONIDASE TREATMENT (S.D.) ,
' ^ m e a n % INGESTION - OF SMG WITH ';HŸALURONïDASE TREATMENT (S-D-)
009 16.526 (11.7) 25.07 (10.9)
025R 11.46 (7.4) 19.1 (4.2)
0258 20.56 (10.3) 32.7 (16.2)
COl 20.8 (9,1) 24.9 (10.5)
C18 14.3 (6-25) 26.7 (4.7)
P02 1.9 (3,2) 2.9 (2.9)
Pll 12,4 (6*1) 21.7 (8.6)
NCTC 11325 12.7 (7.9) 20.1 (7.2)
Mean % ingestion is average of 5 runs performed with 5 different PMNL donors.
FIGURE 6.4 PHAGOCYTOSIS OF POORLY INGESTED STRAIN P02
BEFORE (A) AND AFTER (B) TREATMENT W ITH
HYALURONIDASE.
A V
(A) UNTREATED (Mag. x 500)
m
(B) TREATED (Mag. % 500)
i
FIGURE 6.5 PHAGOCYTOSIS OF W E LL INGESTED STRAIN 025R
BEFORE (A) AND AFTER (B) TREATMENT W ITH
HYALURONIDASE.
t
&
s
(A) UNTREATED (Mag. x 500)
*
(B) TREATED (Mag. x 500)
These observations suggest that the capsule of the SMG 
has antiphagocytic properties.
6.3.4 COMPARISON BETWEEN INDUCTION OF CHEMILUMINESCENCE 
AND RADIOMETRIC INGESTION ASSAYS
Table 6,3 shows chemiluminescence and mean % ingestion 
values for test strains. There was an association 
between the characterisation of phagocytosis as low, 
medium or high, as found by chemiluminescence and 
radiometric assay, in 8/20 strains. As both tests 
measure similar properties it would be expected that a 
high chemiluminescence would subsequently give a high % 
ingestion. However, these tests were often carried out 
on different days with different PMNL donors, and so 
variation may have occured due to high and low activity 
of individual PMNL.
6.3.5 EFFECT OF HYDROPHOBICITY ON SUSCEPTIBILITY TO 
INGESTION BY PMNL
Table 6.3 also shows the relationship between % ingestion 
and bacterial cell surface hydrophobicity. As was stated 
in the previous chapter a hydrophobic nature tends to 
render a bacterium more prone to phagocytic ingestion 
than those with a hydrophilic cell surface. Of four 
hydrophobic strains 3 were moderately to well ingested,
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TABLE 6.3 RELATIONSHIP BETWEEN INGESTION,
CHEMILUMINESCENCE AND HYDROPHOBICITY
STRAIN ; CHEMILUM. % INGESTION HYDROPHOBICITY
008 50.7 (HIGH) 18.16 (MED.) HYDROPHOBIC (M)
009 55.2 (MED.) 19.6 (MED.) HYDROPHILIC (V)
016 139 (HIGH) 43.7 (HIGH) HYDROPHOBIC (M)
025R 65.6 (MED.) 38.9 (HIGH) HYDROPHOBIC (M)
0256 123 (HIGH) 9.9 (LOW) HYDROPHILIC (V)_
041 49.2 (LOW) 20.32 (MED.) N.T.
046 11.2 (LOW) 14.52 (LOW) HYDROPHOBIC (M)
COl 236 (HIGH) 37.7 (HIGH) HYDROPHILIC (M)
C02 43,2 (LOW) 19.6 (MED.) HYDROPHILIC (M)
C06 44.6 (LOW) 24.4 (MED.) HYDROPHILIC (V)
C08 34.5 (LOW) 5.7 (LOW) HYDROPHILIC (V)
CIO 5.9 (LOW) 36.8 (HIGH) HYDROPHILIC (V)
CIS 39.1 (LOW) 26 (MED.) HYDROPHOBIC (M)
POl 6.7 (LOW) 16.41 (MED.) HYDROPHILIC (M)
P02 62.4 (MED.) 11.1 (LOW) HYDROPHILIC (V)
P04 66.8 (MED.) 28.42 (MED.) HYDROPHILIC (V)
PCS 12.1 (LOW) 48.26 (HIGH) HYDROPHILIC (M)
Pll 7.7 (LOW) 42.94 (HIGH) HYDROPHILIC (M)
P13 36 (LOW) 37.02 (HIGH) HYDROPHILIC (V)
NCTC11325 105.1 (HIGH) 43.36 (HIGH) HYDROPHILIC (M)
Chemiluminescence : 0 - 50 (low) 51 ~ 100 (medium)
101 upwards (high).
% Ingestion : 0 - 15% (low) 16 - 30% (medium)
31% upwards (high).
Hydrophobicity as determined by Hydrophobic interaction 
chromatography and categorised as Indicated in Table 3.6. 
N.T. indicates not tested.
while hydrophilic strains showed varying levels of 
ingestion (2/8 high, 3/8 medium and 3/8 low). These 
results were the same as reported in the previous 
chapter, namely that no correlation could be found 
between cell surface hydrophobicity and susceptibility to 
ingestion.
6.4 DISCUSSION
6.4.1 ANTIPHAGOCYTIC EFFECT OF CAPSULAR MATERIAL
The antiphagocytic effect of the hyaluronic acid capsule 
of the SMG was illustrated in two ways. First, there was 
a significant difference between ingestion by PMNL of 
well” and poorly-encapsulat^ strains. Secondly, removal 
of capsule by treatment with hyaluronidase caused 
increased ingestion in all cases. This was in contrast 
to the findings of Lewis et al (1993b) who found that 
ingestion of capsulate and non-capsulate SMG organisms 
did not differ. However, the method employed in the 
study of Lewis et al (1993b) involved microscopical 
counting of the number of ingested organisms in 100 PMNL, 
while the one used in this study measured ingestion of 
radiolabelled bacteria by all PMNL present in the assay, 
which may account for the difference in findings. Also 
no attempt was made by the previous investigators to 
remove capsule and assess the effect of this structure on 
ingestion of capsulate SMG. The use here of
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hyaluronidase to remove capsule of the SMG follows the 
basic methods of a number of investigators examining the 
effects of capsule of Group A and C streptococci. They 
similarly found that treatment with hyaluronidase removed 
capsular material and gave a resultant increase in
phagocytic ingestion (Kass and Seastone 1943). These 
findings led to much more detailed investigation of these 
organisms, arriving at a point today where the capsule 
and surface structures of Group A and C streptococci are 
well documented (Ofek and Doyle 1994). It is hoped that 
the initial work reported in this thesis will prompt the 
same investigation of the SMG.
Removal of capsule did not significantly affect the 
results of the chemiluminescence experiments reported in 
Chapter 5. This may have been due to a number of
factors. First, as suggested in Chapter 5,
chemiluminescence may be triggered by both organisms 
adherent to the phagocytic cell as well as those
ingested, whereas the assay used here measures only
ingestion. Secondly, as was determined in Chapter 3, 
treatment with hyaluronidase for 20 minutes still left 
some organisms with capsular material present. With the 
increase in treatment time to 30 minutes it is possible 
that more capsule was removed and this was reflected in 
the results. Finally, it may simply be due to the number 
of replicates performed in each assay. Any trend towards 
antiphagocytic effect of capsule may not have proved
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statistically significant with only three replicates in 
the chemiluminescence assay, but was definitely 
significant when observed in five runs of radiometric 
uptake.
Using knowledge gained from the study of other 
encapsulated organisms, a role of the capsule in SMG 
resistance to phagocytosis can be suggested. First, 
polysaccharide capsules have a high negative charge and 
are hydrophilic (Van Oss & Gillman 1972). These factors 
are involved in the physico-chemical aspects of non­
specific interaction between cells as detailed in Chapter 
3, where repulsion between like surfaces occurs. This 
would make it difficult for the first stage of 
phagocytosis, recognition, to occur, since close contact 
would be inhibited. However, in the presence of opsonins 
these effects will be over-ridden and specific adhesin- 
receptor interactions will occur between the bacterium 
and phagocyte. Also, with regard to recognition, the 
capsule may provide a protective coating, masking surface 
structures of the cell, thus preventing the PMNL from 
attaching to receptors on the bacterial cell wall (Fox 
1974). Whitnack, Bisno and Beachey (1981) found that the 
hyaluronate capsule of Group A streptococci prevented 
attachment of the organism to macrophages, and treatment 
with hyaluronidase to remove the capsule increased 
adherence. As mentioned in Chapter 5, s,aureus capsule 
shields C3b molecules, deposited on the cell surface
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during opsonization, from receptors on the PMNL surface 
(Verbrugh et al 1982). Similarly the hyaluronate capsule 
of Group A streptococci can mask bound C3b on the 
organism, preventing interaction with the phagocyte 
receptors (Dale et al 1996). Therefore SMG capsule may 
contribute to pathogenicity either with or without 
opsonization by masking the surface of the organism, with 
capsule removal resulting in better interaction between 
phagocyte and bacterium.
It has been suggested by a number of investigators 
(Peterson et al 1978, Edwards et al 1980, Pluschke et al 
1983) that the antiphagocytic properties of bacterial 
capsule revolve around interference with the opsonization 
process, especially that of deposition of complement on 
the bacterial surface. Encapsulated organisms can 
interfere with opsonization via the classical and 
alternative pathways of complement activation. The 
activation of complement by both pathways is illustrated 
in Figure 6.6. The classical pathway is activated by 
immune complexes, with Clq binding to complexes which 
activates Clr and Cls, resulting in formation of active 
Cl. This cleaves C4 and C2 giving two proteins, C4b and 
C2a, which combine to form the classic pathway convertase 
C4b2a, which converts C3 to C3b. There is a steady 
turnover of C3 to C3fo via the alternative pathway 
independent of immune complex. However, this is of a low 
frequency and does not allow for sufficient deposition of
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FIGURE 6.6 SCHEMATIC REPRESENTATION OF COMPLEMENT
ACTIVATION VIA THE ALTERNATIVE AND CLASSICAL 
PATHWAYS
CLASSICAL ALTERNATIVE
Cls'
C3bBbP
C3bBb
C3b
C4 C2 C3
C4b C2a
C3bB
C4b2a
C3b on the surface of the bacterium to permit effective 
opsonization. Amplification of this conversion takes 
place in serum by means of a feedback loop which, due to 
deposition of small amounts of C3b on the bacterial 
surface, causes more factors B, D and P to be recruited, 
resulting in formation of the alternative pathway 
convertase C3bBbP, thereby amplifying conversion. 
However another two serum proteins, H and I, compete with 
factors B and D for C3b deposited on particle surfaces 
and therefore can inhibit opsonization.
Kasper (1986) has suggested that capsular material 
affords resistance to phagocytosis by interfering with 
the deposition of complement on the bacterial cell 
surface. Organisms without capsule are able to activate 
the complement cascade independently of antibody, 
resulting in direct deposition of C3 which is then 
converted to C3b on the cell surface. Encapsulated 
organisms, however, are resistant to this direct 
complement activation mechanism and require immune 
complex formation on their surfaces to activate 
complement. This results in the encapsulated organism 
having insufficient C3b deposited on its surface, and 
therefore it is more difficult for the PMNL to adhere.
Capsular polysaccharide can activate the amplification 
loop in two ways, Edwards et al (1980) showed that 
sialic acid contained in the capsular polysaccharide of
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type III Group B streptococci has a high affinity for 
factor H. This interaction between the two results in 
formation of H-C3b complexes, rather than C3bBbP, 
blocking the amplification loop and giving resistance to 
opsono-phagocytosis in the absence of antibody. In the 
presence of antibody the classical pathway would be 
employed and over-ride the blocking mechanism. Brown et 
al (1983) illustrated a similar mechanism in type 7 and 
12 pneumococcal capsules. These had decreased affinity 
for factor B compared to cell wall, which has a similar 
effect as increased affinity for factor H or I, that is, 
formation of an H-C3b complex which inactivates the 
amplification loop.
Kasper (1986) also suggested that bacterial capsular 
polysaccharides mimic oligosaccharides found on 
glycoproteins throughout the body in order to avoid 
opsonization. As the complement system has a protective 
mechanism to prevent activating itself against the body's 
carbohydrates, encapsulated organisms exhibiting these 
can escape opsonization, being unrecognised as foreign.
Like the SMG, Bacteroldes fragilis Strains have been found to 
cause abscesses in mice when encapsulated organisms were 
used as the inoculum, but not with unencapsulated strains 
(Onderdonk et al 1977). Simon et al (1982) found that an 
increase in the size of capsule of Bacteroides fragilis gave 
increased resistance to phagocytosis and opsonophagocytic
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killing by neutrophils. Therefore, the capsule of 
Bacteroides species has antiphagocytic properties similar 
to the SMG, allowing the organism to persist in the host 
and cause abscesses. It has been suggested that 
Bacteroides species may provide protection against 
phagocytosis for other organisms present in polymicrobial 
infections. This and other possible protective
mechanisms operating within mixed infections will be 
discussed in the following section.
6.4,2 ASSOCIATION OF SPECIES AND SOURCE OF ISOLATE WITH 
RESISTANCE TO PHAGOCYTOSIS
There were no significant differences in the relative 
efficacy of phagocytic ingestion of the three species of 
SMG or in relation to the site of their isolation. 
Therefore the enhanced ability of certain species to 
cause specific diseases is due presumably to factors 
other than antiphagocytic properties.
As organisms of the SMG can foe both the only isolate from 
an infection (Kambal 1987) or one of a number of species 
present (Van der Auwera 1985), it is likely that the 
overall ability of the group to cause disease involves a 
combination of virulence factors of the SMG and 
interaction with other species of the polymicrobial 
infection. Toyoda, Kusano and Saito (1995) found that 
s.constellatus produced lactic and acetic acids, but these
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did not diminish phagocytic killing as they have been 
shown to do in other organisms (see this section). 
However, they did detect reduced phagocytic killing of a 
virulent strain of s. consteiiatus compared to an avirulent 
strain, suggesting it was mediated by a structural 
component of the organism. They suggested that this 
delayed bacterial clearance may be a virulence factor and 
may explain why the SMG can be the sole organism 
isolated.
The SMG are often found in mixed infections, especially 
with anaerobes, where a synergistic relationship has been 
suggested. Anaerobes may contribute to a polymicrobial 
infection in a number of ways : 1. by impairing host
defences, 2. by providing nutrients for other species, 3. 
by altering the environment which then promotes survival 
of other species and 4. by transferring virulence factors 
between organisms, with several of these occurring at 
initial phases of infection (Rotstein, Pruett and Simmons 
1985).
Bacteroides species have been extensively studied as a 
group of anaerobes which may produce these effects in 
mixed infections. They compete with aerobes for 
opsonins, thereby interfering with the phagocytic process 
( Ingham et al 1981 ). Incubation of Bacteroides species 
with serum depletes both heat-stable and heat-labile 
opsonins which results in insufficient opsonization of
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aerobes (Wade, Kasper and Mandell 1983). The location of 
the components responsible for this is subject to 
conflicting reports, with Ingham et al (1981) suggesting 
the intact cell, Connolly et al (1984) the capsule, Wade 
et al (1983) the whole cell but not the capsule and 
Jones and Gemme11 (1986) lipopolysaccharide. Bacteroides 
culture supernatants have also been shown to inhibit 
neutrophil migration, generation of chemiluminescence and 
killing by phagocytes (Namavar et al 1983). This was 
shown to be due to production of short chain fatty acids 
(SCFAs), especially succinic acid. Rotstein et al (1989) 
found the culture filtrate of b . fragilis 9032 to inhibit 
neutrophil migration and phagocytic killing of s.coii,  
while Eftimiadi et al (1990) found SCFAs to inhibit 
phagocytosis of s. aureus > The mechanism of activity is 
suggested to be that SCFAs cross the plasma membrane of 
the neutrophil, lowering the intracellular pH, resulting 
in impaired neutrophil function (Rotstein et al 1987). 
Indeed Finlay-Jones et al (1991) found that abscess- 
derived neutrophils had impaired killing mechanisms 
against E.coii and p.mirabilis. Therefore, in these 
infections there appears to be a synergistic effect 
between aerobes and anaerobes which could contribute to 
the pathogenicity of the SMG. This indeed was reported 
by Shinzato and Salto (1994) who found that s. consteiiatus 
multiplied at a greater rate in culture mixed with 
p. intermedia (formerly bacteroides) or its culture filtrate
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than when cultured alone in broth. Furthermore, the 
culture filtrate of p . i n t e r m e d i a  inhibited the bactericidal 
activity of neutrophils. Therefore, within an abscess 
the SMG may be protected at the initial stages of 
infection by their antiphagocytic capsule until the 
stationary phase is reached, when production of high 
concentrations of SCFAs by anaerobes lowers the pH and 
inhibits phagocytic function.
6.4.3 EFFECT OF BACTERIAL HYDROPHOBICITY ON 
SUSCEPTIBILITY TO INGESTION BY PMNL
As was found previously using the chemiluminescence 
assay, cell surface hydrophobicity had no effect on the 
percentage of ingested bacteria. The more hydrophobic a 
cell surface the more it absorbs IgG, which therefore 
results in increased phagocytic ingestion. In turn, 
opsonization with IgG increases cell surface 
hydrophobicity and therefore increases phagocytosis- 
However, complement is the major opsonin when whole serum 
is used and this effect will be minimal. It is likely 
that cell surface hydrophobicity does not play a large 
role in the adherence between bacterium and polymorph 
when opsonization has taken place. This involves 
specific adhesin-receptor interactions which override any 
physico-chemical attractive/repulsive forces operating. 
Therefore, factors which can either enhance or inhibit 
complement deposition as described in section 6.4.1 are
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likely to be more significant in affecting phagocytic 
ingestion.
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CHAPTER 7 FINAL DISCUSSION AND CONCLUSIONS 
7.x INTRODUCTION
As was stated at the beginning of this thesis, the 
virulence factors of the SMG contributing to their 
pathogenicity had been little studied, and the aim of 
this work was to examine some of the factors which may 
explain their ability to cause purulent infections. This 
chapter will review the findings of this thesis and 
suggest possible further work.
7.2 ISOLATION, IDENTIFICATION AND CHARACTERISATION
A group of strains were isolated from dental abscesses, 
non-oral clinical infections and dental plaque. These 
were identified as one of the three species s.anginosus,
s. consteiiatus or s.Intermedins using both the fluorogenic 
scheme of Whiley et al (1990) and the commercially 
available Rapid ID 32 Strep system (API Laboratory 
Products). Both systems were used as single tests, but 
occasionally provided doubtful identification and 
combination of the two provided further characterisation. 
s. intermedius was found to be the most common isolate from 
plaque, with s.anginosus and S.constellatus at similar levels 
in abscess and clinical isolates. Insufficient numbers 
were studied in these cases to concur with Whiley et al 
(1992), who found s.constellatus to be most common of dental
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abscess isolates. Lancefield groups A, C and F were 
found, with group F most numerous where a grouping was 
found, but with non-groupable strains predominating. 
This was in agreement with a number of investigators, who 
also found Lancefield group G amongst test strains, but 
again insufficient total numbers may account for its 
absence here. Hyaluronldase activity was found in 
s. consteiiatus and S. Intermedius Strains at titres ranging 
from 1/2 to 1/128. One strain of s.anglnosus showed 
hyaluronidase activity, which contradicts the findings of 
other investigators who found it confined to the other 
two species, and who have used this as an identification 
factor (Homer et al 1993). Streptolysin O and S activity 
was also found in a range of isolates at titres from Vz to 
1/64. DNAse activity was found in 71% of abscess 
isolates, 60% of clinical isolates and 38% of plaque 
isolates. Collectively these activities and others not 
screened for by others, such as possession of chondroitin 
sulphate depolymerase, may contribute to the 
pathogenicity of the SMG. It can therefore be seen that 
the SMG represent a heterogenous group exhibiting a wide 
range of toxin and enzyme activities, although some could 
be attributed to either the source of the isolate or the 
species.
7.3 SURFACE PROPERTIES OF THE SMG
As one of the first areas of interaction between the host
1 5 6
and invading organism, the surface of the SMG was 
examined, India ink staining of capsule revealed strains 
had two possible thicknesses of capsule, + or +(s), with 
one strain having no capsule at all. Plaque and clinical 
isolates had smaller capsules, with abscess isolates 
having larger ones. Electron microscopy also revealed + 
type capsule, which was a thick, densely stained mass, 
while +(s) capsule appeared wispier and less heavily 
stained. Treatment with hyaluronidase removed capsule to 
varying extents, and indicated a hyaluronic acid 
component. Strains showed hydrophobic and hydrophilic 
surface characteristics, demonstrated using two test 
systems which correlated well with each other. There was 
no correlation between possession of capsule and cell 
surface hydrophobicxty.
7.4 ADHERENCE OF THE SMG TO BEG
Dental abscess isolates were found to adhere to EEC to a 
greater extent than both clinical and plaque isolates, in 
agreement with the findings of Willcox and Knox (1990). 
Capsule hindered adherence of test strains to EEC, and 
treatment with hyaluronidase to remove capsule resulted 
in correspondingly increased adherence. It was suggested 
that the capsule masked specific adhesins on the SMG 
surface which allowed adherence to EEC. Most poorly 
adherent strains were hydrophilic, but strongly adherent 
strains showed both hydrophilic and hydrophobic
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characteristics, therefore no significance could be 
attributed to cell surface hydrophobicity in adherence of 
the SMG.
7.5 OPSONIC REQUIREMENTS OF THE SMG AND 
CHEMILUMJNESCENCE OF PMNL
Opsonization with normal human pooled serum was found to 
increase chemiluminescence, with serum concentrations of 
15% - 20% or over proving optimum. Neither capsule or 
cell surface hydrophobicity had any effect on 
chemi luminescence, No significance could be attributed 
to either species or isolate type in the ability to 
elicit a chemiluminescent response,
7.6 PHAGOCYTIC INGESTION OF THE SMG
The capsule of the SMG was found to be antiphagocytic, 
and strains with small capsules were more readily 
ingested than those with large capsules. Removal of 
capsule increased the ingestion of most strains. Cell 
surface hydrophobicity had no effect on ingestion, and no 
significance could be placed on species or isolate type 
and ingestion.
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7.7 CONCLUSIONS
At the beginning of this work the aim was to investigate 
some of the virulence factors of the SMG which helped 
them to cause pyogenic disease. The group of organisms 
was found to be highly heterogeneous, with strains 
possessing a variety of toxin and enzyme activities and 
various cell surface characteristics. As had been 
suggested by previous investigators (Brook and Walker 
1985; Lewis et al 1988), capsule was found to contribute 
to the pathogenicity of the SMG. First, it had a 
negative effect by inhibiting the adherence of strains to 
BEC and secondly, the positive effect of resistance to 
phagocytosis. Other virulence factors of SMG strains 
found by other investigators include the ability of 
Lancefield Group C SMG to bind albumin which may be 
related to their ability to aggregate human platelets 
(Willcox et al 1994). Willcox et al (1990) also found 
that isolates from clinical infections bound fibronectin 
to a greater extent than other strains, which may aid 
pathogenicity. Homer et al (1994) suggested that the 
ability of s. intermedius strains to produce 
glycosaminoglycan-depolymerising activity may help to 
explain its association with deep-seated abscess 
formation, especially in the brain, Lima et al (1992) 
also found s. intermedius to produce an immunosuppressive 
protein which may aid survival in the host.
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Therefore, although the SMG can be a part of the normal 
flora and cause no harm to the host there are specific 
factors attributable to either specific species or 
isolate types which can be considered as virulence 
factors. However, these are unlikely to fully explain 
the ability of the SMG to cause abscesses and 
endocarditis amongst other infections, and the effect of 
other organisms present in these infections must be 
considered. The findings of this work have only 
discovered a small section of the overall pathogenicity 
factors of the SMG and much further work is needed to 
gain a full understanding of this clinically significant 
group.
7.8 FURTHER WORK
The preliminary findings of the experiments performed in 
this investigation have raised a number of questions to 
be addressed in further work. First, do the
pathogenicity factors demonstrated in vitro, such as 
hyaluronidase and haemolysin activity and capsule, elicit 
an immune response in vivo- This may be investigated by 
collecting blood and pus samples from patients with SMG 
infections such as dental abscesses. The organism can 
then be isolated, cultured to elaborate various 
exoenzymes and the serum used in immunoblotting in order 
to determine if antibodies have been produced against 
these factors.
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Secondly, the capsule of the SMG has been confirmed as 
having a role in pathogenicity, and it is therefore 
important to understand the structure of the capsule. 
Hyaluronic acid was shown to be a component, due to 
digestion with hyaluronidase, but it is not known whether 
there are other elements. Also useful in further 
defining the role of capsule would be the creation of a 
capsule-free mutant strain. Wessels et al (1991) 
confirmed a hyaluronic acid capsule as a virulence factor 
for mucoid group A streptococci by deriving an acapsular 
mutant through transposon mutagenesis. This showed that 
the acapsular strain was sensitive to phagocytic killing 
and had 100-fold reduction in virulence in mice. The 
same method could be employed to confirm its role in the 
SMG.
Thirdly, further investigation of the phagocytosis of the 
SMG would be valuable. In addition to resistance to 
ingestion, organisms can resist intracellular killing, 
persisting within the phagocyte, thus helping the 
organism to cause disease. This can be measured using a 
killing assay, where after incubation of the 
bacteria/PMNL mixture a sample is added to distilled 
water to lyse the PMNL, 10 fold dilutions are made and 
plated out and counts taken, after which a killing index 
can be calculated (Rotstein et al 1985), This method has 
been used to study the SMG. Shinzato and Saito(1994) 
found a culture filtrate of Prevoteiia intermedia inhibited
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phagocytic killing of a strain of s , consteiiatus, while 
Toyoda et al (1995) found a culture filtrate of 
s. consteiiatus from a pulmonary infection inhibited 
phagocytic killing. Both these studies were performed on 
a few strains of s. consteiiatus, and it would be interesting 
to perform similar investigation on the range of isolates 
collected for this work. This would enable the 
determination of relevance of species or isolate. 
Another area concerning phagocytosis of the SMG which 
could be investigated is that of the activity of abscess- 
derived neutrophils. Finlay-Jones at al (1991) suggested 
that these neutrophils have depleted intracellular 
killing mechanisms, thus allowing bacteria such as 
B.fragiiis and P.mirabilis to persist in abscesses whilst 
surrounded by neutrophils. This may also be the case for 
SMG strains and experiments may be carried out with 
abscess derived neutrophils and compared with those 
results found here with normal human PMNL,
Another area of investigation by other researchers which 
would be interesting to carry out on the collection of 
strains in this work is the ability of the SMG to utilise 
sialic acid (Byers et al 1996) and chondroitin sulphate 
(Shain et al 1996a). Both groups suggest ability of the 
SMG to utilise these substrates allows them to persist at 
an otherwise nutritionally compromised site of infection, 
Shain et al (1996b) purified a novel glycosaminoglycan 
depolymerase frcan s.intermedius UNS 35 which showed activity
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of a hyaluronidase rather than a chondroitin sulphate 
depolymerase as originally thought. Screening of the 
strain collection in this work would prove interesting in 
comparison, but may also clear up the anomaly of the 
S.anginosus Strain detailed in section 2.4.6 which appeared 
to possess the ability to degrade hyaluronic acid, 
despite this property being unreported in the species. 
It may be producing this novel substance.
Finally, all these observations have been factors of the 
SMG themselves, which are inportant as they have been the 
sole organism isolated from infections, but equally 
important is the interaction of the group with other 
organisms in mixed infection. Whether it is production 
by the SMG of substances which promote their survival 
(Toyoda et al 1995) or substances produced by other 
organisms aiding the growth and survival of the SMG 
(Shinzato and Salto 1994), it is clear that the mixed 
infection is a complex ecosystem which requires further 
work to understand the role of the SMG .
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APPENDICES
Appendix i Solutions and Growth Media
Saline (Oxoid) : 0.85% saline (normal saline) was
prepared by adding 1 tablet to 500 ml 
of distilled water and autoclaving at 
121°C for 15 minutes.
PBS (Oxoid) : 1 phosphate buffered saline tablet per 
100 ml of distilled water. Autoclaved 
at 121°C/15 min.
Gel Hanks : 10 ml of X 10 Hanks Balanced Salts 
solution (Flow lab.) + 10 ml of 1% 
gelatine + 80 ml sterile distilled 
water. 100-200 ul 0.1 M NaOH to 
adjust pH to 7.1.
Luminol (Sigma) : 1.77 mg of luminol ( 5-Amino-2,3"
dihydro-1,4 phthalazinedione) 
dissolved in 1 ml of Dimethyl 
sulphoxide to give a concentration of 
10 Working solution diluted to 10
M with PBS.
Po1ymo rphprep 
(Nycomed)
: Sodium metrizoate 13.8% w/v + Dextran 
500 8.0% w/v. Density 1.113 g/ml 
Osmolality 460 mOsm.
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8 “ H^ Adenine 
(Amersham)
Radioactive concentration 37.0 MBq/ml 
1.0 mCi/ml,
Seven Salts 
Solution
NaCl 23.48 g/1
Na^SO^ 1.96 g/1
NaHCO] 0 . 1  g/ 1
KCl 0.33 g/1
MgCl. 2.49 g/1
CaCl, 0.55 g/1
H3BO3 0 . 0 1  g/ 1
Peptone mixture
BROTH Yeast Extract
Sodium Chloride 
Agar no 1 
L-Cystein HCl 
Resazurin
Sodium Bicarbonate
Haemin
Vitamin K
15.0
10.0
Sodium Thioglycollate 0.5
2.5
0.75
0.5
g / 1
g/ 1
g/ 1
g/ 1
g/ 1  
g/ 1
0 . 0 0 1  g/ 1
0.4 g/1
0.005 g/1
0.0005 g / 1
BHI Broth 
(Oxoid)
37 g/1 Autoclaved 121^C / 15 minutes 
Calf brain infusion solids 12.5g 
Beef heart infusion solids 5.0g 
Proteose peptone 10.Og
Sodium chloride 5.0g
Dextrose 2.0g
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Disodium phosphate 2.5g
Mueller Hinton 
Broth (Oxoid)
: 21 g/1 Autoclaved 121°C / 15 minutes 
Beef, dehydrated infusion 300g 
Casein hydrolysate 17. 5g
Starch 1. 5g
Blood Agar Colombia agar (Gibco)
5% vol/vol defibrinated horse blood
Appendix i l  Electron Microscopy Solutions
Solution A M sodium cacodylate 20 ml
Distilled water 70 ml
Adjust to pH 7,4 
Distilled water to 100 ml
Solution B 25 % glutaraldehyde 2.4 ml
Distilled water 14.2 ml
Solution C Ruthenium red 
Distilled water
0.15 g 
1 0 0  ml
Solution D : 4% Osmium tetroxide
Primary fixative : Soln. A
Soln, B 
Soln. C
10 ml (0.07M) 
1 0  ml (1 .2 %)
10 ml (0.075%)
Buffer wash : Equal parts of Soln, A + C
Post fixative (Prepared just before use)
: Soln. A 1 ml
Soln. B 1 ml
Soln. C 1 ml
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Appendix ill Media, Chemical and Equipment Suppliers
Amersham Buckinghamshire, England.
API Laboratory Hampshire, England.
Products
Bio Orbit Turku, Finland
Clinicon Life Sciences UK Ltd., Basingstoke,
England.
Detroit, Michigan.
Leicestershire, England.
East Kilbride, Scotland,
New York, USA.
Gomshal1, Surrey.
Dif CO
Fisons
Gallenkamp
Heat Systems
Mickle
Engineering
Miles
Scientific
National
Diagnostics
Nucleopore
Nycomed
Oxoid
Pharmacia
Sigma
Tech Gen
Technical
Ames Division, Indianna, USA.
Atlanta, Georgia, USA.
Chicago, USA.
Birmingham, England. 
Basingstoke, England.
Uppsala, Sweden.
Poole, Dorset, England. 
London, England.
Bury, England.
Service Consulatants
Titertek
Wallac
Weber
Scientific
Wellcome
Flow Laboratories Ltd., Irvine, Scotland 
Turku, Finland.
Sussex, England.
Dartford, England.
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